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Abstract 
Small molecules that bind selectively to a DNA sequence in the human genome are 
potentially useful tools for molecular biology and human medicine. Polyamides containing 
N-methylimidazole (1m) and N-methylpyrrole (Py) are small molecules that bind DNA 
according to a set of "pairing rules" with affinities and specificities that rival natural 
transcription factors. By directly competing with a given transcription factor or other DNA 
binding protein for its binding site, polyamide can cause inhibition of diverse biological 
processes, such as retroviral integration and gene transcription. Polyamides are presented 
which inhibit the in vitro integration activities for two retroviruses, M-MuLV and HIV-l. 
Polyamides are described that inhibit TBP binding to the HER2 promoter, a gene implicated 
in human breast cancer. Failure to achieve inhibition of HER2 transcription in cell culture 
led to the surprising discovery that polyamide-fluorescent dye conjugates are cell-
permeable, but that nuclear localization does not occur in many cell lines. Efforts toward 
modified polyamides with enhanced nuclear localization properties are presented. In order 
to extend the number of sequences amenable to high affinity recognition, alteration of the C-
terminal polyamide tail has been investigated. The development of conditions for polyamide 
solid-phase synthesis on a new resin, which allows for the generation of "truncated tail" 
polyamides, is presented. During the original route to one of these compounds, an 
unexpected reaction was uncovered that leads to entirely different C-terminal tails. 
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Background 
DNA is the storehouse of genetic information, containing all the information 
required for the growth and development of every organism. I DNA is composed of 
deoxyribose-phosphate polymers that display four heterocycles bases, adenine (A), 
thymidine (T), guanine (G), and cytosine (C). DNA is self-organized as a double-helical 
duplex of antiparallel strands, which are held together by Watson-Crick hydrogen 
bonding of A,T and G,C base pairs.2 The recent sequencing of the human genome refers 
to deciphering the linear order of billions of these base pairs which code for 30,000-
40,000 genesY Understanding the complex interrelationships between these genes and 
their protein products is the central question in molecular biology and human medicine. 
Aberrant regulation of gene expression, though mutations or the intervention of 
pathogens, is responsible for a variety of disease states.5 Synthetic ligands which can 
affect gene expression by binding to specific predetermined DNA sequences will be 
powerful tools for our growing understanding of the human genome, and potentially will 
be valuable therapeutic resources.6 
Figure 1.1 
Figure 1.1. CPK model (left) and ribbon representation (right) of B-form duplex DNA. The sugar 
phosphate backbone is shown in either blue or red. The base pairs are in yellow. 
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Figure 1.2 
Major Groove 
,H 
'\.--Ito' .. 'H-N N 
f( :N-H"" 'N~l N~ ~N R 
A 00 \) 
() 
Minor Groove 
G~C C~G Akr-e-elT T~A 
Figure 1.2. The edges of the base pairs present different hydrogen bond donor and acceptor combinations 
to the major and minor grooves in the DNA double helix. The top of the bases, as drawn projects into the 
major groove and the bottom projects into the minor groove. Below the base pairs, the minoT groove is 
shown in schematic representation, where circles with dots represent lone pairs of N(3) of purines (A,G) 
and 0(2) of pyrimidines (C,T), and circles containing an H represent the 2-amino group of G. 
DNA Recognition 
The common B-form of DNA is characterized by a wide (12 A) and shallow 
major groove and a narrow (4-6 A) and deep minor groove (Figure 1.1).7 In addition, 
sequence-dependent structural variations, conformational properties, and solvent and 
counterion organization can distinguish local DNA structures.7 Individual sequences are 
distinguished by the pattern of hydrogen bond donors and acceptors present at the edges 
of the base pairs (Figure 1.2). Proteins which recognize DNA take advantage of specific 
hydrogen bonding or van der Waals contacts with functional groups in the grooves, 
Coulombic attraction to the negatively charged phosphodiester backbone or to the 
Figure 1.3 
GCN4 TBP Zif268 
Figure 1.3. Representative X-ray crystal structures of DNA binding proteins.8-10 Proteins contact the DNA 
via interactions with the bases in the major (GCN4, Zif268) and/or minor groove (TBP), as well as the 
sugar phosphate backbone. Some, such as TBP, cause a large distortion from common B-form DNA. 
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electrostatic potential in the grooves, and/or intercalation of aromatic functional groups 
between the DNA bases.8 DNA binding proteins adopt a variety of structural motifs for 
sequence-specific recognition including zinc finger9 and leucine zipper!! motifs (Figure 
1.3). Specificity for target sites is achieved through specific noncovalent interactions 
between the protein side chains and the nucleobases and phosphates of the DNA. 
However, no single motif exists that represents a general amino acid-base pair code for 
all DNA sequences.!2 Recognition by some proteins, such as the ubiquitous transcription 
factor TBP,1O involves large distortions of the target DNA from its common B-form 
structure, including bending and unwinding of the helix. 
Figure 1.4 
C~O=;~UN '" 
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Figure 1.4. Structures of four natural products and a synthetic compound (Hoechst 33258) which bind in 
the minor groove of DNA. Note the similar crescent shape of distamycin, CC-1065 and Hoechst 33258. 
Many small molecule natural products also recognize DNA, with varying degrees 
of sequence specificity by diverse binding modes including groove binding and 
intercalation.!3.!5 The minor groove is a particular rich environment for recognition by 
small molecules (Figure 1.4).16,!7 Many of these compounds, such as the calicheamicin 
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0Iiogsaaccharide,18, 19 CC_1065,2o,21 and Hoeschst 33258,22,23 possess modular structures 
that have allowed chemists to synthesize numerous derivatives in order to understand and 
modify their sequence specificity and binding affinity . Distamycin,24 which binds five 
base pair A,T rich sequences, is particularly well suited to modification, owing to its 
relatively simple structure composed of N-methylpyrrole carboxamides.22,25.28 
Pyllm targets C· G 
PylHp targets A·T 
Hp/Py targets T· A 
Im/Py targets G· C 
Figure 1.5. A schematic representation of the polyamide pairing rules. 
DNA Recognition by Polyamides 
A twenty year research effort in the laboratories of Prof. Peter B. Dervan have led 
to the development of a class of minor-groove binding small molecules which can 
recognize a large number of predetermined DNA sequences with affinities that rival 
natural transcription factors. 6,29,3o DNA binding polyamides contain N-methylpyrrole (Py) 
carboxamides, the structural repeat of distamycin, as well as N-methylimidazole (1m) and 
N-methyl-3-hydroxypyrrole (Hp) carboxamides. DNA recognition depends on side-by-
6 
side amino acid pairings in the minor groove that stack the aromatic rings against each 
other and the walls of the groove allowing backbone amide hydrogens and the 
substituents at the 3-position of the Py, 1m, and Hp residues to make specific contacts 
with the edges of the DNA base pairs. Each pair of polyamide residues is selective for a 
specific DNA base pair based on steric factors and the matching of hydrogen bond donor 
and acceptor functionalities (Figure 1.5). A pairing of 1m opposite Py (lmJPy) targets a 
Goe base pair, while Py/lm targets CoG. A PylPy pairing is degenerate, targeting both 
AoT and ToA base pairs. An Hp opposite a Py (Hp/Py) discriminates ToA from AoT, 
while Py/Hp targets AoT in preference to ToA and both of these from Goe and CoG. 
Footprinting, NMR, and X-ray structure studies validate these pairing rules for DNA 
minor groove recognition (Figure 1.6).29.31 
Figure 1.6 
Figure 1.6. Space filling representation of the polyamide dimer ImHpPyPy-~-Dp bound in the minor 
groove of DNA derived from a high-resolution X-ray co-crystal structure.3l 
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While many different recognition motifs based on pyrrole-imidazole polyamides 
are possible, the design known as the hairpin (Figure 1.5) has been widely used for 
biological applications.32 The N- and C-terminal strands of Pyllm aromatic amino acids 
are connected by an alkyl amino acid--either y-aminobutyric acid (y), or the chiral, 
amine-functionalized derivative (R)-2,4,-diaminobutyric acid «R)H2Ny) __ in an antiparallel 
orientation relative to each other and, generally, a 5'-3' N-C orientation relative to DNA. 
The linker between Py/Im strands is considered the "tum" of the hairpin, and alkyl units 
f3-alanine (13) and N,N-dimethylaminopropylamine (Dp) are typically used to form a C-
terminal "tail." All of these alkyl units are specific for both A,T base pairs. f3-alanine 
(13) can also be used internally to form 13/13, f3/Py, and f3lIm pairs, which has extended the 
binding site size amenable to recognition by the hairpin polyamides and in certain cases 
results in increased affinity and specificity.33 Tandem hairpin dimers have been produced 
which bind with high affinity and specificity.34.35 The hairpin motif is also a versatile 
scaffold for the production of conjugates with diverse functions including sequence-
specific DNA-alkylation36.37 and recruitment of Topoisomerase e s 
Gene Regulation 
Hairpin polyamides have shown the ability to block transcription factors from 
binding to their DNA target sites and thereby inhibiting transcription (Figures 1.7 and 
1.8).29,32 In the first demonstration of this approach, an eight-ring hairpin polyamide was 
targeted to the binding site of the zinc finger transcription factor TFIIIA in the Xenopus 
5S RNA gene promoter, at a sequence which coincides with a zinc finger-minor groove 
interaction (Figure 1.8).6 Transcription by RNA polymerase III was suppressed in in 
vitro transcription assays and following treatment of whole Xenopus kidney-derived 
fibroblast cells with the match polyamide. Very recently it has been demonstrated that 
polyamides are able to inhibit the binding of certain zinc finger proteins (including 
Zif268, Figure 1.3) that bind without any minor groove contacts, presumably by an 
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allosteric mechanism.39 Allosteric interactions between the major and minor grooves 
were recently shown to be critical for inhibition of the major-groove binding protein UL9 
by a minor-groove binding oligopyrrole small molecule (GLX, an indole bridged bis-
netropsin).40 However, minor-groove binding ligands including hairpin polyamides can 
also co-occupy DNA while certain proteins (such as GCN4, Figure 1.3) occupy the major 
groove. 41 GCN4 binding has been inhibited by hairpin polyamides containing "positive 
patches" targeting protein-phosphate contacts,42.43 and by polyamide-intercalator 
conjugates.44 
Figure 1.7 
i.::!::J 
i.:::::) 
i.::::> 
,.m:::> 
Figure 1.7. Inhibition of gene transcription by hairpin polyamides. A pair of hairpin polyamides targeted 
to the DNA sequences adjacent to the binding sites for Ets-I, LEF-l, and TBP inhibit assembly of the 
transcriptional machinery and transcription of the HIV -I genome.45 Polyamides are shown in ball-and-stick 
format. Red and blue circles represent imidazole and pyrrole residues, respectively. ~-Alanine and the y-
turn are depicted as green diamonds and curved lines, respectively. The plus sign represents the 
dimethylaminopropylamide tail. 
Minor -groove binding transcription factors, such as TBP (Figure 1.3), LEF-l, and 
TAX, have been excellent targets for polyamide inhibition, resulting in inhibition of RNA 
polymerase II transcription of targeted genes in vitro such as HIV -1 and HTL V-I (Figure 
1.8):5.47 Interestingly, in the absence of TAX the polyamides shown on the HTL V-I 
promoter or another polyamide targeted to the center of the CREB site, do not inhibit the 
association of major-groove binding CREB with DNA.47 However, in the presence of 
TAX, which forms a complex with CREB, the polyamides shown inhibited CREB 
Figure 1.8 
TFIIIA 
I 3-1 
58 RNA Promoter 
----
70 80 
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HlV-l Promoter TBP 
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~
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Ets-1 LEF-1 HIV-I Promoter 
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""" 
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TAX CREB TAX H1LV-l Promoter 
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B+.~ 
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Figure 1.8. Examples of gene promoters where transcription factor binding sites that have been targeted 
by hairpin polyamides, resulting in blocking transcription factor binding and inhibition of transcription by 
RNA polymerase III (SS RNA) and RNA polymerase II, or activation of transcription by blocking the 
repressor IE86.6,45-48 Polyamides are shown in ball-and-stick format as in Figure 1.7, with 1m as a filled 
circle, Pyas an open circle, and ~-alanine as a grey diamond. 
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binding. A similar result was obtained on the HIV -1 promoter with a polyamide 
targeting Ets-l (Figure 1.8, polyamide on the left), which was able to inhibit binding of 
NF-KB to an adjacent DNA site by blocking the formation of a cooperative Ets-loNF-KBo 
DNA ternary complex.49 These results show that polyamides are able to inhibit proteins 
that they do not directly contact, and may provide a general method for inhibition of the 
association of major-groove binding transcription factors with their target DNA. 
Proteins that have a majority of major-groove contacts and few or even one 
minor-groove contact have been efficiently inhibited by hairpin polyamides. The binding 
of two Ets transcription factors, Ets-l and ESX, to the HIV-l and HER2 promoters, 
respectively, has been efficiently inhibited by hairpin polyamides (Figure 1.8).45.46.49 Ets 
proteins have a winged-helix-turn-helix motif and bind primarily in the major groove 
with additional phosphate contacts across the adjacent minor groove(s). Polyamide 
inhibition of the binding of NF-KB, which has one such contact across the minor groove, 
is likely due, at least in part, to allosteric interactions between the grooves.50 However, in 
another case of polyamides inhibiting transcription factor binding with only one 
phosphate contact outside the major groove, synthetic modification of the bHLH domain 
of the Drosophila Deadpan showed that the inhibition depended on the specific lysine 
residue responsible for the phosphate contact.51 Inhibition by two polyamides with 
distinct binding sites was then used to demonstrate unusual asymmetric binding of this 
homodimeric bHLH protein. This highlights the use of polyamide not only for inhibition 
but also for the study of transcription factor-DNA complexes. 
Recently, in vitro transcription inhibition has been demonstrated for a hairpin 
polyamide binding to sites that do not involve sequence-specific protein-DNA 
interactions. A "promoter scanning" experiment52 was devised to probe the portion of the 
HIV-1 promoter around the TATA box, using a series of DNA constructs in which a 
hairpin polyamide binding site was placed at various distances from the TATA box.53 As 
expected, for the constructs with polyamide sites proximal to the TAT A box, TBP 
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binding and transcription by RNA polymerase II were inhibited. However, repression of 
transcription was also observed for sites removed from the TAT A box, which did not 
show inhibition of isolated TBP binding. As seen in Figure 1.7 , the RNA polymerase II 
transcriptional machinery is a huge complex, which occupies at least 40 base pairs of 
DNA up stream of the transcription start site (the TATA box is at -28 of the HIV-I 
promoter). Inhibition was traced to polyarnides blocking the TFIID-TFIIA-DNA ternary 
complex, which is not affected by the DNA sequence, based on prior mutagenesis results. 
This study suggests that the range of potential target sites for transcription inhibition by 
polyarnides may be considerably larger than was previously thought. 
In addition to inhibition, polyamides have also been shown to activate 
transcription. This was accomplished with standard hairpin polyarnides by inhibiting the 
binding of a transcriptional repressor protein, IE86, to its cognate site in the viral CMV 
major intermediate early promoter (Figure 1.8).48 In vitro transcriptional activation has 
also been accomplished by hairpin polyamides linked to known activation peptides.54.55 A 
peptidic dimerization domain in the original design has been replaced by successively 
shorter linkers, down to eight atoms, without a significant loss of activation. Promoter-
specific activation over 30-fold above basal levels has been observed.55 Since 
polyamides can target large variety of sequences with high affinity, this approach has 
great potential for gene-specific activation by small molecules. 
In order to activate or inhibit transcription in vivo, polyamides will have to 
interact with DNA that is not free in solution but organized in the cell nucleus in 
chromatin. The fundamental repeat of chromatin is the nucleosome, which consists the 
nucleosome core particle (NCP) and 20-80 base pairs of linker DNA. The NCP consists 
of two tight superhelical turns of DNA (147 base pairs) wrapped around a disc-shaped 
core composed of eight histones (Figure 1.9) .56 The histones are not simply structural 
proteins, they are intimately involved in virtually all cellular processes involving DNA, 
through direct interactions with other proteins and by affecting the accessibility of 
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Figure 1.9 
Figure 1.9. Representation of the X-ray crystal structure of the NCr used for studying the binding of 
hairpin polyamides to nuc1eosomal DNA.'6 Due to their flexibility, only one of the histone tails showed up 
in the crystal strucure. 
specific sequences. In particular, reversible acetylation of the histone tails plays a major 
role in transcription.57 Surprisingly, most of the DNA on an isolated NCP was found to 
be accessible to polyamide binding, including sites where the minor groove faces into the 
histone octamer, although affinity was reduced at those sites.58 The only sites which were 
found to be inaccessible to polyamide recognition were blocked by the passage of the 
histone tails through the minor groove. The nucleosomes remained fully folded upon 
polyamide binding and the hairpins did not interfere with reconstitution of the NCPs from 
free DNA and histones. Recently similar results on the accessibility of minor groove 
sites both facing away from and into the histone core without disruption of the NCP were 
obtained for the smaller minor-groove binder Hoechst 33258 (Figure 1.4).59 These 
studies suggest that the vast majority of DNA sites in nucleosomes will be available for 
recognition by hairpin polyamides. However, it should be noted that nucleosomes are 
only the first level of chromatin organization. 
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Polyamides have been shown to regulate gene expression in vivo. The two most 
powerful demonstrations are the inhibition of HIV -1 replication in human cells by 
polyamides targeted to the TBP, Ets-I, and Lef-I sites on the HIV-J promoter by hairpin 
polyamides (Figures 1.7 and 1.8),45 and the activation and repression of selected genes in 
living Drosophila melanogaster by one-to-one binding polyamides targeted to highly 
repeated satellite DNA sequences.60•61 In the latter study Laemrnli and co-workers 
demonstrated that monomeric and dimeric one-to-one binding polyamides showed 
specificity for satellite repeat sequences in DNase I footprinting assays, as well as in 
isolated chromosomes and nuclei as measured by epifluorescence microscopy 
visualization of fluorescently tagged polyamides. They also showed that monomeric 
compounds mediated chromatin opening of heterochromatic satellite DNA containing the 
target repeat. 60 Next, the monomeric polyamides were fed to developing flies, which 
proceeded to show specific gain- and loss-of-function phenotypes based on the chromatin 
opening of the targeted DNA satellites.61 Laemrnli and co-workers have followed up on 
these studies by developing fJuorescently tagged tandem hairpin dimers targeted to insect 
and vertebrate telomere repeat sequences.62 These were shown to be excellent probes for 
staining telomeres and rapidly estimating telomere length. 
In the HIV -1 study, the laboratories of Dervan, Gottesfeld, and Mosier showed 
that a combination of two hairpin polyamides which inhibited the binding of three 
transcription factors and in vitro transcription of the HIV -1 promoter, reduced HIV-I 
replication 99.9% (below the detection limit, similar to postive control AZT) in isolated 
human peripheral blood lymphocytes infected with a T-cell tropic strain of HIV_1.45 
Individually the polyamides were also quite effective, causing 60% and 80% reduction in 
virus. Mismatch polyamides showed no inhibition, and the mRNA levels of seven other 
genes with different proximal sequences to their TAT A boxes were not effected by the 
polyamide treatment. The concentration of polyamide required for maximal inhibition, 
1 J.1M of each, was not appreciably toxic to the cells. 
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Scope of this Work 
This thesis describes work examining DNA binding polyamides in biological 
systems. Chapters 2 and 3 are both conceptually related to the HIV -1 study with hairpin 
polyamides. Chapter 2 describes the development of polyamides as integrase inhibitors, 
which represents a complimentary attack on the retrovirallife-cycle. Potent inhibitors of 
M-MuLV (a retrovirus related to HIV-l) integration in cell-free assays are discussed in 
Chapter 2A. Chapter 2B presents a series of hairpin polyamides designed to inhibit HIV-
1 integration. Following on the inhibition of a viral gene in human cells, the Dervan 
laboratory sought to inhibit the transcription of an endogenous human gene in human 
cells. HER2, a gene overexpressed in human breast cancer, was chosen as a target. 
Chapter 3 describes a series of polyamides targeting the TAT A box of the HER2 
promoter. Chapter 4 describes confocal microscopy studies of polyamide-fluorescent dye 
conjugates which followed from failure to achieve HER2 inhibition in vivo. Chapter 4A 
suggests that hairpin polyamides are indeed cell-permeable, but that nuclear localization 
does not occur in many cell lines. Efforts toward modified poly ami des with enhanced 
nuclear localization properties are described in Chapter 4B. Chapter 5 describes efforts 
to increase the number of sequences amenable to high-affinity recognition by hairpin 
polyamides by alteration of the C-terminal tail. Chapter 5A presents the development of 
conditions for polyamide solid-phase synthesis on a new resin, which allows for the 
generation of "truncated tail" polyamides. Chapter 5B describes the original route to one 
of these compounds, during the development of which an unexpected reaction was 
uncovered that led to entirely different C-terrninal tails. 
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CHAPTER 2 
Inhibition of Retroviral Integration by 
DNA Binding Poly ami des 
The text of this chapter was taken in part from a manuscript submitted for publication 
coauthored with Professor Peter Dervan (Caltech) and Fan Yang, Rodrigo Villanueva, 
and Profressor Monica Roth (Robert Wood Johnson Medical School). 
(Yang, F.; Belitsky, 1.M.; Villanueva, R.M.; Dervan, P.B.; Roth, M.l. "Inhibition of 
Moloney murine leukemia virus integration using polyamides targeting the long-terminal 
repeat (LTR) sequences" Biochemistry, submitted 2002.) 
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Abstract 
The retroviral integrase (IN), which carries out the integration of the viral DNA 
into the host genome, is a potential target for antiviral therapy. Both IN and the DNA 
sequences at the viral long terminal repeat (L TR) are required for the integration 
function. Chapter 2A describes the investigation of a series of minor groove binding 
hairpin polyamides targeting sequences within terminal inverted repeats of the Moloney 
murine leukemia virus (M-MuL V) LTR which were synthesized as potential inhibitors of 
integration. Using cell-free in vitro integration assays, polyamides targeting the 
conserved CA dinucleotide with cognate sites closest to the terminal base pairs were 
effective at blocking 3' processing but not strand transfer. Polyamides which efficiently 
inhibited 3' processing and strand transfer targeted the LTR sequences through position 
9. Polyamides that inhibited integration were effective at nanomolar concentrations and 
showed subnanomolar affinity for their cognate LTR sites. These studies develop the use 
of polyamides for antiretroviral therapy. 
Chapter 2B describes an extension of these studies to the inhibition of HIV-l 
integration. Hairpin polyarnides targeting sequences within the US LTR of HIV-l were 
synthesized and shown to bind their cognate sites with subnanomolar affinity. These 
compounds were found to be submicromolar inhibitors of 3' processing and strand 
transfer in preliminary cell-free integration assays . Comparison with the M-MuL V 
results and potential approaches to integrase inhibitors with greater potency are 
discussed. 
Chapter 2A: 
Inhibition of Moloney murine leukemia virus integration using polyamides 
targeting the long-terminal repeat (LTR) sequences 
Introduction 
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Emergence of drug-resistant strains of human immunodeficiency virus (HIV) 
calls for the identification of new antiviral targets. The retroviral IN is a rational target 
for antiviral therapy both because it is essential for the viral replication and because it has 
no cellular counterpart. The integrase catalyzes the integration of viral DNA into the host 
genome. In addition to the integrase, the DNA sequences present in the long terminal 
repeat (LTR) at the ends of the linear viral DNA are also required for integrationY The 
integration process can be divided into two steps. First, IN cleaves two nucleotides from 
the 3' ends of both LTR termini, exposing the conserved a 5'-CA-3' dinucleotide. 
Second, the 3' processed-ends of the viral DNA are joined to the host DNA in a 
coordinated fashion. In vitro assays have been developed to recapitulate both steps of 
integration by using purified integrase protein and short oligonucleotide duplexes 
mimicking the viral LTR.3.s In addition, purified integrase is able to carry out an in vitro 
concerted two-end integration reaction using the LTR oligonucleotide as donor and 
plasmid DNA as target.6,7 
Multiple potential IN inhibitors have recently been identified and classified into 
four groups based on the proposed sites of action. Inhibitors that target the metal binding 
site include salicylhydrazidesB and styrylquinolines.9 The proposed mode of action of 
these compounds is through chelating the divalent metal ions required by IN. A second 
class targets a potential nucleotide binding site and includes 5-N3-AZTMP,1O 
plsopdApdC,JI and guanosine quartets , 12·1 5 These inhibitors are proposed to compete 
with the viral DNA binding site. Alternative nucleic acid binding sites act as potential 
targets. Two inhibitors in this class, 5-CITEp16 and naphthalene disulfonate,17 were 
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found to bind to the active site of the integrase by structural studies . Compounds 
containing diketo acids are recently reported to specifically block strand transfer by 
competing for the target binding site. 18.19 
The viral DNA is also a target for inhibitors. Inhibitors in this class include DNA 
intercalators20 as well as DNA minor-groove binders such as distamycin dirners.21.24 Of 
particular relevance to this study, the minor groove binder netropsin has been shown to 
inhibit Moloney murine leukemia virus (M-MuLV) IN at micromolar concentrations.25 
N etropsin binds to A + T rich sequences of 4-7 base pairs in length. The terminal seven 
nucleotides of the M-MuL V LTR (5' -AATGAAA) are A + T rich, and contain sequences 
especially favorable for netropsin binding.25 
Studies with modified L TRs containing nucleotide analogues indicate that the IN 
does contact the LTR minor groove.26 However, the molecular details of integration 
remain elusive. Integration is a complex and dynamic process, which despite intense 
efforts,27.29 has resisted direct structural characterization. There is evidence that different 
IN-LTR interactions are important for the individual steps of integration. 18.30 In the 
absence of a crystal structure, DNA binding molecules may shed light on the molecular 
interactions of integrase with the viral L TR. In this regard, it would be especially useful 
to place minor groove DNA binders at precise but incrementally different positions 
within the 13 base pair IN recognition sequence, 5' -AATGAAAGACCCC-3'. 
Hairpin poly ami des containing N-methylpyrrole (Py) and N-methylirnidazole (1m) 
carboxamides are small molecules that bind DNA in the minor groove with high affinity 
in a sequence-specific manner.31.32 Based on pairing rules, polyamides can target a large 
number of predetermined DNA sequences. This level of target flexibility and precision, 
which allows unambiguous recognition of DNA sites with single base pair resolution, is 
not available to classical DNA binding agents. Polyamides have been shown to block 
transcription factors from binding to their cognate recognition sequences, thus inhibiting 
transcription.33.35 Poly ami des targeted to TBP and Lef-l binding sites in the HIV-l 
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promoter have been shown to inhibit viral replication in human cells?3 If polyamides can 
effectively target the LTR termini, they should act as integrase inhibitors in analogy to 
netropsin, which would represent a complimentary attack on the retroviral life cycle. 
Furthermore, a series of polyamides that recognize distinct L TR sites with high affinity 
would be molecular probes for understanding the mechanism of integration. 
In this study, the ability of a series of polyarnides (1-8), including two mismatch 
controls, to inhibit the in vitro integration activities of M-MuLV IN was determined. 
Inhibitors effective at nanomolar concentrations fell into two classes, based on the 
position of their cognate sites within the M-MuLV LTR. The characterization of these 
first generation polyamide inhibitors is presented. 
Experimental Procedures 
Materials. Crude (y_32p) ATP (7,000 Ciimmol) was purchased from ICN. T4 
polynucleotide kinase, T4 DNA ligase, DNase I and restriction enzymes were obtained 
from New England Biolabs. Nj2+-nitrilotriacetic acid agarose was purchased from 
Qiagen. Target plasmid pGEM-3Zf(+) was purchased from Promega. 
Polyamides. All polyamides were synthesized by solid-phase methods as 
previously described/6.38 and characterized by analytical HPLC and MALDI-TOF mass 
spectrometry. ImPyPyPylm-y-PyPyPyPyPy-~-Dp (1) [M+H) 1466.99, 1466.57 
calculated for [M+H]. ImPy-/3-Pylm-(R)-H2Ny-PyPyPyPyPy-/3-Dp (2) [M+H] 1430.94, 
1430.67 calculated for [M+H). ImPy-~-Pylm-(R)-H2Ny-PyPy-~-PyPy-/3-PyPy-/3-Dp (3) 
[M+H) 1695.08, 1694.79 calculated for [M+H) . IrnPy_~_PyIm_(R)_H2Ny_pyImPyPyPy_~_ 
Dp (4) [M+H) 1431.48, 1431.66 calculated for [M+H). BZlrnPyPy_(R)_H2Ny_pypyPyPy_ 
~-Dp (5) [M+H) 1233.6, 1233.57 calculated for [M+H). BZPyPyPy_(R)_H2Ny_PylrnPyPy_ 
/3-Dp (6) [M+H) 1233 .54, 1233 .57 calculated for [M+H]. BzPyPyPy_(R)_H2Ny_ 
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PyPylmPy-~-Dp (7) [M+HJ 1233.6, 1233.57 calculated for [M+H]. ImPyPylm_(R)_H2Ny_ 
PyPylmPy-~-Dp (8) [M+HJ 1238.73, 1238.58 calculated for [M+H]. 
DNase I footprinting. DNase I footprinting reactions were performed as 
previously described/9 using a 183 base pair 5'- 32P-Iabeled DNA fragment containing 
one copy of the M-MuLV LTR terminus. The labeled fragment was generated by the 
PCR method34,40 using primers 5'-AGACAGGATATCAGTGGTCCA and 5'-
CATGCCTTGCAAAATGGCGTT, corresponding to positions 10968-10988 and 43-63, 
respectively, of the M-MuLV linear provirus-containing plasmid, NCA-C,41 which was 
used as the template . Primers were prepared and purified by the Caltech Biopolymer 
Synthesis Facility. The sequence of the labeled fragment is listed here with the terminal 
13 base pairs of the M-MuLV LTR shown in bold: 5,_32p CATGCCTTGCAAAATGG 
CGTTACTTAAGCTAGCTAGCTTGCCAAACCTACAGGTGGGGTCTTTCATTCC 
CCCCTTTTTCTGGAGACTAAATAAAATCTTTTATTTTATCTATGGCTCGTACTA 
TAGGCTTCAGCTGGTGATATTGTTGAGTCAAAATAGAGCCTGGACCACTGAT 
ATCCTGTCT. 
Oligonucleotides. DNA oligonucleotides used as substrates were prepared by the 
University of Medicine and Dentistry of New Jersey Biochemistry Department DNA 
Synthesis Facility and purified by electrophoresis on 20% denaturing polyacrylamide 
gels. Oligonucleotides used in this study are referred to by their synthesis numbers and 
were labeled with (y_32p) ATP by kinase reaction as previously described.42 
Oligonucleotides 2783 (5 ' -GTCAGCGGGGGTCTTTCA TT) and its complementary 
strand 2785 (5'-AATGAAAGACCCCCGCTGAC) were used for 3' processing assay. 
Oligonucleotides 2784 (5'-GTCAGCGGGGGTCTTTCA) and its complementary strand 
2785 were used for strand transfer and concerted two-end integration assays. 
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Purificatiou of M-MuL V integrase. Recombinant M-MuL V integrase (WT IN) 
containing a hexahistidine tag were expressed in Escherichia coli BL21(DE3) (Novagen) 
and purified by Ni2+-nitrilotriacetate agarose chromatography (Qiagen) as previously 
described.42 
In vitro assays. Strand transfer and 3' processing reactions were performed as 
previously described. 42 The reaction buffer contains 20 roM morpholine-ethanesulfonic 
acid (MES, pH 6.2), 10 roM DTT, 10 roM MnCl2, 10 roM KCl and 10% glycerol. The 
condition for integration into an exogenous target was the same as that of the strand 
transfer reactions except that 200 roM KCl and 10% DMSO (dimethylsulfuroxide) were 
added. The LTR oligonucleotide (2783 or 2784) was 5' labeled by T4 polynucleotide 
kinase and mixed with complementary strand at a ratio of 1 :2. The oligonucleotides were 
annealed by heating for three minutes at 95° C and then cooling to room temperature. 
Typically, one reaction mixture (30 Ill) contains 1 pmol of labeled LTR, 0.61lg of target 
plasmid DNA and 20 pmol of IN protein. After the pre-incubation of the LTR and the 
polyamides, the IN protein was added and incubated on ice for 5 minutes and 37" C for 5 
minutes. The target DNA and KCl were then added. The reactions were incubated at 37" 
C for two hours and stopped by addition of 10 roM EDTA, pH 8.0, 0.5% SDS and 100 
Ilg/ml proteinase K and incubated at 37°C for one hour. 10 III of the reaction was subject 
to electrophoresis on a 1 % agarose gel. After gel electrophoresis, the gel was dried and 
exposed to Kodak X-Omat Blue XB-l film. In all reactions, the polyamides were mixed 
with the LTR substrate first and incubated at room temperature for 18 hours before 
adding the IN protein, unless indicated otherwise. Films were scanned and quantified 
with a densitometric plot using the Scion Image 1.62c program (based on NIH image). 
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Results 
Polyamide design. The termini of the MuL V L TRs including the conserved 
CA::GT dinucleotide, consist of a 13 base pair (bp) inverted repeat sequence (5'-
AATGAAGACCCC). The MuLV U5 and U3 termini sequences are therefore identical. 
This degree of conservation of the L TR termini is not found in HIV -1 and Rous sarcoma 
virus (RSV) genomes. This facilitates the generation of sequence directed polyamide 
inhibitors which would simultaneously recognize both ends of the viral DNA. A series of 
polyamides which target the MuLV LTR were generated (Figure 2.1). The pairing rules 
are outlined below for hairpin polyamide binding to DNA.3! A pyrrole opposite an 
imidazole (Pyllm pairing) targets a CoG bp whereas an ImlPy pair binds a GoC bp. A 
PylPy pair recognizes both AoT and ToA pairs. Internal f3-alanines (13) may be introduced 
to improve both flexibility and specificity of the polyamides. 13/13, f3/Py, and Py/f3 pairs 
recognize both AoT and ToA pairs. The "turn" and "tail" residues, y-aminobutyric acid 
(y), (R)-2,4,-diaminobutyric acid ((R)H2Ny), unpaired f3-alanine, and dimethyl amino-
propylamine (Dp), are also AoT and ToA specific. Recently a benzoyl group (Bz) has 
been shown to be a high affinity AoT and ToA specific N-terminal residue when paired 
with py.38 
Figure 2.1 
A) 
B) 
1 3 5 7 9 11 13 
5 ' -A A T G A A A G A C C C C-3 ' 
1 ~
2 
3 
4 
5 
6 
7 
8 
3'-T T ACT T T C T G G G G-5' 
5 ' -A AT G A A A G A C C C C-3' 
+~ 
3'-T T ACT T T C T G G G G-5' 
5'-A A T G A A A G A C C C C-3' 
~3 '-T T ACT T T C T G G G G- 5 ' 
5 ' -A A T G A A r,i\IG A C C C C-3 ' 
+~ 
3 '-T T ACT T L'l;.ic T G G G G- S' 
5' -~GAC C C C-3' 
+ + 
3'-T T A CT T T C T G G G G- 5 ' 
5 ' -A ~~ Ace C C-3 ' 
3'-T T~T C T G G G G- 5 ' 
5'~+GACCCC-3' 
3' -T~T T C T G G G G- 5' 
5' - AfA1 T Giii.-!A A G A C C C C-3' ~!; + + I ' I I I 
3 ' -T L! J A CLTJT T C T G G G G-S' 
27 
Figure 2.1. (A) Chemical structures of selected polyamides. (B) Ball-and-stick representations of the 
polyamides and their binding sites within the M-MuLV LTR. Numbering of the LTR is shown above the 
top entry. Mismatches are highlighted. The symbols for polyamides are: open, filled and slashed circles, 
1m, Py and Bz rings, respective ly; curved lines, y-aminobutyric acid; diamonds, l3-alanine; 
dimethylaminopropylamine tail and amino group of (R)-2,4-diaminobutyric acid, plus signs. 
The most conserved feature of all retroviral termini is the CA/GT dinucleotide 
pair, invariably found precisely at the site of joining to the host DNA. Sequences internal 
to the CA, extending up to 15 bp from the termini, have a more limited effect on IN 
activity .430 46 All polyarnides generated target the CA dinucleotide and vary in the extent 
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of the surrounded sequences to which they bind (Fig. lB). Polyamides 1-3 were designed 
to bind a core sequence from positions 2-9 of the LTR. The central PylPy pair of 1 was 
varied to a ~lPy (2) or ~/~ pair (3). Polyamide 1 contains the standard y-turn, whereas 
hairpins 2 and 3 contain the charged chiral analog, (R)H2Ny. These latter compounds are 
doubly charged. Polyamide 3, which contains a C-terminal extension of ~-Py-Py, is 
designed to bind a larger site, placing a Py ring at position 1 of the L TR. Polyamide 4 
represents a single base pair mismatch for the 2-9 region. Another control compound, 
polyamide 8, is a double base pair mismatch for the LTR sequence. The recent 
development the AoT and ToA selective N-terminal Bz residue allowed for the targeting 
of additional sequences, which place the core of the hairpins closer to the terminus of the 
LTR (5-7). Polyamides 5 and 7 cover positions 1-7, and polyamide 6 covers positions 2-
8. While polyamides 1-4 place a IrnlPy pair and un-paired ~-alanine against the CA 
dinucleotide, polyamides 5-7 place two central ring pairings against the CA dinucleotide, 
which may serve as a greater steric impediment to interaction with the integrase. 
High-affinity binding of the polyamides to the viral L TR sequence. 
Quantitative DNase I footprinting titration experiments40 were performed to determine 
the equilibrium association constant (Ka) of the polyamides with the M-MuL V LTR 
sequence (Table 2.1, see also Chapter 3). Individual polyamides were incubated with a 
32p labeled DNA fragment containing an internal copy of the LTR, followed by DNase I 
digestion. Note that this procedure requires an excess of polyamide, and the amount of 
DNA used in this procedure is on the order of 5 pM.40 Representative DNase I 
footprinting gels for polyamides 2 and 6 are shown in Figure 2.2. Polyamides 5-7, which 
are constitutional isomers, varying only by the position of a single nitrogen atom within 
the molecule, are readily differentiated by the LTR sequence (Table 2.1). Among the 
polyamides tested, polyamide 5 has the highest equilibrium association constant 
Table 1. Equillibriwn association constants for 
polyamides with internal coPY ofMuLV LTR. 
Polyamide Sequence Ka (M-l) 
J ~ 5' -GGGAATGAAAGACC-3' 2.2 x 109 
2 ~ 5' -GGGAATGAAAGACC- 3' 3.6 X 109 
5' -GGGAATGAAAGACC-3' 2.7 x 109 
4 ~ S' - GGGAATGAAAGACC - 3' 2.1 X 107 
5 +~ 5 t -GGGAA~GACC-3 ' 4.0 x 1010 
(; ~ 5'-GGG~GACC-31 1.7 X 10'" 
7 +~ 5'-GGGAATGAAAGACC-3' 3.0 x 109 
8 ~ S' -GGG~GACC-3' ~5 x .106 
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Table 2.1. Values reported are the mean values obtained from three DNase I footprint titration 
experiments. The binding site for each polyamide is underlined. Mismatches are shown in bold. The 
assays were carried out at 22° C, 10 mM Tris-HCI (pH 7.0), 10 mM KCI, 10 rnM MgCI20 and 5 mM CaCI2 • 
(Ka = 4 X WID M- I ), while the double base pair mismatch 8 has the lowest binding 
constant (Ka ::; 5 X 106 M-I ) . 
The similar affinity (Ka = 1.9 - 3.6 x 109 M-I ) of polyamides 1-3 is of interest. 
Polyamide 1 appears to be particularly well matched for the LTR sequence, given its 
relatively high affinity, and observations that substitution with a central WP pair and/or 
the positively charged (R)H2N,y-turn failed to increase its affinity (data not shown). 
Additionally, substitution with a central PlPy pair yielded a drop in affinity, which was 
recovered by substitution with (R)H2Ny (polyamide 2). With the internal copy of the LTR 
sequence used for these experiments, the tail of the extended polyamide 3 is placed 
against G·e base pairs, which represents a mismatch that is not present in the L TR itself. 
It is important to note that, since the DNase I footprinting titrations were performed on an 
internal copy of the LTR sequence, the affinity constants generated are only a model for 
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Figure 2,2. (A) Quantitative DNase I footprint titration experiment with polyamide 2 on a 5' 3Zp labeled 
183 base pair DNA fragment containing an internal copy of the M-MuLV LTR: lane I, A reaction; lane 2, 
G reaction; lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, SO pM, 100 pM, 200 pM, 500 pM, 1 nM, 
2 nM, 5 nM, and 10 nM polyamide; lane 14, intact DNA. All reactions contained 10 mM Tris-HCI (pH 
7.0) , 10 mM KCl, 10 mM MgCI2, and 5 mM CaCI2, and were performed at 22° C. (B) Quantitative DNase 
I footprint titration experiment with polyamide 6 on a 5' 32p labeled 183 base pair DNA fragment 
containing an internal copy of the M-MuLV LTR: lane 1, A reaction; lane 2, G reaction; lane 3, DNase I 
standard; lanes 4-13, 10 pM, 20 pM, SO pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, and 10 nM 
polyamide; lane 14, intact DNA. All reactions contained 10 mM Tris-HCI (pH 7.0), 10 mM KCI, 10 mM 
MgCI2, and 5 mM CaClz, and were performed at 22° C. 
binding to the M-MuLV LTR termini. The binding of polyamides 5-7 was of particular 
interest, given the proximity of their cognate sites to the absolute end of the LTR. DNA 
melting experiments using oligonucleotides with terminal or internal cognate sites were 
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performed to address this issue.47 Comparisons of melting curves with and without 
polyamides 5-7 showed that the Tm shifts induced by these polyamides were similar for 
both sets of oligonucleotides, although slightly lower in each case for the terminal 
cognate site (see Appendix). In all cases, the Tm shifts for both sets of oligonucleotides 
with polyamides 5-7 were considerably greater than the Tm shifts induced by a mismatch 
polyamide. These results indicate that polyamides can bind with high affinity to the 
absolute ends of DNA fragments. However, since the Tm shift for the terminal cognate 
site was slightly lower than the internal cognate site for polyamides 5-7, the affinity 
constants determined by DNase I footprinting for these compounds (Table 2.1) should be 
considered as upper limits for their affinity to the M-MuLV LTR termini. 
Figure 2.3 
L TR·L TR product 
5'*-----<:ATT LTR 
3· 
IN 13 .. process,ng 
'------<:A 
S'*-CA--L---3·~--AC--* 
two-end product (linear) 
one-end product 
(circular) 
Figure 2.3. Schematic illustration of in vitro integration assays. IN first removes the "IT" dinucleotide 
from the 5' '2p labeled blunt LTR duplex, leaving a single-strand tail. Then IN integrates the cleaved strand 
into the target: either the L TR itself in the strand transfer assay , or the plasmid DNA as an exogenous 
substrate. The major products of integration are as listed. 
Inhibition of the 3' processing. The ability of the polyamides to inhibit 
integration was tested in in vitro integration assays . Figure 2.3 schematically outlines the 
in vitro assays utilized in these studies. In the 3' processing assay, a 20 base-pair (bp) 
blunt-end oligonucleotide duplex mimicking the viral LTR end was used as the substrate 
Figure 2.4 
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Figure 2.4. Inhibition of 3' processing reactions by the polyamides. 3' processing reactions were 
performed as described in the Materials and Methods. The position of the -2 3 ' processing product is 
indicated at the left. Lane 1, no protein control; lane 2, M-MuLV IN alone. Lanes 3-9, IN plus polyamide 
1; lanes 10-16, IN plus polyamide 2; lanes 17-23, IN plus polyamide 3; lanes 24-30, IN plus polyamide 4; 
lanes 31-37, IN plus polyamide 5; and lanes 38-44, IN plus polyamide 6. The concentrations of the 
polyamide used are (left to right): 0.4, 16,40, 100,256,640 and 1600 nM. 
(Figure 2.3, top line). The strand containing the conserved CA dinucleotide was 5' 32p 
labeled. IN dependent 3' processing of the dinucleotide yields an 18 base product, which 
is monitored on a denaturing acrylarnide gel. It is of note that the concentration of DNA 
substrate in these and the following integration assays is significantly greater (33 nM) 
than the concentration of DNA in the DNase I footprinting titrations . Figure 2.7 
summarizes the effects of the polyarnides on the 3' processing reaction. The results of an 
exemplary 3' processing assay with selective polyamides is shown in Figure 2.4. The 
eight polyamides could be divided into three classes, according their inhibition 
efficiencies (Figure 7). The first class includes polyarnides 1,3, 5, and 6 all having an 
ICso under 250 nM. The second class includes polyarnides 2 and 7 with an ICso between 
450 and 650 nM. Polyarnides 4 and 8 belong to the third class, which has an ICso at or 
above 1400 nM. The polyamides are designed to bind with sequence specificity. The 
inhibitory effect of the polyarnides correlates with the ability to efficiently bind the LTR 
sequences and is therefore not due to nonspecific interactions with the IN protein. A 
single mismatch within the polyamide was found to decrease the Ka value by lOa-fold 
and showed little of evidence of inhibition of 3' processing and strand transfer. This is 
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exemplified by polyamide 4 (Figure 2.4 and data not shown), with a Ka of 2.1 x 107 M· I , 
and an IC50 value at or greater than 1600 nM. 
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Figure 2.5. Inhibition of strand transfer reactions by the polyamides. Strand transfer assays, based on 
oligonucleotides substrates were performed as described in the Materials and Methods. Strand transfer 
yields 32P-labeled products larger than the input substrate, indicated at left of panel. Lane 1, no protein 
control; lane 2, M-MuLV IN alone. Lanes 3-9, IN plus polyamide 1; lanes 10-16, IN plus polyamide 2; 
lanes 17-23, IN plus polyamide 3; lanes 24-30, IN plus polyamide 4; lanes 31-37, IN plus polyamide 5; and 
lanes 38-44, IN plus polyamide 6. The concentrations of the polyamide used are (left to right) : 004, 16, 40, 
100,256,640, and 1600 nM. The asterick indicates the formation of the enhanced integration product. 
Inhibition of strand transfer. The polyamides were tested for inhibition of 
strand transfer. In this assay, a precleaved substrate (Figure 2.3, second row) was used 
instead of the blunt-end substrate, with integration occurring into a second double-
stranded oligonucleotide (Figure 2.3, left arrow). Strand transfer is highly efficient using 
a precleaved substrate,48 and allows for the separation of the two steps in the analysis. 
Similar to 3' processing, the polyarnides can be separated into three classes based on their 
IC50 for the strand transfer reactions (Figure 2.7). An exemplary strand transfer assay 
using selective polyamides is shown in Figure 2.5. The first class consists of 1 and 3, 
with the IC50 under 250 nM. Moderate inhibition is found with the second class, 
including 2 and 5 with IC50 at 450 and 1100 nM, respectively. The third class includes 4 
and 6-8. The IC50 of the third class are at or above 1400 nM. 
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Although polyamides 5 and 6 were among the most effective inhibitors of 3' 
processing, they showed little effect on strand transfer. Poly ami des 1 and 3, though, are 
highly effective at inhibition of both the 3' processing and strand transfer reactions. This 
raises the interesting possibility that distinct regions of the viral termini are required for 
3' processing and strand transfer. Additionally, the absence of the TT dinucleotide in the 
strand transfer substrate will affect the binding of polyamides, particularly 5-7, whose 
cognate sites are closest to the end of the viral DNA. Each of these polyarnides was less 
effective at inhibiting strand transfer than 3' -processing, whereas polyamides 1-3 showed 
the same efficacy in both assays (Figure 2.7). This further emphasizes the importance of 
cognate site recognition in integrase inhibition. 
In the oligonucleotide based assay, the L TR substrate functions both as the viral 
and target DNA. Previous analysis of binding site selection indicated that the major 
groove was the main determinant within the target DNA for IN docking.49•s3 Therefore it 
was believed that binding of the polyamides to the target DNA should not influence 
target site selection. Experimentally, variations in target site selection were observed. In 
the presence of high concentration of polyamide 2 (640 and 1600 nM, Figure 2.5 , lanes 
15 and 16), loss of integration at the predominant sites was paralleled with enhanced 
production of a single product of slow electrophorectic mobility (marked by the asterisk). 
This product was also observed at saturating levels of polyamide 3 (Figure 2.5, lanes 21-
23) . Formation of this large product is a result of integration at one end of the target 
DNA. Target site selection using polyamide 5 was also altered, with preference for the 
faster mobility products at the highest polyamide concentrations (Figure 2.5, lanes 36-
37). 
Inhibition of strand-transfer into an exogenous target. To separate the effects 
of polyamide binding to the viral versus target site, an alternative in vitro integration 
assay was used (Figure 2.3), in which a precleaved LTR oligonucleotide donor was 
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Figure 6. Polyamides inhibit in vitro strand transfer into an exogenous substrate. 32P·labeled LTR 
substrate was analyzed for integration into an unlabeled plasmid DNA. The migration on an agarose gel of 
the single-end lariat integration product is indicated at the left of the panel. Lane 1, no protein control; lane 
2; M-MuLV IN alone. Lanes 3-8, IN plus polyamide 1; lanes 9-14, IN plus polyamide 2; lanes 15-20, IN 
plus polyamide 3; lanes 21-26, IN plus polyamide 4; lanes 27-32, IN plus polyamide 5; and lanes 33-38, IN 
plus polyamide 6. The concentrations of the polyamide used are (left to right): 16, 40, 100, 256, 640 and 
1600 nM. 
integrated into a nonspecific circular target plasmid. The target DNA does not encode 
the L TR sequence and therefore only the effect of the polyamide on the L TR is 
examined. Integration of the L TR into the target plasmid would result in two products: 
circular "lariat like" DNA from integration of one LTR end, and linear DNA from 
integration of two LTR ends in coordination (Figure 2.3 , right and center arrows, 
respectively). The integration products into the plasmid DNA are visualized after 
separation on an agarose gel. Using WT MuLY IN, the predominant product was the 
lariat product (Figure 2.6). The general efficiency of the polyamides was as found with 
the oligonucleotide based assay. Examples of polyamides in which no inhibition was 
observed include polyamides 4 and 6 (Figure 2.6, lanes 21-26 and lanes 33-38, 
respectively). Inhibition by polyamide 2 and 5 (Figure 2.6, lanes 14 and 32, respectively) 
was observed at the highest concentration tested (1600 nM). Polyamides 1 and 3 (Figure 
2.6, lanes 3-8 and 15-20, respectively) were effective in inhibiting strand transfer 
between 250 and 640 nM. Interestingly, polyamide 3 yielded reproducibly the lowest 
ICso, indicating recognition of the LTR sequence in the presence of excess nonspecific 
target DNA. Longer exposure of the gels for the two-end linear products paralleled the 
results for the one-end integration (data not shown). The similar profiles observed in 
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both the two-end integration assay and the strand transfer assay indicate that the two are 
mechanistically the same. 
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Figure 2.7. ICso of polyamides on oligonucleotide-based M-MuLV integrase activities. The inhibitory 
effect of each polyamide (0.5-1600 nM) was titrated in either the 3' processing (grey) or strand transfer 
(black) assays . Individual bands of reaction products were quantified using Scion Image 1.62C. For each 
assay, reaction products of the MuLV IN catalyzed in the absence of polyamides was defined as 100% 
activity. Equivalent fractions from lanes in the absence of enzyme were taken as background and 
substracted from each reaction. ICso values were determined as the concentration of each polyamide that 
inhibited IN activities by 50%. 
Discussion 
With the appearance of HIV strains resistant to both the protease and the reverse 
transcriptase inhibitors, the need to develop potent inhibitors against new targets 
including the integrase is more urgent.54 The increased interest for inhibitors which target 
the integrase has provided lead compounds,1954 although no clinically effective inhibitor 
is available to date. 
In this report, a series of poly ami des were designed and tested as inhibitors for 
integration by the M-MuLV IN. Previous studies have shown that DNA-binding agents 
can effectively inhibit retroviral integration.21,22,25,55,56 However, all the compounds have 
very limited sequence specificity and can bind to a very large number of potential DNA 
sites. The polyamides developed in this report bind specifica]]y to the minor groove of 
sequences required for retroviral integration, those at or flanking the conserved CA 
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dinucleotide. Polyamides were identified with subnanomolar binding constants. The 
polyamides were tested in three different integration assays in cell free experiments. The 
inhibition of retroviral integration observed was due to binding of the polyarnides to the 
L TR termini. Polyamides with mismatch recognition of the MuL V L TR were much less 
efficient inhibitors. This is exemplified by polyamides 4 and 8, which both bind to the 
M-MuLV LTR with Ka values of no greater than 2 x 107 M·1 and have ICso at or greater 
than 1400 nM. The inhibition observed, therefore, is not due to a nonspecific binding of 
the polyamides to DNA or to the IN protein. A clear dependence on cognate site 
recognition is demonstrated by the discrepancy between the 3' processing and strand 
transfer results for polyamides 5-7. The binding site of these polyamides is affected by 
the removal of the terminal TT dinucleotide, and thus the cognate polyamides showed 
reduced strand transfer inhibition as compared to 3' processing, where the cognate site is 
intact. 
Despite the importance of cognate site recognition, the Ka values determined by 
DNase I footprinting with an internal copy of the M-MuLV LTR were not direct 
predictors of the efficacy of integrase inhibition. In general, all of the polyamides 
containing an ICso lower than 640 nM, had binding constants in the nanomolar range or 
lower. However, this correlation is not reciprocal. Polyamides with perfect sequence 
matches show subtle variations with the correlation of the Ka values and the effective 
IC5o . Polyarnides 2 and 7 have Ka values near 3.0 x 10
9 M· I , yet are not as effective at 
inhibiting 3' processing as polyamides 1 and 3 , which have association constants in the 
same range. As noted, given the proximity of its binding sites to the end of the L TR, the 
Ka value for 7 should be considered an upper limit. This may also explain why the 
efficacy of polyamides 5 and 6 does not exceed that of polyamides 1 and 3 . The lower 
activity of 2 is more difficult to explain, given its moderately higher affinity than 1. 
The similarity efficiency of 1 and 3 is of interest. When footprinted against the 
internal copy of the LTR, the tail of polyamide 3 was placed over G·C base pairs, which 
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is considered a mismatch.57 Under these conditions, its association constant was quite 
close to polyamide 1. These G·C pairs are not present in the 3'-processing substrate 
L TR, where the tail of 3 extends beyond the terminal base pair. It is thus possible that 
placing the ~-Dp tail of this extended-hairpin polyamide beyond the terminal base pair 
has energetic consequences similar to placing it against G·C base pairs. However, if 1 
and 3 do have the same affinity, one might expect that 3 would be the better inhibitor of 
3' -processing, due to its C-terminal extension, which places Py residues against the bases 
to be excised. Given that these bases are absent in the strand transfer substrate, it is also 
interesting that 3 maintains its activity in this assay, while the activity of 5-7 drops. In 
fact, in the presence of excess unlabeled DNA in the exogenous target assay, polyamide 3 
was the most effective strand transfer inhibitor. Since the hairpin portion of 3 is internal 
to the excised nucleotides, it can be speculated that 3 maintains high affinity binding 
through its hairpin portion. Perhaps the long C-terrninal tail provides a steric impediment 
to strand transfer, even in the absence of cognate base-paired DNA. 
It is also significant that all of the effective strand transfer inhibitors bind 
positions 7 through 9 of the M-MuLV LTR. This is consistent with the observations of 
Balakrishnan and others in the respective HTLV (human T-lymphotropic virus) and HIV-
1 systems of the importance of these residues in related viral L TRs. 45,46,58 Positions 7-9 
are bound by either the tailor turn of polyarnides 5-7, or are outside of the binding site of 
these polyamides. The turn and tail residues are not considered to be as effective steric 
blockades of the minor groove as ring pairings. Thus, reduced blockage of positions 7-9 
relative to polyarnides 1-3 correlates with reduced strand transfer inhibition, although this 
analysis is complicated by the expectation that polyamides 5-7 will have reduced affinity 
for the strand transfer substrate. It would be interesting to test the ability of a polyamide 
that binds internally to positions 7-9 to act as a strand transfer inhibitor. 
The integration process itself is a dynamic process. Current models predict 
conformational changes accompanying cleavage of the viral DNA terminus.30 
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Differential cross-linking efficiencies to the HIV-l LTR sequences were observed for 
substrates for 3' processing, strand transfer, and disintegration.30 In addition, the binding 
of the diketo acid inhibitor L-731,988, required the assembly of the IN protein with the 
viral end. L-731 ,988 competes with the target DNA, indicating the target binding site is 
generated after the binding of the viral L TR. These compounds selectively inhibited 
strand transfer, without any effect on 3' processing.18 Cross-linking studies with mV-l 
IN indicate that the C-terminal domain of one IN monomer acts in trans with the catalytic 
core of another monomer for each viral end.30 This in trans assembly may involve the 
sequences upstream of the viral L TRs, within the region bound by polyamides 1 and 3. 
Similarly, structural studies of Tn5 transposase have demonstrated that both the internal 
and the terminal regions of the transposon DNA are contacted by the transposase.59 This 
conformational change conceptually follows the assembly and transport of the 
preintegrative complexes. In vivo, 3' processing is temporally and spatially independent 
of strand transfer. 60 3' processing occurs in the cytoplasm for MuL V, whereas strand 
transfer occurs in the nucleus. Initial binding of the viral DNA requires the recognition 
of the linear viral terminus, including the CA dinucleotide. The requirements of protein 
domains for 3' processing are stringent; for MuL V IN all domains, including the 
N-terminal HHCC region, are required.7,61.62 
The substrate for 3' processing is a blunt-end double strand DNA. Fraying or 
unwinding of the termini has been proposed to be a requisite step in the 3' processing 
reaction. 63•64 Several of the polyamides target the terminal dinucleotides. It was possible 
that the binding of polyamide might impede the unwinding step. However, no 
preferential inhibition of 3' processing was observed for the polyamides which bound to 
the terminal TT sequence. Polyamides which bind to the terminal nucleotides may, 
however, sterically hinder subsequent assembly of a strand transfer complex. Polyamide 
3 recognizes the largest binding site, from position 1 to position 9 of the LTR, including a 
single-stranded tail covering the terminal TT dinucleotide. As discussed, this may 
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contribute to the overall effectiveness of inhibition by polyamide 3 in both the 3' 
processing and strand transfer assays. 
The variation in target site selection in the presence of polyamides is of interest. 
Previous studies indicated for HIV -1 IN, target sites were preferred within nucleosomes 
with wide major grooves (50). Altered target site selection induced by the polyamides 
binding to the minor groove can indicate either that minor-groove contacts are important 
or that structure of the major groove can be altered by binding of polyamides to the minor 
groove. Structural evidence suggests that hairpin polyamides bind a wide minor groove, 
with requisite narrowing of the major groove (65-68). Therefore, it is possible that 
presence of the polyamides can have an indirect effect on the interaction of the pre-
integrative complex within the major groove. It is also expected that binding of 
polyamides in the minor groove will reduce the flexibility of a given stretch of DNA, 
reducing access to DNA conformations that could be important in the dynamic process of 
target site selection. 
These studies represent the first generation of polyamides which inhibit MuL V 
integration. Four potent inhibitors were developed, two which inhibit 3' -processing (5 
and 6), and two which inhibit both 3' processing and strand transfer (1 and 3). These 
different classes of inhibitors could be useful tools for unraveling the complex 
mechanism of integration. Both sets of compounds are effective at a less than lO-fold 
excess over substrate DNA and less than half an equivalent of integrase protein. Next 
generation polyamides can incorporate hydroxypyrrole68 and hydroxybenzamide38 
residues, which break the A-Trr-A degeneracy of the PylPy and Bz/Py pairs, allowing 
for greater sequence specificity. Strategies other than increasing the binding efficiency 
could make the inhibitors more potent. Alterations in the structure of the polyamides 
could change the conformation of the LTR and/or interfere with the binding of the IN. 
Modified polyamides which may be able to clamp the terminal TT dinucleotide by 
alkylation69,7o may be envisioned. Certainly, a crystal structure of an IN-LTR complex 
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would aid the design of polyamide inhibitors. Alternatively, the polyamides can serve as 
the matrix to be coupled with additional inhibitors, for example, compounds that bind the 
enzyme active site.7 ! Delivery of these compound inhibitors to the enzyme would be 
facilitated by the binding of the polyamides to the viral DNA. 
The HIV -1 IN and M-MuL V IN share the same mechanism of integration. It is 
very likely that the same strategy of designing polyamide inhibitors can be applied to the 
HIV-l IN. Studies are currently underway to test polyamides with the HIV-1 INILTR 
system. Given the previously demonstrated efficacy of polyamides targeted to HIV -1 in 
human cells (33), this approach may ultimately yield potent in vivo HIV-l IN inhibitors. 
The modular nature of polyamide recognition and synthesis should allow for rapid and 
rational changes to the inhibitors in response to viral mutations . 
Appendix: DNA Melting Experiments 
A set of DNA melting experiments was designed to test the ability of hairpin 
polyamides to bind to the absolute ends of DNA fragments. Duplex A represents the 
terminal 13 bp of the M-MuLV LTR, 5'-AATGAAAGACCCC-3' (Figure 2.8). Duplex 
B has the same nucleotide composition, with two base pairs moved from the 3' to the 5' 
end of the duplex, which shifts the binding site of the polyamides away from the end of 
the duplex. Polyamide 5 places Dp against position 1 of duplex A and position 3 of 
duplex B. Polyamide 6 places the tum ((Rl2Ny) against position 2 of duplex A and 
position 4 of duplex B. Polyamide 7 places the tum ((R)H2Ny) against position 1 of duplex 
A and position 3 of duplex B. Polyamide 8 is a double base pair mismatch for both 
duplexes. Melting curves were obtained by standard UV-vis spectroscopy (80° C-15° 
C, 1° C/minute, scan at 260 nM every 30 seconds) for both duplexes (2 f..lM) in the 
absence and presence of 2 f..lM polyamide (5-8). These experiments were preformed 
using buffered conditions (see legend, Table 2.2) designed by Pilch et al. to be similar to 
those used for DNase I footprinting titrations. 47 
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Figure 2.8 
A) 
5' 3' Duplex A 3' 5' 3' 
DuplexB 
3' 5' 3' 
Match Site 
DNA ~ ~ 
Polyamide 
3' 5' 3' 5' 3' 5' 3' 5' 3' 5' 
B) 
Duplex A DuplexB 
5 
SI-C C 
6 
T C T G G G G-5' 
'--------' 
3 1 _G G 
7 
8 
Figure 2.8 A) Cartoon of the DNA melting experiments. The same binding site is placed at the end and 
middle of two short DNA duplexes. B) Sequences of the duplexes A and B with ball-and-stick models for 
the polyamides showing the binding site in a box and mismatches in gray. 
All polyamides tested increased the stability of both duplexes as measured by an 
increase in the melting temperature (TM) of the duplex in the presence of the 
polyamide(Tale 2.2). As expected, for duplex B with the internal match site, the LiTm for 
match polyamides was significantly higher than the mismatch polyamide and the order of 
increasing LiTm matched the order of increasing Ka as measured by DNase I footprinting 
(8«7<6<5). The same order was observed for duplex A, and the LiTm of the match 
polyamides were all significantly higher than the mismatch. This indicates that 
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Table 2.2. DNA melting with internal and terminal olyamide binding sites" 
Ka Tm Tm ~Tm ~Tm ~~Tme % 
(DNase I)b Duplex Duplex B' Ad MTmI 
(M- l ) B'(°C) Ad(0C) CC) (0C) (0C) ~TmB 
45.9 46.9 
5 4 .0xlOlO 69.9 68.0 24.0 21.1 2.9 12% 
6 l.7xlOlo 67.5 66.4 2l.6 19.5 2.1 10% 
7 3.0x109 63.0 62.5 17.1 15.6 l.5 9% 
8 ~5x106 54.8 53.9 8.9 7.0 l.9 21% 
Table 2.2 "Melting curves (80° C-1So C, 1° C/minute) were obtained in 10 mM sodium cacodylate, 10 
mM KCl, 10 mM MgClz" 5 mM CaCI2, 2 11M polyamide and 2 11M DNA duplexes A or B were used in 
each experiment. bSee Table 2,1 and Experimental Procedures, '~Tm B is defined in the difference in 
melting temperature of duplex B with the addition of polyamide, d~Tm A is defined in the difference in 
melting temperature of duplex A with the addition of polyamide, 'MTmis defined as ~Tm B - ~Tm A, 
polyamides can bind specifically to a match site at the absolute end of a DNA fragment 
with high affinity, although in each case ~Tm A was slightly lower than ~Tm B, For 
each of the match polyamides, the ~~Tm was approximately 10% of ~Tm B. A rough 
calculation using the relationship ~ Tm oc In Ka suggests that poly ami des 5-7 have a 3-
fold lower affinity for the terminal match site as compared to an internal match site 
(assuming that polyamides 5-7 bind the match site on duplex B with similar affinity to 
the same match site on the larger fragment used for DNase I footprinting). It is 
interesting to note that the penalty for binding to the end of duplex A is essentially the 
same whether the turn or the tail is placed against the first base pair, or the turn is placed 
against the second base pair. The lack of difference between the terminal two base pairs 
is likely due to fraying of terminal A ,T base pairs. Duplex A, which represents the natural 
M-MuLV termini, may be especially prone to fraying of the terminal base pairs, as this is 
likely an important structural element for integrase recognition.63 
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Chapter 2B: 
Inhibition of HI V-I Integration by Hairpin Polyamides I 
Introduction 
As discussed in Chapter 2A, hairpin polyamides are effective inhibitors of the in 
vitro integration of M-MuLV, a retrovirus related to HIV-l. HIV-l integrase is 
increasingly the focus of antiviral research. 2- 11 In addition to being an important 
therapeutic target, inhibition of HIV -1 integration is a promising goal for hairpin 
polyamides, given the positive cellular uptake and nuclear localization properties of 
polyamide-fluorescent dye conjugates in both cultured and primary human T -cells as 
compared to other cell-lines (Chapter 4). Previous studies have shown that polyamides 
targeted to HIV -1 promoter inhibited viral replication in human peripheral blood 
lymphocytes. 12 Thus, the current generation of hairpin polyamides, if they are shown to 
be effective HIV -1 integrase inhibitors, may have sufficiently favorable uptake and 
localization properties to be useful biochemical tools for understanding HIV -1 integration 
in cell culture, and as lead compounds for therapeutics. This chapter describes 
preliminary studies aimed at generating potent polyamide inhibitors of HIV -1 integration. 
Unlike M-MuLV, in HIV-l the two ends of the reverse-transcribed DNA are not 
the same, thus HIV-l integrase has two different recognition sites, the termini of the U3 
and U 5 L TRs. Our studies focused on the terminal base pairs of the U 5 L TR, 5'-
ACTGCTAGAGATTTT-3' (Figure 2.9A). Seven polyamides (8-14) were designed to 
bind sites ranging from positions 1 to 15 of the HIV-l U5 LTR (Figures 2.9B and 2.10). 
The affinities of polyamides for their target sites were measured by DNase I footprinting 
titrations using an internal copy of the HIV-I U5 LTR terminus. Several of the 
compounds designed for the M-MuLV LTR were also investigated as mismatch controls. 
Polyarnides were screened in preliminary cell-free assays for inhibition of 3' processing 
and strand transfer. 
Figure 2.9 
A) s· -ACTGI 
3' -TGAC USLTR Reverse Transcribed HIV ·1 
//// US IN recognition site """"""""", ..... . 
..- 1 3 5 7 9 11 13 ....• 
S'-A C T GeT A GAG A T T T-3' B) 
3'-T G A eGA T eTC T A A A-S' 
U3LTR ICAGT-3' GTCA-S' 
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U3 IN recognition site 
Figure 2.9. A) Schematic representation of the HIV -1 genome following reverse transcription. HIV-l 
integrase recognizes two distinct sequences at the termini of the viral DNA. This work focuses on 
polyamides targeted to the U5 LTR terminus, sequence and numbering as shown. The conserved 5'-CA-3' 
residues are underlined. The two terminal bases to the 3' side of the CA dinucleotide, 5'-GT-3', are 
excised in the 3' -processing step by HIV -1 IN. B) Chemical structures of the polyamides targeted to the 
U5 L TR terminus. 
Results and Discussion 
Polyamide Design. A general discussion of the pairing rules and other aspects of 
polyamide design is provided in Chapter 2A. Compared to the M-MuLV LTR terminus, 
the HIV-l U5 LTR terminus has a greater G,C content on the terminal half of the 
sequence, and a greater A,T content on the internal half (compare Figure 2.10 to 2.1B). 
Figure 2.10 
8 5'~GAGAT TTT-3' 
3'-T G A C GAT C T C T A A A A-5' 
5'-A '(:' T G C TAG A GAT T T T- 3' 
9 1~
3' -T 'G' A C GAT C T C T A A A A-5' 
5'-A c i T G C TAG A GAT T T T-3' 
10 ~
3' -T a ,A C GAT C T C T A A A A-5' 
5'-A C T G C TAG A GAT T T T-3' 
11 ~~ 
3'-T G A C GAT C T C T A A A A-5' 
5'-A C T G C TAG A GAT T T T- 3' 
12 ~
3'-T G A C GAT C T C T A A A A-5' 
5' -A C T G C TAG A GAT T T T-3' 
13 ~
3'-T G A C GAT C T C T A A A A-5' 
14 5'-A C T G C T A~3' 
3'-T G A C G A T 'CT C T A A A A-5' 
Figure 2.10. Ball-and-stick representations of 
the polyamides and their binding sites within the 
HIV-l US LTR terminus. Mismatches with the 
Dp tail are highlighted. For description of the 
ball and stick representation see Figure 2.1B. 
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Whereas in M-MuL V the internal half of the 
integrase recognition site was largely 
blocked from efficient recognition by the 
current generation of hairpin polyamides by 
the presence of five G·C base pairs in a row, 
this region was readily amenable to poly-
amide design in the HIV-l U5 LTR (Figure 
2.10). In particular, positions 6-12 were 
targeted with the known "Im-/3-Im" 
polyamide 11,13 and positions 8-15 were 
targeted with the known I-imidazole ten 
ring polyamide 14.14 Note that 14 is not a 
perfect match for this sequence as it places 
the Dp tail against a G·C base pair. 15 New 
polyamides 12 and 13 were designed as 
extensions of the Im-/3-Im motif of 11 to 
larger binding sites. Polyamide 12 
incorporates this motif into a ten-residue 
polyamide, targeting positions 6-13. 
Polyamide 13 has an unusual Im-/3-Im-/3-PyPy N-terminal strand, paired with a 2-/3-3 C-
terminal strand, designed to target a nine base pair sequence (positions 6-14). 
Polyamides 8-10 were designed to occupy the center of the integrase recognition site, 
including the conserved 5'-CA-3' dinucleotide (positions 3-4). The /3/Py pair containing 
polyamide 9 is the exact analog of polyamide 2 (Chapter 2A), both are targeted to 
positions 2-9 of their respective LTRs. Previously known polyamide 10 is the /3//3 pair 
analog of 9. 14 However, unlike 2 with the M-MuLV sequence, 9 and 10 are not perfect 
match compounds, since the Dp tail is placed against a C·G base pair. Polyamide 8, 
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which served as a mismatch compound for the M-MuLV study, was designed to bind at 
the absolute end of the U5 LTR, as well as the critical CA dinucleotide, covering 
positions 1-7. 
Quantitative DNase I Footprinting. Quantitative DNase I footprinting 
titrations l6 were performed to determine the equilibrium association constants (K,) of 
polyamides 8-14 for their target sites in the HIV-1 U5 LTR, using a 194 bp DNA 
fragment derived from an HIV-1 circle junction (Table 2.3). Polyamides 2-3 were also 
investigated as mismatch controls. The circle junction was formed from the joining of 
the two ends of reverse-transcribed HIV-1 genome, such that the U5 and U3 LTR termini 
are adjacent internal sequences in the circle junction plasmid (HIV _cj).17 This is a 
convenient plasmid for identifying integrase inhibitors, since both of the viral termini are 
present on the same fragment. Polyamide 8 bound its target site at the absolute end of the 
U5 LTR with reasonable affinity (Ka = 2 x 109 Mol) and excellent specificity (Figure 
2.11). Polyamides 9 and 10 bound their match site with reasonably good affinity 
considering the Dp mismatch, with the 2-~-2 polyamidel0 preferred by a factor of 4. 
However, the mismatch control polyamide 2 bound this sequence with only slightly 
lower affinity than 9, and mismatch control polyamide 3 bound with the same affinity as 
8 and 10. Polyamide 2 is a single base pair mismatch of 9-10 as well as 14, and binds 
both overlapping cognate sites (positions 2-15, Ka = 2 X 108 Mol). Polyamide 3 also 
bound this entire region. Polyamide 11 was specific for its match site, but showed low 
affinity equal to mismatch 2. Polyamide 11 generally exhibits a :?::lO-fold higher K,,18 the 
low affinity in this case is consistent with an energetic penalty for recognition of 5' -GA-
3' steps as compared to 5'-GT-3' steps.19 Polyamides 12 and 13 bind the same site as 
polyamide 11, extended internally by one and two base pairs, respectively. Very unusual 
behavior was observed at this site for polyamide 12, in that a hypersensitive cleavage 
band appeared to grow in within the footprint, precluding reliable quantitation at this site. 
Table 2.3. Equilibrium association constants for 
an internal copy of the HIV -1 U5 LTR terminus. 
Polyamide 
8 ~ 
9 ~  
10 ~ 
11 ~ 
12 ~\!-
13~ 
14 .OO~ f>+OOO + 
Sequence 
5'-agtACTGCTAgag-3 1 
S' -gtaGTGCTAGAgag-3' 
5'-gtaCIGCTAGAgag-3' 
5'-tgcTAGAGATttt-3' 
S'-tgcTAGAGATTttc-3' 
5'-tgcTAGAGATTTtcc-3' 
5'-ctaQ8GATTTTcca-3' 
5'-gta~GCIAGAgag-3Ib 
5'-ctaG~GATTTLcca-31 
3 ~r. 5 r -c caGIAC.T.GC'!:bGAgag-3 I 
~5'-ctg~AG~GATTT~ca-3' 
Ka (M-l) 
2 x 109 
5 x 108 
2 x 109 
1 x 108 
a 
-1 x tolO 
2 x 1010 
1 x 1010 
2 x 108 
b 
2 x 109 
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3'5' 
I I 
AI' 
CG 
TA 
J- GC CG 
TA 
AT 
II 
5'3' 
32p 
Table 2.3. Values reported are the mean values obtained from at least two DNase I footprint titration 
experiments. Mismatched residues are underlined. The assays were carried out at 22° C, 10 mM Tris-HCI 
(pH 7.0), 10 mM KCl, 10 mM MgCI2, and 5 mM CaCI2. (a) This value is an estimate, not quantitative (see 
text). (b) Overlapping sites. 
Figure 2.11. Quantitative DNase I footprint titration experiment with polyamide 8 on a 5' 32p labeled 194 
base pair DNA fragment containing an internal copy of the HIV -1 US L TR terminus: lane 1, A reaction; 
lane 2, G reaction; lane 3, DNase I standard; lanes 4-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 
1 nM, 2 nM, 5 nM, and 10 nM polyamide, respectively; lane 14, intact DNA. All reactions contained 10 
mM Tris-HCl (pH 7.0), 10 mM KCl, 10 mM MgCI2, and 5 mM CaCI2 , and were performed at 22° C. 
Visual inspection of the gels suggests that the affinity (K" - 1 x 1010 M· l ) is considerably 
higher than for polyamide 11. The large polyamide 13 bound this region with high 
affinity without exhibiting unusual behavior, however, it coated the DNA (bound to all 
sequences uniformly) at relatively low concentrations. Polyamide 14 bound its match 
site with high affinity (Ka = 1 x 1010 M· l ) and good specificity. 
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Figure 2.12. Preliminary ICso of polyamides on oligonucleotide-based HIV -1 integrase activities. Each 
polyamide (25-1600 nM) was titrated in either the 3' processing (grey) or strand transfer (black) assays. 
IC50 values were determined as the concentration of each polyamide that inhibited IN activities by 50%. 
In Vitro HIV-1 Integration Assays. Preliminary cell free assays of HIV-1 
integrase activity were performed in analogy to the assays reported for M-MuLV 
integration in Chapter 2A. It should be noted that the M-MuL V IN assays were 
following overnight incubation of the polyamides with the substrate DNA. The 
preliminary HIV -1 IN assays were performed with a much shorter pre-incubation time 
(::;1 hour). The ICso values for 3' processing and strand transfer ranged from a moderate 
400 nM to 2':1600 nM (Figures 2.12 and 2.13). A major conclusion of Chapter 2A is that 
polyamides which bind at the termini of the M-MuLV LTR were much more effective 
inhibitors of the 3' processing reaction than the strand transfer reaction, while polyamides 
that bound internally through position 9 had similar efficacy for both reactions . 
Polyamide 8 was the only polyamide designed for the absolute end of the HIV -1 U5 
L TR, and unfortunately was a poor inhibitor of both 3' processing and strand transfer 
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Figure 2,13. A) Schematic of the strand transfer assay with the sequence of the labeled oligonucleotide 
shown below. HIV-l IN is added to the precleaved duplex which yields 32P-Iabeled products larger than 
the input substrate, as well as smaller products from the invaded strand. B) An HIV·I IN strand transfer 
assay with polyamides 2,3,9,10, highlighting the enhanced bands resulti ng from novel cleavage of the 
substrate or altered target site selection. Lane 1, no protein control; lanes 2,7,12, and 17 HIV-l IN alone. 
Lanes 3·6, IN plus polyamide 2; lanes 8·11, IN plus polyamide 3; lanes 13-16, IN plus polyamide 9; lanes 
18·21, IN plus polyamide 10. The concentrations of the polyamide used are (left to right); 1, 10, 100 and 
1000 nM. 
(IC50 ~ 1600 nM). Polyamide 9 was the only polyamide tested which displayed a 
difference in inhibition between assays, favoring the 3' -processing assay by a factor of 2. 
The majority of polyamides tested were 800 nM inhibitors in both assays. Mismatch 
control 2 had the same values as match compounds 9-11 and 13-14 in the 3' processing 
assay, and outperformed its analog 9 in strand transfer inhibition. Similarly, extended 
hairpin 3, also intended as a mismatch control, was one of only two 400 nM inhibitors. 
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The other moderately potent inhibitor was polyamide 12, which displayed both high 
affinity and unusual behavior in the DNase I footprinting experiments. 
Figure 2.13B shows a set of strand transfer assays highlighting novel cleavage 
bands which were observed for some, but not for all of the polyamides tested. These 
bands may be the result of direct cleavage of the substrate DNA by the nuclease activity 
of HIV-1 at a site other than the 5'-CA-3' dinucleotide, or they may represent altered 
target site selection events, as seen for M-MuLV. However, further work is necessary to 
define this. Note that for 2 and 10, the novel cleavage bands occurred at the same (high) 
concentration as inhibition of the normal strand transfer products, but for 9 inhibition did 
not occur at an appreciable extent, even though the novel cleavage bands are quite 
intense. Independent of inhibition, the ability of polyamides to alter target site selection 
or to induce direct cleavage of the substrate viral DNA at unnatural sites suggests 
exciting new roles for polyarnides in HIV -1 integration research. 
Overall the preliminary results are encouraging, although similar compounds 
appear to be somewhat less potent for HIV-1 integration inhibition than M-MuLV 
integration inhibition. This may reflect structural differences in the integrases 
themselves/o differences in substrate recognition by the integrases,21.23 potential 
differences in oligomeric state of the proteins on and off the DNA;24-28 or, simply that 
optimal polyamides have not yet been generated for the HIV-1 U5 LTR terminus. Lower 
inhibition for HIV-1 than M-MuLV with polyarnides targeted to the same positions with 
essentially the same affinity (compare 8(HIV-1) with 7(M-MuLV), and 10(HIV-l) with 
I(M-MuL V)), is consistent with studies of modified LTRs containing nucleotide analogs 
that suggested that changes to the minor groove had a lesser affect on HIV -1 integrase 
activity than M-MuLV integrase activity.22 Thus, it may require polyamides with higher 
affinities to reach the same levels of inhibition. 
In terms of optimizing binding affinity, polyamides 9,10 and 14 might benefit 
from replacement of the ~-Dp tail by a shorter derivative such as methyl amide (see 
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Chapter 5), which would elimate Dp mismatches. However, in terms of inhibition, 10 
would probably benefit from an extended tail rather than a truncated tail, since 3 (which 
has the C-terminal extension), even as a mismatch was one of the two most potent 
inhibitors in this study, and for M-MuLV it was most potent in the more demanding assay 
of strand transfer into an exogenous target. The M-MuL V study also suggests that the 
ten-ring analog of 9 and 10, potentially with the y-turn instead of the (R)H2Ny_turn, may be 
an especially effective inhibitor (in analogy to 1). 
A hypothesis from the M-MuL V study was that polyamides targeting internal 
sites such as 14 might be better strand transfer inhibitors than 3' -processing inhibitors. 
While this does not appear to be the case for HIV -1 integrase, the fact that a polyamide 
which binds so far away from the viral terminus is an inhibitor at all suggests that good 
inhibition may be obtained by targeting this internal site and the viral terminus 
simultaneously with two polyamides binding nonoverlapping sites. Toward this end, a 
methylamide tail for 14 would be especially beneficial as it would open up an extra base 
pair in the target region for a second polyamide to bind. It would also be interesting to 
investigate truncated tail analogs of the most potent match inhibitor 12, which would 
open up a base pair in the target region and may shed light on the usual behavior of 12 
with regards to DNase I footprinting. 
In order to target two polyamides to the HIV-l U5 LTR, better options that 8 will 
have to be found for the LTR terminus. Here, the affinity for the substrate DNA will be 
lower than for the K. obtained by footprinting analysis (see Chapter 2A appendix), and 
only compounds (5,6) with equilibrium association constants above 1010 M·I were truly 
effective inhibitors of M-MuL V integration. It was noted these compounds were not 
effective strand transfer inhibitors for M-MuL V, and it will be interesting to see if tighter 
binders for the terminal portion of the HIV-l U5 LTR behave similarly. 
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Conclusions 
The polyamides described here, while at present are only moderate inhibitors of 
the in vitro reactions of HIV -1 integrase, are valuable lead compounds for further 
development. Particularly noteworthy was the high activity of mismatch polyamide 3, 
which argues that a C-terminal extension at the viral terminus is beneficial for inhibition, 
and the inhibitory activity of polyamides which bind internally from the viral terminus 
such as 12 and 14. With the development of higher affinity compounds targeted to the 
terminus, this should allow for synergistic inhibition by two polyarnides, which has been 
successful in other studies on HIV -1 inhibition. 12 Thus far, the U3 LTR terminus remains 
an unexplored target for polyamide inhibition of HIV -1 integration. In addition to 
polyamides with improved binding affinity and placement within the U5 and U3 LTRs, 
potent inhibitors may be obtained by modified polyamides which could be designed to 
deliver known integrase inhibitors to the enzyme, or to trap the terminal nucleotides by 
alkylation, as discussed in Chapter 2A. Additionally, "positive patch" polyamides29. 31 
may be able to directly target the phosphate group that is attacked by HIV- l integrase in 
the 3' processing step. Finally, the most interesting result of the current study is the 
novel cleavage bands that are observed in the in vitro assays with some, but not all, of the 
polyamides, and which did not appear to be directly related to inhibition. Further study 
of this unusual phenomenon may outline new roles for poly ami des in the study of HIV-1 
integration. 
Experimental 
Polyamides. All polyamides were synthesized by solid-phase methods as 
previously described/2,33 and characterized by analytical HPLC and MALDI-TOF mass 
spectrometry. For polyamides 1-8, see Chapter 2A. ImPy_~_PyIm_(R)_H2Ny_PyPyPyIm_ 
Py-~-Dp (9) [M+H] 1431.84, 1431.68 calculated for [M+H]. IrnPy_~_PyIm_(R)_H2Ny_ 
PyPy-~-ImPy-~-Dp (10) [M+H] 1380.83 , 1380.67 calculated for [M+H]. Im-~-IrnPy-
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(R)_H2N'Y_pypyPyPy_~_Dp (11) [M+H] 1186.65, 1186.57 calculated for [M+Hl Im-~­
ImPyPy_(R)_H2N'Y_pyPypyPyPy_~_Dp (12) [M+H] 1430.74, 1430.67 calculated for 
[M+H]. Im-~-Im-~-PyPy-(R)-H2N'Y-PyPy-~-PyPyPy-~-Dp (13) [M+H] 1572.97, 1572.74 
calculated for [M+Hl IrnPyPyPyPy_(R)_H2N'Y_PyPyPyPyPy-~-Dp (14) [M+H] 1480.82, 
1480.60 calculated for [M+Hl 
DNase I Cootprinting. DNase I footprinting reactions were performed as 
previously described;6 using a 194 base pair 5,-32P-labeled DNA fragment derived from 
an HIV-l circle junction, such that the HIV-l U5 and U3 LTR terminal sequences are 
connected in the center of the fragment. The labeled fragment was generated by the PCR 
method14.16 using primers 5'-GTTGTGTGACTCTCGGTAACTA and 5'-GTCAGTGGAT 
ATCTGATCCT and an HIV-l circle junction-containing plasmid (HIV-cj, provided by 
the Roth group)17 as the template. Primers were prepared and purified by the Caltech 
Biopolymer Synthesis Facility. The sequence of the labeled fragment is listed here with 
the terminal 14 base pairs of the HIV-l U5 LTR shown in bold: 5'_32p GTTGTGTGACT 
CTCGGTAACTAGAGATCCCTCAGACCCTTTTAGTCAGTGTGGAAAATCTCTA 
GCAGTACTGGAAGGGCTAATTCACTCCCAACGAAGACAAGATATCCTTGATC 
TGTGGATCTACCACACACAAGGCTACTTCCCTGATTAGCAGAACTACACACC 
AGGGCCAGGGATCAGATATCCACTGAC. 
In vitro assays. Cell-free integration assays were performed by Fan Yang in the 
Roth group using standard methods34 analogous to the reactions described in Chapter 2A 
for M-MuLV integration. 
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CHAPTER 3 
DNA Binding Polyamides for the 
Inhibition of HER2 Transcription 
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Abstract 
Overexpression of the growth factor receptor/tyrosine kinase HER2 is observed in 
approxmately 30% of human breast cancers. HER2 overexpression is associated with 
tumor metastasis and resistance to chemotherapy. HER2 is itself an important target for 
chemotherapy, and has been the focus of antisense and antigene therapies. A 
comprehensive series of DNA binding polyamides has been designed to bind proximally 
to the TAT A box on the HER2 promoter. The affinity and specificity of the polyamides 
for the target site has been determined and compared with related site. The same series 
of polyamides behaves quite differently in these two ostensibly similar contexts. For the 
HER2 site, high-affinity compounds were obtained which were strong inhibitors of TBP-
binding and in vitro transcription of the HER2 gene. HER2 transcription inhibition in 
cell culture remains an ongoing goal. 
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Introduction 
The growth factor receptor/tyrosine kinase HER2 (also known as neu and erbB-2) 
is overexpressed in approximately 30% of human breast cancersY HER20verexpression 
is associated with tumor metastasis and resistance to chemotherapy.3 In addition to breast 
cancer, HER2 has also been linked to ovarian and lung cancers, wherein overexpression 
correlates with shorter patient survival time.4 Overexpression does not appear to result 
from a transforming mutation in the HER2 gene itself, suggesting that the wild type is 
oncogenic under these conditions. Overexpression has been shown to result from both 
gene amplification5 and transcriptional upregulation.6 HER2 is a member of the 
epidermal growth factor (EGF) class of receptorltyrosine kinases, which includes 
epidermal growth factor receptor (EGFR, erbB-l), erbB-3, and erbB-4. 4,7 These four 
receptors are known to interact with over thirty growth factor ligands such as EGF and 
transforming growth factor (TGF)-a. Two populations of receptors for the same growth 
factor are typically observed: a low-affinity population, which has been interpreted as the 
monomer, and a high-affinity population, which has been interpreted as the dimer, 
although this generally accepted view has been recently challenged. 8,9 A HER2-specific 
ligand has not yet been isolated, and indeed such a ligand may not exist. Instead, HER2 
appears to be a shared, low-affinity receptor (co-receptor) for multiple growth factors 
which HER2 binds as a heterodimer with each of the other three erbB receptors (Figure 
3.1).4 HER2 is the preferred heterodimerization partner among the erbB receptors and 
acts as a potent tyrosine kinase in the heterodimer.7 The erbB receptors also form 
homodimers which are active in signal transduction, although the physiological role of 
the HER2 homodimer is a subject of debate.1O With input from more than thirty growth 
factor ligands, the four erbB receptors activate more than fifty effectors.4 All of these 
effectors appear to activate MAP-kinases, which ultimately trigger cellular growth and 
differentiation. It is readily apparent that disturbing this complex regulatory network by 
overexpressing the most permissive of the erbBs can lead to cancer. Among the down-
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Figure 3.1 
A) 
B) 
Figure 3.1. HER2 (also known as neu, erbB-2) is an EGF receptor/tyrosine kinase, which acts as a low-
affinity co-receptor for ligands such as TGF-Cl, and as a co-activator for effectors such as Ras-GAP, which 
ultimately activate MAP-kinases, leading to cell growth and differentiation. A) Schematic of ligand 
recognition by erbB dimers. B) Overview of the erbB signaling signaling network4 
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stream targets of HER2 are promoters of metathesis and angiogenesis, which are likely 
responsible for the aggressively malignant phenotype observed in HER2-overexpressing 
breast cancers.6,11 . 13 Additionally, several of the downstream targets are transcription 
factors which upregulate transcription of the HER2 gene itself, largely through the 
intermediacy of the Ets transcription factor ESX, resulting in positive feedback.13•1s Thus, 
even an initially minimal amount of HER2 overexpression can have considerable 
transforming potential. 
HER2 is an important target for breast cancer chemotherapy. In particular, 
trastuzumub, a humanized monoclonal antibody targeting the HER2 receptor, has proven 
to be highly effective for the treatment HER2-positive breast cancer, particularly in cases 
with high overexpression of the HER2 gene, both as a first-line therapy and in 
combination with more traditional chemotherapeutic agents. 16•17 Trastuzumub (marketed 
as Herceptin), one of the first monoclonal antibodies used clinically for human cancer 
therapy, is widely considered a biotechnology success story. The clinical efficacy of 
trastuzumub has prompted considerable interest in additional HER2-related therapeutics, 
including second generation antibodies l 8,19 and peptides derived from the HER2 receptor 
itself as tumor vaccines.20 
There is also significant interest in HER2 as a target of anti gene and antisense 
studies.21 The typical HER2-overexpressing, aggressively malignant tumor has two to ten 
copies of the HER2 gene and one million copies of the HER2 receptor, providing a 
mathematical rationale for antisense or antigene therapy. Antisense oligonucleotides 
have been shown to reduce HER2 mRNA and protein levels in a dose-dependent, 
sequence-specific manner. 22.23 Oligonucleotide-induced down-regulation resulted in 
inhibition of cell-cycle progression at G1 and apoptotic cell death of cultured HER2-over-
expressing breast cancer cells. Induction of apoptosis was synergistically enhanced by 
the co-administration of conventional chemotherapeutics (which these HER2-over-
Figure 3.2 
The HER2 Promoter 
5'-CCCGGGGGTCCTGGAAGCCACAAGGTAAACACAACACATCCCCCTCCTTGACTATGCAATTTTACTA 
GAGGATGTGGTGGGAAAACCATTATTTGATATTAAAACAAATAGGCTTGGGATGGAGTAGGATGCAAGCT 
. CCCCAGGAAAGTTTAAGATAAAACCTGAGACTTAAAAGGGTGTTAAGAGTGGCAGCCTAGGGAATTTATC 
CCGGACTCCGGGGGAGGGGGCAGAGTCACCAGCCTCTGCATTTAGGGATTCTCCGAGGAAAAGTGTGAGA 
AP-2 
ACGGCTGCAGGCAACCCAGGCGTCCCGGCGCTAGGAGGGACGACCCAGGCCTGCGCGAAGAGAGGGAGAA 
AGTGAAGCTGGGAGTTGCCGACTCCCAGACTTCGTTGGAATGCAGTTGGAGGGGGCGAGCTGGGAGCGCG 
CCAAT box Polypurine/polypyrimidine mirror repeat Ets TATA box 
CTTGCTC~CACAGGAGAAGGAGGAGGTGGAGGAGGAGGGCTGCTTGAGGAAGTATAAGAATGAAGT 
ZONAS 
TGTGAAGCTGAGATTCCCCTCCATTGGGACCGGAGAAACCAGGGGAGCCCCCCGGGCAGCCGCGCGCCCC 
A+1 --
TTCCCACGGGGCCCTTTACTGCGCCGCGCGCCCGGCCCCCACC-3' 
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Figure 3.2. Sequence of the HER2 promoter2• with the main transcription factor binding sites (postive 
regulators AP-2, CCAAT box, Ets, and the TATA box, and repressor ZONAB), structural elements (the 
polypurine/polypyrimidine mirror repeat), and the major transcription start site (+1) shown 21 Translation 
of the protein begins at + 178 relative to the major transcription start site. 
expressing cells are resistant to in the absence of antisense oligonucleotides). Triplex-
forming oligonucleotides have been used to successfully target a polypurine/poly-
pyrimidine minor repeat which is an important structural regulatory element in the HER2 
promoter24 (Figure 3.2), resulting in transcription inhibition in cells when administered 
with lipofection.25 The HER2 promoter has also been successfully targeted by designed 
zinc finger transcription factors. 26 In a powerful demonstration of designed gene 
regulation, fusions of the designed zinc finger with transcriptional repressor and activator 
domains were able to repress and activate, respectively, HER2 transcription in cell-
culture. 27 Repression in HER2-overexpressing breast cancer cells by the designed zinc 
finger transcription factors resulted in G 1 accumulation, similar to the inhibition of cell-
cycle progression observed with antisense oligonucleotides. Together these studies 
demonstrate the potential of transcriptional and posttranscriptional regulation for the 
treatment of HER2-overexpressing human breast cancers. 
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The Dervan laboratory has also been interested in the HER2 promoter, as part of a 
program aimed at the development of small molecule modulators of gene regulation?8,29 
Polyamides composed of N-methylpyrrole (Py) and N-methylimidazole (1m) 
carboxamides can be designed to bind specifically to a large number of predetermined 
DNA sequences, with affinities that rival natural transcription factors .30,3 1 In a hairpin 
polyamides, the N- and C-terminal strands of Py/lm aromatic amino acids are connected 
by an alkyl amino acid-either y-aminobutyric acid (y), or the chiral, amine-
functionalized derivative (R)-2,4,-diaminobutyric acid ((R)H2Ny)_and bind side-by-side 
in the minor groove of DNA with an antiparallel orientation relative to each other and a 
5' -3 ' N-C orientation relative to DNA. This binding motif results in amino acid pairings 
in the minor groove that stack the aromatic Py/lm rings against each other and the walls 
of the groove allowing backbone amide hydrogens and the substituents at the 3-position 
of the polyamide residues to make specific contacts with the edges of the DNA base 
pairs. These specific contacts translate into a set of pairing rules for DNA recognition by 
hairpin polyamides. A Py/lm pair targets a CoG base pair, an ImlPy pair targets a G-C 
base pair, and a Py/Py pair binds to an A-T or T-A base pair. The N-methyl-3-
hydroxypyrrole (Hp) residue has been developed to break the degeneracy of the Py/Py 
pair. Hairpin polyamides which bind six to seven base pair sites with high affinity (109 _ 
10 10 M· I ) have been shown to be effective in cell-free assays at the inhibition of 
transcription by interfering with transcription factor binding.29 Polyamides have also 
been shown to bind their cognate sites on isolated nuc1eosomes.32 In vivo, polyamides 
targeted to transcription factor binding sites in the HIV -1 promoter resulted in inhibition 
of retroviral replication in human cells. 33 Two polyamides targeted to sequences 
proximal to the DNA recognition sites for the ETS-1, LEF-1, and TBP transcription 
factors in the HIV-1 promoter acted in synergy at 111M each to obtain >99.9% inhibition 
of retroviral replication. 
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Figure 3.3. Examples of poly ami des targeted to transcription factor binding sites on the HER2 promoter. 
The promoter is shown schematically in the center beginning with the major transcription start site (+1) on 
the right, with the positions of transcription factor binding sites shown to scale. The sequences shown 
above and below highlight the transcription factor binding sites (boxes) and targeted polyamides (ball-and-
stick models). The symbols for polyamides are open, filled, and slashed circles, 1m, Py and Bz rings, 
respectively; curved lines, y-aminobutyric acid; diamonds, l3-alanine; dimethylaminopropylamine tail and 
amino group of (R)-2,4-diaminobutyric acid, plus signs. Polyamides designated PA (PA-I, PA-9, PA-13) 
were prepared by Roland Burli. Polyamide S, this work. 
In addition to the therapeutic potential of targeting the HER2 promoter, inhibition 
of HER2 transcription in vivo would demonstrate the efficacy of polyamides for 
regulation of an endogenous human gene in human cells. Polyamides have been targeted 
to three of the most important transcription factor binding sites in the HER2 promoter, 
the AP_2/4 Ets/s and TBP binding sites (Figures 3.2 and 3.3). This work focuses on the 
TAT A box, the recognition element for the TAT A Binding Protein (TBP), a saddle-
shaped protein that binds in the minor groove of DNA, causing a large bend in the double 
helix (Figure 3.4)?5 TBP is the DNA binding subunit of the TFIID transcription factor, 
which nucleates the assembly of the RNA polymerase II transcription machinery. The 
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Figure 3.4 N 
Figure 3.4. The TATA-binding protein (TBP, TFIID). TBP2 from Arabidopsis thaliana shown 
complexed with the Adinovirus major late promoter TATA element.35 +1 represents the transcription start 
site. 
TATA box is a ubiquitous transcriptional element found in many human promoters.36 
Minor-groove contacts are made on both sides of the consensus TAT A sequence, and 
polyamides targeted to proximal sequences are likely to inhibit TBP binding by direct 
competition for the minor groove, and by allosteric stabilization of B-form DNA as 
compared to the TBP-induced bend.29 Polyamides targeted to sequences proximal to the 
TATA box of a given promoter may be promoter-specific inhibitors of transcription, 
rather than genome-wide inhibitors of TBP binding. This approach was previously used 
for the HIV-l promoter, where polyamides targeting sequences proximal to the TATA 
box inhibited TBP binding and in vitro transcription as well as viral replication in vivo. 33 
The mRNA levels of seven other genes with different proximal sequences to their TATA 
boxes were not effected by the polyamide treatment. 
In this work, a comprehensive series of polyamides was designed to target the 
sequence adjacent to the HER2 TATA box on the downstream (3') side (Figures 3.3 and 
Figure 3.5). Polyamides targeted to this sequence, 5'-AAGAATGA-3', would also be 
expected to bind a similar sequence, 5'-ATGAAAGA-3', which occurs at the terminus of 
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the M-MuLV LTR (Chapter 2A). Quantitative DNase I footprinting titrations reveal that 
the same series of polyamides behaves quite differently in these two ostensibly similar 
contexts. For the HER2 site, high-affinity compounds were obtained which were strong 
inhibitors of TBP-binding and in vitro transcription of the HER2 gene. These studies 
were performed in collaboration with Joel Gottesfeld and co-workers at the Scripps 
Research Institute, who also investigated the in vivo properties of the compounds 
extensively in HER2-overexpressing breast cancer cells. 
Results and Discussion 
Polyamide Design. The two G'C pairs flanked by A,T base pairs and separated 
by three A,T base pairs in the target site 5' -AAGAATGA-3' suggested a ten-residue 
hairpin polyamide37 with ImlPy pairs at the first and last positions (Figure 3.5). "Ten-
residue" refers to the residues in the "core" of the polyamide, not counting the C-terminal 
"tail" which is composed of ~-alanine (~) and N,N-dimethylaminopropylamine (Dp), or 
the linker between N- and C- terminal strands, yor (R)H2Ny, which is referred to as the 
"turn." All of these alkyl units are specific for both A,T base pairs.38 In a ten-residue 
polyamide, the central pair of rings can be replaced by a ~/~ pair (specific for both A,T 
base pairs), which provides increased flexibility and in many cases results in increased 
affinity .39.40 The ~lPy pair has also been to provide high-affinity recognition of both A,T 
base pairs in certain cases.41 Polyamide 1 is considered the "parent" ten-ring polyamide. 
Polyamide 2 represents a one residue change from polyamide 1, with the central Py/Py 
replaced by a ~/Py pair. Polyamide 3 with a central ~/~ pair represents a two residue 
change from 1.42 Subsitution of the y-turn by the chiral, amine-functionalized derivative 
(R)H2Nyoften results in increased affinity. In a singly charged six-ring polyamide, it was 
shown that the (R)H2Ny substitution resulted in a IO-fold gain in affinity.43 In larger and/or 
doubly charged polyamides affinity gains of up to IO-fold have also been observed, 
although smaller changes are also common.44 Polyamides 4-6 are the doubly charged 
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Figure 3.5. A) Ball-and-stick representations of the polyamides in this study and the target site on the 
HER2 promotor. The TATA hox is shown as a box. Mismatches are highlighted. OH represents 
ethanolamine. B) Chemical structures of the designed match polyamides 1-8. 
73 
(R)H2Ny analogs of 1-3, respectively. Polyamide 7 is a singly charged (R)H2Ny analog of 
polyamide 5, where Dp has been replaced by ethanolamine. Polyamide 8 is an analog of 
polyamide 6 which has a C-terminal extension45 of -~-PyPy. In the target site, this C-
terminal extension is placed directly in the TATA box, whereas polyamides 1-7 place 
only the tail inside the TATA box. Polyamides 9 and 10 are control compounds, 
designed as single base mismatches for the target sequence. Both resent single residue 
changes from polyamide 5, with Py to 1m substitutions in the C-terrninal strand. 
Quantitative DNase I Footprinting. Quantitative DNase I footprinting 
titrations46 were performed on the series of hairpin polyamides (1-11) targeted to the site 
5'-AAGAATGA-3' adjacent to the TATA box on the HER2 promoter, using a 188 base 
pair DNA fragment derived from the HER2 promoter28 (Table 3.1). Representative 
DNase I foot-printing gels for polyamides 1 and 6 are shown in Figure 3.6, and the results 
of Table 3.1 are presented graphically in Figure 3.7. As a series, compounds 1-8 showed 
moderate to good specificity (5- to 25-fold) for the target site over mismatch sequences. 
Equilibrium association constants (K.) ranged from 4.0 x 108 M· l for the parent hairpin 1 
to 2.1 X 1010 M· l for the extended hairpin 8. More than half of this 50-fold increase in 
affinity for the match site occurs between the parent polyamide 1 and polyamide 6 (Ka = 
1.2 x 1010 M· l ), the small increase in affinity with the C-terrninal extension (8 compared 
to 6) represents the rest. This small increase in affinity came with reduced specificity, as 
polyamide 6 showd good selectivity (>20-fold over mismatches, see Figure 3.6B), and 
extended hairpin 8 was the least selective (-5-fold selectivity) . The -3D-fold gain in 
affinity for polyamide 6 over polyamide 1 appears to be the result of both substitution of 
the central Py/Py pair to W~ and substitution of the y-turn to the (R)H2Ny_turn. Both 
changes to polyamide 1 resulted in an -lO-fold increase in affinity (polyamides 3 and 4), 
and then the complimentary change resulted in a further -3-fold affinity gain (6 as 
compared to 3,4). 
Table 3.1. Equilibrium association constants 
for the site 5'-atAAGAATGAag-3' adjacent 
to the TAT A box on the HER2 promoter. a 
Polyamide Ka (M-l) 
1 ~ 4.0x 108 
2 ~ 5.5 X 108 
3 ~ 4.8 X 109 
4 ~ 4.3 X 109 
5~ 3.8 x 109 
6~ 1.2 x 1010 
7H~ 2.5 x 109 
~ 2.1 x 1010 
9~ 7.2 X 108 
10~ 6.9 X 108 
Table 3.1. Values reported are the mean values 
obtained from at least three independent DNase I 
footprint titration experiments. The assays were 
carried out at 22° C, 10 mM Tris-HCI (pH 7.0), 10 
mM KCl, 10 mM MgCI2, and 5 mM CaCI,. (a) 
Polyamide 8 recognizes the larger binding site, 5 ' -
taTATAAGAATGAag-3' . 
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The central /3 IPy pair 
compounds were of similar affinity 
to the central PylPy pair polyamides 
and lower affinity than the central 
PI/3 pair polyamides having the same 
tum and tail (1 "" 2 < 3; 4 "" 5 < 6). 
Based on the central /3/Py pair 
compounds, the affinity increases 
observed for the (R)H2Ny_tum are due 
not only to the resulting polyamides 
being doubly charged, but also to a 
specific gain for the placement of an 
amine group in a chiral position on 
the y-tum: singly charged (R)H2Ny_ 
containing compound 7 shows a 4.5-
fold increase in affinity from 2, more 
than half of the 7-fold affinity 
increase for 2 to 5. The two control 
compounds 9 and 10 also have a 
central /3/Py pair, and, while their 
remarkably similar affinities are 2-
fold lower than 5, they are actually 
greater than 2 by a small margin. 
Relatively strong binding of mismatch compounds is generally not desired, but it 
is potentially advantageous for polyamide 9 on the HER2 promoter. This is because 
there is a cognate site (5' -CTGCTTGA-3', not a perfect match site due to a Dp mismatch, 
underlined) for 9 adjacent to the Ets site (bound by PA-l in Figure 3.3). Polyamide 9 
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Figure 3.6. Quantitative DNase I footprint titration experiments on a 5,-32P-labeled 188-bp DNA fragment 
of the HER2 promoter. 28 All reactions contain 15 kcpm DNA fragment, 10 mM Tris- HCl (PH 7.0), 10 mM 
KCl, 10 mM MgCI2, and 5 mM CaCI2• A) Lane 1, A reaction; lane 2, DNase I standard; lanes 3-12, 20 pM, 
50 pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM, and 20 nM polyamide 1, respectively; lane 
13, intact DNA. B) Lane 1, A reaction; lane 2, DNase I standard; lanes 3-12,10 pM, 20 pM, 50 pM, 100 
pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, and 10 nM polyamide 6, respectively; lane 13, intact DNA. 
binds this site with 2-fold higher affinity (K. = 1.2 x 109 M·I ) than the 5'-AAGAATGA-3' 
site (mismatch underlined). The relatively similar affinity for both sites suggests that 
polyamide 9 may be able to interfere with the binding of both transcription factors, which 
could be beneficial for transcription inhibition. 
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Table 3.2. Equilibrium association constants for the M-MuL V DNA fragment. 
PolyamideIBinding Site PolyamideIBinding Site 
5'-G A A T G A A A G A C C-3' 
1 +' -~ 2.2 x 109 
3'-C T ;~T G G-5' 
5'-G A A T G A A A G A C C-3' 
6 ~ 1.6 x 109 
3'-C T T A CT T T C T G G-5' 
5'-G A AT G A A A G A C C-3' 5'-G A A T G A A A G A C C-3 ' 
2 +' -~ 4.8xlOS 
3' -C T T~T G G- 5' 7 H- -~ l.9xl09 3' - C T ~T~G G-5' 
5'-G A AT G A A A G A C C-3' 
3 +' -~ 1.8 x 109 
3'-C T ~ G G- 5' 
5' -G G~· ~ A A T G A A A G A C C-3' 
8 r 27xl09 
3' -C C 'c C T T ACT T T C T G G-5' 
5' -G A A T G A A A G A C C- 3' 
4 ~ 25xl09 
3'-C T T ACT T T C T G G-5' 
5' -G A A T G ~A A G A C C-3' 
9 +'_ 27xl07 
3' - C T T~T~G G-5' 
5'-G A A T G A A A G A C C- 3' 
5 +' -~ 3.6 x 109 
3' - C T ~T~G G-5' 
5'-G A A T G A A !Ai G A C C-3' 
10 +' _ ~ 23xl07 
3' -C T ~T'G G-5' 
Table 3.2. Values reported are the mean values obtained from at least three independent DNase I footprint 
titration experiments. The assays were carried out at 22° C, 10 mM Tris-HCl (pH 7.0), 10 mM KCl, 10 
mM MgCI2 , and 5 mM CaCl,. Mismatches are highlighted in grey. 
Comparison with the site S'-ATGAAAGA-3' from the M-MuLV LTR. The 
effects of ~-alanine substitutions/9-41 the y-turn or (R)H2Ny_turn,43 and C-terminal 
extensions45 have all been studied previously, but have typically been considered 
separately. Rarely have these substitutions been considered together for a series of 
polyamides targeting two different binding sites on two different DNA fragments. In 
addition to the HER2 site, 5'-AAGAATGA-3', polyamides 1-10 were also investigated 
on a second binding site, 5'-ATGAAAGA-3', which occurs near the terminus of the M-
MuLV LTR (Chapter 2A). Quantitative DNase I footprinting titrations with a 183 base 
pair DNA fragment containing an internal copy of the M -MuL V L TR were performed as 
described in Chapter 2A. (For a representative DNase I footprinting gel, see Figure 2.2A, 
compound "2" in Chapter 2A is polyamide 5 in this chapter). The equilibrium 
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Figure 3.7. Comparison of polyamides 1-10 for two similar binding sites. 
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association constants of polyamides 1-10 on the M-MuLV fragment are listed in Table 
3.2 and a comparison with the results from the HER2 fragment (Table 3.1) is shown in 
Figure 3.7. Compared to the HER2 site, the range of affinities for the M-MuLV site is 
much tighter, with seven of the eight designed match polyarnides clustering between Ka = 
1.6 X 109 M· I (6) and K. = 3.6 X 109 M· I (5). It should be noted that extended hairpin 8 
places the P-Dp tail against GoC base pairs, so this site is not a fair comparison to the 
HER2 site for 8. All of the compounds were more specific for the match site on the 
HER2 fragment than the M-MuLV fragment, where specificity for the target site was 
generally less than 2-fold. Polyamides with an ImJPy pair adjacent to the turn (either y or 
(R)H2Ny) including 1-8 on the M-MuLV fragment, have shown a high propensity to bind 
A,T base pairs as well as GoC at that position (in contrast to a Py/lm pair adjacent to the 
turn, which is highly specific for CoG). The specificity of this series for the target site on 
the HER2 fragment may be due to the fact that this common mismatch is under-
represented on this heavily G,C-rich region of the HER2 promoter (Figure 3.2). 
It is interesting that the compounds that are the most similar in absolute affinity 
between the two sites are the central P/Py pair match polyamides (2,5,7), while the 
central P/Py pair mismatch polyamides (9,10) bind the M-MuLV site with 30-fold lower 
affinity than the HER2 site. Two other compounds which vary significantly between the 
two sites are the parent ten-ring polyamide 1 and the central PIP pair, (Rt2Ny-turn 
containing 6 . The 30-fold difference in favor of 6 for the HER2 site has vanished. 
Whereas for the HER2 site parent polyamide 1 had lower affinity than the control 
compounds, for the M-MuLV site it has lOO-fold higher affinity than the controls. The 
affinity of polyamide 1 is 5.5-fold higher for the M-MuLV site than for the HER2 site, 
but this affinity was not improved by single p-alanine substitution (2, a 4.5-fold drop 
from 1), the central PIP pair (3 '" 1), or the (R)H2Ny_turn (4 "'1). While the (R)H2Ny_turn did 
not effect the central PIP pair compounds (6 '" 3) either, it did have a significant effect on 
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the central ~lPy pair compounds, and as for HER2, the affinity increase (7.5-fold, 2 to 5) 
was not solely due to the presence of two charges (2 to 7, 4-fold increase). 
The differences observed between these two ostensibly similar sites are likely the 
result of structural differences between the sites themselves, differences in the flanking 
sequences, and differences between the DNA fragments as a whole. Both sites are 
largely homopurineihomopyrimidine tracts and contain 5'-GA-3' steps, which are known 
to be difficult for polyamide recognition.44,47 Despite or perhaps because of this, the 
parent polyamide 1 appears to be especially well matched for the M-MuLV sequence, as 
changes in the structure failed to improve binding significantly. The parent polyamide 1 
was disfavored by the HER2 site, even compared to the control polyamides (9,10). 
However, changes in structure produced up to 50-fold higher affinity binders, with the 
highest affinity compounds (6,8) being -5-fold tighter binders than the highest affinity 
compound for the M-MuLV site (5) . While central W~ pair and (R)H2Ny_turn substitutions 
are not general solutions for all homopurine/homopyrimidine tracts with 5' -GA-3' steps, 
the affinity increases afforded by these structural alterations for the 5'-AAGAATGA-3' 
site generated good candidates for the inhibition of HER2 transcription. 
Inhibition of TBP-binding and HER2 in vitro transcription. Selected 
polyamides were tested for the inhibition of TBP-binding to the TAT A box of the HER2 
promoter in electrophoretic mobility shift assays (Figure 3.8). Polyamide 3 displayed an 
ICso (the concentration required for 50% inhibition of TBP-binding) between 20 and 50 
nM. A control single base mismatch compound (not shown in Figure 3.8) showed 25% 
inhibition at 50 nM. Polyamides 5 and 8 were extremely potent inhibitors. The ICso 
between 5 and 10 nM for polyamide 5 is surprising compared to the value for 3, given the 
similar, and in fact slightly higher, affinity of 3 (K. = 4.8 x 109 M· I compared to 5, K. = 
3.8 X 109 M·I). The extended hairpin 8 was the most effective, yielding 40% inhibition at 
2 nM and 85% inhibition at 5 nM. TBP-binding was completely inhibited at 10 nM. 
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Figure 3.8. Inhibition of TBP binding to the HER2 promoter in electrophoretic mobility shift assays. 
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The potent inhibitors of TBP-binding were tested in in vitro transcription assays 
with the HER2 promoter. Polyamide 5 showed 70% inhibition at 1 /l-M (ICso= 600 nM) 
and extended hairpin 8 showed complete inhibition at 1 /l-M with an ICso value just above 
100 nM (45% inhibition at 100 nM). These values are quite promising for in vitro 
transcription experiments with the HER2 promoter,28 and all further efforts with 
polyamides 1-10 were concentrated on in vivo assays. However, in vitro assays with 6 
and 7 would be useful. The similar affinity and structure of polyamide 6 to the extended 
hairpin 8 could be used to gage whether the extremely potent inhibition demonstrated by 
8 is due to high affinity alone (K. = 2.1 x 1010 M· l ) or if the C-terminal extension into the 
TAT A box is particularly beneficial. The higher efficacy of 5 as compared to 3 may be 
due to the former being doubly charged, or perhaps the position of the amino group on 
the (R)H2Ny-turn of 5 in the minor groove plays a role. These possibilities could be 
partially distinguished by polyamide 7. These additional studies would be informative 
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for the design of future polyamide inhibitors of TBP-binding. Additionally, based on 
affinity, polyamide 6 should be a strong inhibitor of HER2 transcription. 
Effect of polyamides on HER2 transcription in HER2-overexpressing breast 
cancer cells. The ultimate goal of this project has been the inhibition of transcription of 
an endogenous human gene in human cells. Towards that end polyamides from this 
series, particularly 3, 5, and 8, have been studied extensively in a variety of different in 
vivo assays with SKBR-3 and MCF-7 HER2-overexpressing human breast cancer cells. 
These include RT-PCR analysis of the HER2 mRNA, RNase protection assays with a 
probe specific for the HER2 mRNA, fluorescence-activated cell sorting (FACS) analysis 
of the HER2 protein with an anti-HER2 antibody, and cell motility, which been has 
shown to a function of the amount of HER2 protein present in the membrane of HER2-
overexpressing cancer cells such as SKBR-3. In all cases except FACS (which, in 
retrospect may be the most reliable assay) , initial positive results were obtained which did 
not prove to be reproducible. In the case of the mRNA-based assays, the initial results 
were extremely positive with ICso values less than 50 nM obtained for polyamides 5 and 
8. Control experiments using probes for eight other genes in the RNase protection assay 
showed that these mRNA levels were not significantly affected by 5, and SKBR-3 cells 
were shown to be viable at up the 3 IJ.M 5. Since down-regulation of HER2 in SKBR-3 
cells often results in cell-cycle arrest and apoptosis,22,23,27 the cells probably should not 
have maintained viability with 3 IJ.M of a 50 nM inhibitor. Indeed, further RNase 
protection assays showed no inhibition by 5 or other polyarnides. Selected polyamides 
from the 1-10 series were tested with by FACS analysis of the HER2 protein levels after 
treatment with polyamide, both alone and in combination with ESX-binding inhibitors of 
HER2 in vitro transcription such as PA_l,28 and no inhibition was observed. 
Concurrent to these efforts in the Gottesfeld group (F ACS analysis and cell 
motility in collaboration with Dr. Susann Shenk and Professor Vito Quaranta), the 
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Beerman group at Roswell Park Cancer Institute was investigating the effects of the 
ESX-binding inhibitors28 and AP-2 binding inhibitors (see Figure 3.3) on SKBR-3 cells. 
No inhibition was observed in vivo. It was hypothesized that polyamides may have poor 
uptake properties in SKBR-3 cells. Surprisingly, polyamide-fluorescent dye conjugates 
were permeable to live SKBR-3 cells but did not localize to the nucleus (see Chapter 4A). 
Based on the dye-conjugates, the failure of inhibition in vivo, and other supportive 
indirect evidence, hairpin polyamides such as 1-10 probably do not localize to the 
nucleus of SKBR-3 or MCF-7 cells. 
Conclusions and Outlook 
A series of ten polyamides including two mismatch controls was designed to bind 
to the sequence 5'-AAGAATGA-3' adjacent to the TATA box of the HER2 promoter. A 
variety of substitutions to the parent ten-ring polyamide structure produced high-affinity 
binders for this site. The effect of these substitutions was further tested by targeting a 
closely related sequence 5'-ATGAAAGA-3' derived from the M-MuLV LTR. The 
parent ten-ring polyamide was especially well matched for the latter sequence, as the 
structural alterations which produced a 30-fold increase in affinity for the HER2 site 
showed little effect. Polyamides targeted to the HER2 site were potent inhibitors of TBP-
binding to the TATA box and in vitro transcription of theHER2 gene. However, 
extensive experiments in cell culture have shown that these potent in vitro inhibitors are 
not effective in vivo. It is likely that the hairpin polyamides used in this study do not 
localize to the nucleus of the breast cancer cells examined thus far. Efforts are underway 
to screen additional breast cancer cell-lines, find reagents to allow normal hairpin 
polyamides to reach the nucleus, and produce modified polyamides with enhanced 
nuclear localization properties (Chapter 4). When these efforts are successful, 
polyamides from this series, or modified polyamides based on the lessons learned from 
this series, may prove to be potent inhibitors of HER2 transcription in human cells. 
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Appendix: Blocking Transcription Through a NucIeosome* 
*Gottesfeld, I .M.; Belitsky, I.M.; Melander, c.; Dervan, P.B .; Luger, K. "Blocking 
Transcription Through a Nucleosome with Small DNA Ligands." 1. Mol. Biol. submitted 
2002. 
One of the compounds from the series designed to bind adjacent to the TATA box 
in the HER2 promoter was used by 10el Gottesfeld in an exciting demonstration of 
transcription inhibition not directly related to HER2. * Previous studies have established 
that most sites on nucleosomal DNA are accessible to polyamides, and that nucleosomes 
remain fully folded upon ligand binding. Polyamide 3 was one of four polyamides 
targeted to a DNA fragment containing the sea urchin 5S gene nucleosome positioning 
sequence linked to a T7 RNA polymerase promoter. Transcription of this construct in the 
presence and absence of polyamides and pre-formed histone octamers. Polyamide 3 and 
another polyamide bound within the sea urchin 5S gene nucleosome positioning sequence 
and inhibited both heat-induced nucleosome sliding and transcription by T7 RNA 
polymerase from the nucleosomal template but not from histone-free DNA. These 
polyamides also prevented repositioning of the histone octamer by RNA polymerase, 
thereby inhibiting passage of the elongating polymerase through nucleosomal DNA. The 
results establish the requirement for octamer mobility for transcription of nucleosomal 
templates by T7 RNA polymerase. The effect of the polyamides may be due to the 
prevention of rotation of the DNA on the surface of the histone octamer. This may 
ultimately provide a means of transcription inhibition that does not depend on competing 
with transcription factors and may be amenable to inhibition from sites within the coding 
region of genes, rather than being limited to promoter sites. 
Experimental 
Polyamides. All polyamides were synthesized by solid-phase methods as 
previously described,43.48 and characterized by analytical HPLC and MALDI-TOF mass 
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spectrometry. ImPyPyPyIm-(R)-y-PyPyPyPyPy-I3-Dp (1) [M+H) 1466.99, 1466.57 
calculated for [M+H). ImPy-I3-Pylm-(R)-y-PyPyPYPyPy-I3-Dp (2) [M+H) 1415.66, 
1415.65 calculated for [M+H). ImPy-I3-Pylm-(R)-y-PyPy-I3-PyPy-I3-Dp (3) [M+H) 
1364.88 1364.64 calculated for [M+H). ImPyPyPylm-(R)-H2Ny-PyPyPyPyPy-I3_Dp (4) 
[M+H) 1481.98, 1481.68 calculated for [M+H). ImPy-I3-PyIm-(R)_H2Ny-PyPyPYPyPy-l3_ 
Dp (5) [M+H) 1430.94, 1430.67 calculated for [M+H). ImPy-I3-Pylm-(R)-H2Ny-PyPy-l3-
PyPy-I3-Dp (6) [M+H) 1379.91, 1379.65 calculated for [M+H). ImPy-I3-Pylm-(R)_H2Ny_ 
PyPyPyPyPy-I3-EtOH (7) [M+H) 1389.63, 1389.60 calculated for [M+H) . ImPy-l3-
PyIm-(R)_H2Ny-PyPy-I3-PyPy-I3-PyPy-I3-Dp (8) [M+H) 1695.08, 1694.79 calculated for 
[M+H). ImPy-I3-PyIm-(R)_H2Ny-PyPyPyImPy-I3-Dp (9) [M+H) 1431.84, 1431.68 
calculated for [M+H). ImPy-I3-Pylm-(R)-H2Ny-PylmPyPyPy-I3-Dp (10) [M+H) 1431.48, 
1431.68 calculated for [M+H). 
DNase I footprinting. DNase I footprinting reactions were performed as 
previously described47 for 32P-Iabeled DNA fragment derived from the HER2 promotor2B 
and an internal copy of the M-MuL V LTR (Chapter 2A). 
In vitro assays. Electrophoretic mobility shift assays measuring polyamide 
inhibition of TBP binding to a DNA fragment derived from the HER2 promoter and in 
vitro transcription assays with the HER2 promoter were performed according to standard 
methods as previously described. 2B.33 
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CHAPTER 4 
Cellular Uptake and Localization of DNA Binding 
Polyamide-Fluorescent Dye Conjugates 
The text of this chapter was taken in part from a manuscript submitted for publication 
coauthored with Paramjit Arora and Professor Peter Dervan (Caltech) and Stephanie 
Leslie and Professor Terry Beerman (Roswell Park Cancer Institute). 
(Belitsky, 1.M.; Leslie, S.l.; Arora, P.S.; Beerman, T.A.; Dervan, P.B. "Cellular Uptake 
of N-MethylpyrroleIN-Methylimidazole Polyamide-Dye Conjugates." Bioorg. Med. 
Chem, in press.) 
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Abstract 
The cellular uptake and localization properties of DNA binding N-
methylpyrrolelN-methylimidazole polyamide-dye conjugates in a variety of living cells 
have been examined by confocal laser scanning microscopy. Chapter 4A provides an 
introduction to these studies and our initial results. With the exception of certain T-cell 
lines, polyamide-dye conjugates localize mainly in the cytoplasm and not in the nucleus. 
Reagents such as methanol typically used to fix cells for microscopy significantly alter 
the cellular localization of these DNA-binding ligands. 
Chapter 4B describes confocal microscopy studies of modified polyamide-dye 
conjugates in a wide variety of cell lines. Different motifs such as the cycle, tandem, and 
one-to-one binding polyamide-dye conjugates have been examined, and point to 
molecular weight as an important factor for nuclear localization in some cell lines. 
Modifications include the alkylating agent chlorambucil, carrier peptides such as TAT, 
and small molecules aimed at receptor-mediated uptake. Of these, cationic peptide 
conjugates have proven the most useful. However, these compounds show poor DNA 
binding properties. Efforts to balance nuclear localization with favorable DNA binding 
specificity are discussed. Multiple solutions for several cell lines have emerged, and on-
going experiments should define further solutions. 
Introduction 
Chapter 4A: 
Cellular Uptake of N-MethylpyrroleIN-Methylimidazole 
Polyamide-Dye Conjugates 
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Cell-permeable small molecules with the ability to target predetermined DNA 
sequences and interfere with gene expression would be useful tools in molecular biology 
and, potentially, human medicine. Polyamides containing aromatic amino acids N-
methylpyrrole (Py), and N-methylimidazole (1m) are synthetic ligands that have an 
affinity and specificity for DNA comparable to naturally occurring DNA-binding 
proteins.1•2 Based on pairing rules for recognition in the minor groove, polyarnides can be 
designed to target a large number of predetermined DNA sequences. Polyamides have 
been shown to inhibit several classes of transcription factors, and thus regulate 
transcription in cell-free systems. 3 Modification of the DNA binding polyamide scaffold 
has produced agents capable of sequence-specific DNA-alkylation,4.5 recruitment of 
Topoisomerase 1,6 and gene activationY Significantly, polyamides have recently been 
shown to bind specific DNA sequences in isolated nucleosomes.9 
Current impetus in our laboratories is directed at evaluating the potential of these 
molecules as potent regulators of specific gene transcription in cell culture assays. 
Polyamides targeted to the HIV -1 promoter inhibited viral replication in human 
peripheral blood lymphocytes.' 0 Laemmli and coworkers have shown that polyamides 
targeting heterochromatic satellite DNA induced specific gain- and loss-of-function 
phenotypes in Drosophila presumably as a result of chromatin opening." ·l2 Together 
these studies indicated that polyarnides are cell-permeable and, assuming that DNA is the 
cellular target of polyamides, localize to the nucleus at least in some cases. 
In order to determine the potential of polyamides to inhibit the transcription of 
endogenous genes in human cells, our initial studies focused on the HER21neu gene. 
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Overexpression of the HER21neu gene is implicated in human breast cancer and 
associated with poor prognosis. 13.14 Hairpin polyamides targeted to the Ets binding site of 
the HER21neu promoter were shown to inhibit binding of the transcription factor ESX at 
nanomolar concentrations and to inhibit transcription of the HER21neu gene in cell-free 
experiments. ls However, despite the demonstrated in vitro activity, no transcription 
inhibition was observed in HER2-overexpressing SKBR-3 cells .16 In order to test 
whether this result might be due to poor cellular uptake or nuclear localization, a series of 
polyamide conjugates incorporating the fluorophore Bodipy FL were synthesized. 
Confocal microscropy was used to study the cellular distribution of polyamide-Bodipy 
conjugates in SKBR-3 cells. In initial microscopy studies, cells were incubated with 
polyamide-Bodipy conjugates and visualized after treatment with cell-fixing reagents. 
Polyamide-dye conjugates were observed to localize in the nucleus of fixed cells. 
However, it was discovered that the common procedure of fixing cells prior to imaging 
had a drastic effect on conjugate localization, and that in living SKBR-3 cells without 
fixation, nuclear localization was not observed within detection limits. This suggested 
that a study of the cellular localization of polyamides in a variety of living cells was 
warranted. Here we report our initial findings on this key issue for gene regulation by 
polyamides. 
Results 
Polyamide-Bodipy Conjugates. Bodipy FL was chosen as a fluorophore 
because of its enhanced photostability relative to fluoroscein and its relatively small 
size.17 The fluorescence of Bodipy is independent of pH in the physiological range, and 
the free dye is not known to localize to the nuclei of cells which should limit false 
positive results. Three polyamide-Bodipy FL conjugates, eight-ring hairpins 1 and 2 and 
a 2-~-2 hairpin (3) were synthesized (Figure 4.1). Polyamides 1 and 2 are the same size 
but differ in sequence and the number of ImlPy rings. The polyamide precursors were 
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Figure 4.1 
Figure 4.1. Po\yamide-Bodipy FL conjugates. 
synthesized by solid-phase methods l8 with one Py residue modified to yield a free amine 
upon cleavage from the resin. 19 The free amine of the precursor polyamides was allowed 
to react with the succinimidyl ester of Bodipy FL (Molecular Probes) affording 
polyamide conjugates 1-3. The purity and identity of the dye conjugates were verified by 
analytical HPLC, UV-Vis spectroscopy, and MALDI-TOF mass spectrometry. 
Additionally, DNase I footprinting experiments20 were performed to assay the ability of 
the conjugates to bind DNA. Despite the short tether between the bulky dye and the 
polyamide backbone, the Bodipy conjugates still maintain high affinity and specificity for 
their match sites (Ka = 107_109 M-I ) although with a loss of 10- to IOO-fold in affinity 
relative to their parent polyamide. The fluorescence of conjugates was unaffected by the 
presence of cognate DNA or acidic pH. There was a 2-fold increase in fluorescence in 
methanol as compared to buffer. 
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Confocal Microscopy. Confocal microscropy was used to study the distribution 
of polyamide-Bodipy conjugates in SKBR-3 cells. Using a procedure that included 
fixing the cells in methanol before imaging, rapid uptake and nuclear localization was 
observed.2 1 However, in a control experiment without fixation, significantly reduced 
fluorescence located in a punctate pattern in the cytoplasm was observed (Figure 4.2A). 
With the observation that methanol influences cellular localization of polyamides, an 
effort to screen a variety of live cells with the Bodipy-polyarnide conjugates was initiated. 
Cells were incubated with 5 J..lM concentration of conjugate 1-3 or free Bodipy FL as 
control in a total volume of 100 J..lL for 20 hours under normal growth conditions for each 
cell line (see Legend, Table 4.1). Most incubations were performed in culture dishes 
equipped with glass bottoms for direct imaging (MatTek Corporation). Adherent cells 
were allowed to grow in the glass bottom culture dishes for 24 hours prior to the twenty-
hour incubation with the dyes. To reduce evaporation due to the extremely small total 
volume in these experiments, cells which grow at room temperature without a humified 
CO2 incubator were incubated with 1-3 in 96 well plates and then transferred to glass 
bottom culture dishes for imaging. Imaging was performed with a Zeiss LSM 5 Pascal 
inverted confocal microscope, equipped with a 40x oil immersion objective lens. Images 
were captured at 0.88 J..ls/pixel scanning rate. The results for seven cell lines are shown in 
Table 4.1. Cell lines, ranging from cultured insect and human cancer cells to primary 
human CD4+ T -cells, were chosen based on availability, relevance to previous studies, 
and ongoing gene inhibition studies in cell culture. 
Under nonfixing conditions , typically two distinct populations of fluorescent 
cells were observed in a given field. Live cells generally showed relatively dim 
fluorescence in the cytoplasm, while dead cells generally showed relatively bright 
fluorescence throughout the cell, including the nucleus. To determine the amount of dead 
cells in a given sample, solutions of cells on glass bottom culture dishes (with and 
without pre-incubated 1-3) were treated with 1 J..lM Sytox Orange for ten minutes and 
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Table 4.1. Cellular localization of polyamide-Bodipy conjugates. 
SKBR-3 CEM T-cells NB4 293 Sf9 Kc 
Human human human human human 
Conjugate breast cultured primary leukemia kidney Insect Drosophila 
cancer T-cells T-cells fibroblast 
1 cytoplasm nuclear nuclear cytoplasm cytoplasm cytoplasm cytoplasm 
2 cytoplasm nuclear nuclear cytoplasm cytoplasm cytoplasm cytoplasm 
3 cytoplasm nuclear nuclear cytoplasm cytoplasm cytoplasm cytoplasm 
Table 4_1. Localization of polyamide-Bodipy conjugates in live cells as determined by confocal 
microscopy. The designation "nucleus" indicates observation of fluorescence in the interior of the nucleus. 
The designation "cytoplasm" indicates cellular, non-nuclear fluorescence (see text) . Cells were imaged 
directly following 20-hour incubation with 5 11M 1-3 under normal growth conditions for each cell line. 
SKBR-3 is an adherent, human breast cancer cell line grown in McCoy ' s 5A Medium, supplemented with 
10% Fetal Bovine Serum and 1 % penicillin-streptomycin, at 37" C in 5% CO,. CEM is a non-adherent 
human T-cell line (ATCC, # CCL-119) grown in RPMI 1640 Medium, supplemented with 10% Fetal 
Bovine Serum and 1 % penicillin-streptomycin, at 37" C in 5% CO,. Primary human CD4+ T_cells23 were 
incubated at 37° C in 5% CO2• NB4 is a non-adherent human acute promyelocytic leukemia cell line 
grown in RPM! 1640 Medium, supplemented with 10% Fetal Bovine Serum and 1 % penicillin-
streptomycin, at 37° C in 5% CO2 • 293 is an adherent human kidney fibroblast cell line grown in 
Dulbecco' s Modified Eagle Medium, supplemented with 10% Fetal Bovine Serum and 1 % penicillin-
streptomycin, at 37° C in 5% CO2• Sf9 is a non-adherent insect (Spodoptera Jrugiperda) cell line grown in 
TNM-FH insect media, supplemented with 10% Fetal Bovine Serum and 1 % penicillin-streptomycin, at 
25° C. Kc is a non-adherent Drosophila cell line grown in HyQ-CCM3 supplemented with 10% Fetal 
Bovine Serum, at 25° C. 
then imaged directly. As shown in Figure 4.3, the bright nuclear-stained Sf9 cells are 
dead or damaged as indicated by localization of the membrane impermient Sytox Orange 
dead cell stain (Molecular Probes). For each experiment shown in Table 4.1, a control 
sample of cells was incubated under the same conditions as the sample containing the 
conjugate. These cells were then imaged to gauge background fluorescence and then 
treated with Sytox Orange to determine percentage of dead cells in the control sample. 
Given that cells are imaged directly in growth media, background fluorescence can be 
significant, but in all cases fluorescence of the dyes and polyamide-dye conjugates far 
exceeded background. A comparison of the amount of dead cells in the control sample 
96 
Figure 4.2 
A) 
B) 
Figure 4.2. A) Conjugate 1 in live SKBR-3 cells . The fluorescent image is on the left, bright field image 
on the right. Bar: 20 /-Lm. B) Conjugate 1 in SKBR-3 cells after the addition of MeOH (1:1 MeOH: 
media) . The fluorescent image is on the left, bright field image on the right. Bar: 20 /-Lm. 
and the dye-containing sample allowed the conclusion that 5 f..lM 1-3 did not cause cell-
death under the experimental conditions, but that polyamide-Bodipy conjugates readily 
localize in the nucleus of dead cells. 
Figure 4.3 
Figure 4.3. Conjugate 1 and dead cell stain Sytox Orange in Sf9 cells. The fluorescent emission of Sytox 
Orange (Rhodamine filter) is shown on the left. The fluorescent emission of conjugate 1 (FITC filter) is 
shown on the right. Note the different appearance of conjugate 1 in live and dead cells, as distinguished by 
uptake of Sytox Orange. Bar: 20 /-Lm. 
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Figure 4.4 
A) 
B) 
Figure 4.4. A) Conjugate 2 in live Sf9 cells. The fluorescent image is on the left, bright field image on the 
right. Bar: 20 J.!m. B) Conjugate 2 in Sf9 cells after the addition of MeOH (1: I MeOH: media). The 
fluorescent image is on the left, bright field image on the right. Bar: 20 J.!m. 
In controls, free Bodipy FL was either noncellular or localized in the cytoplasm, 
within the detection limits, in the seven cell lines examined. All live cell lines evaluated 
were permeable to conjugates 1-3 under the tested conditions (5 j..lM dye, 20-hour 
incubation, 25° or 37° C). The designation "cytoplasm" in Table 4.1 is broadly defined as 
any cellular location other than the interior of the nucleus. The actual location and extent 
of nonnuclear uptake of 1-3 varied from the punctate pattern observed with 1 in SKBR-3 
cells in Figure 4.2A to the more general cytoplasmic staining seen with 2 in Sf9 cells in 
Figure 4.4A. Rapid nuclear localization was induced in both cases by the addition of 
methanol (1: 1 methanol/media) directly to the solutions of cells and 1 or 2 (Figures 4.2B 
and 4.4B). The same behavior was observed for other polyamides and cell lines as well 
as for other common fixing agents, including organic solvents such as ethanol and cross-
linking agents formaldehyde and paraformaldehyde.22 
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Figure 4.5 
A) 
B) 
Figure 4.5 A) Conjugate 1 in live CEM cells. The fluorescent image is on the left, bright field image on 
the right. Bar: 20 ~m. B) Conjugate 3 in live CEM cells. The fluorescent image is on the left, bright field 
image on the right. Bar: 20 ~m. 
The polyamide-dye conjugates were mainly in the cytoplasm, not the nucleus in 
five of the cells studied. For the cultured human T-cell (CEM), broad cellular staining 
including the nucleus was observed with 1 (Figure 4.SA). Fluorescence from conjugate 3 
was also observed in the nucleus of live CEM cells, although to a lesser extent (Figure 
4.SB). Since conjugates 1 and 3 both contain the same Bodipy dye, the differential 
nuclear localization may be related to the polyamide structure. Polyamide 3 is an 
imidazole-rich 2-B-2 hairpin, while polyamide 1 is an eight-ring hairpin containing only 
an N-terminal imidazole residue. The imidazole rich eight-ring hairpin 2 exhibited a 
cellular distribution more similar to 1 than to 3. Thus, the addition of internal beta-
alanines (eight ring to 2-B-2) may diminish nuclear localization. 
Given the in vivo results on HIV -1 inhibition and the observed nuclear 
localization in the cultured human T-cell line CEM, it was of interest to test the Bodipy 
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conjugates with primary human CD4+ T -cells . A similar cellular distribution of 
conjugates 1-3 was observed in primary human CD4+ T-cells as in cultured CEM cells 
(Table 1).23 However, it should be noted that over 20 different cell lines have now been 
examined by the method described here, and nuclear localization of 1-3 was only 
observed in CEM and primary human T -cells. 
Discussion 
While polyamides are larger molecules (MW -1200) than typical 
pharmaceuticals, they are considerably smaller than some proteins which can cross 
through the nuclear pores.24 Thus, it was believed that if polyarnides could gain entry to a 
cell, they should be able to localize to their DNA targets in the nucleus, given their high 
affinity for DNA and fast association kinetics.z5 However, while the Bodipy conjugates 
examined in this study were found to be permeable to all cell lines tested, nuclear 
localization was only observed in certain T -cells. In this preliminary study the screening 
conditions chosen (5 11M conjugate, 20 hrs incubation) were arbitrary, and the detection 
limits in this study were lower than under fixed cell conditions. Given that the amount of 
polyamide in the nucleus necessary to generate a biological effect is unknown, a small 
amount of conjugate in the nucleus missed by our screen could be significant. As 
expected, free Bodipy FL was observed to be noncellular or cytoplasmic in all cell lines 
tested, which indicates that this dye is unlikely to yield false positive results . The 
observation in CEM and primary human T -cells that the extent of nuclear localization 
varies with polyamide structure suggests that polyamide redesign might influence cellular 
distribution. We cannot rule out the possibility that the choice of fluorescent dye may 
have biased the conjugates against nuclear localization. Further research is in progress to 
construct other fluorescent polyamides for the purpose of studying cell distribution. The 
positive results for HIV -1 inhibition in primary T -cells and negative results for inhibition 
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of HER21neu transcription in SKBR-3 cells, suggest that the Bodipy conjugates reflect 
the behavior of unmodified polyamides. 
Lown and co-workers have recently investigated a fluorescently labeled 
derivative of distamycin in human ovarian adenocarcinoma (SKOV-3) cells.26 
Distamycin contains three pyrrole carboxamides and is considered the parent DNA 
binding polyamide molecule.27 Nuclear localization was not observed within detection 
limits, and the primary cellular location of the fluorescent derivative was found to be the 
mitochondria. In conjunction with their studies targeting heterochromatic satellite DNA 
in Drosophila, Laemmli and coworkers have shown specific staining of chromosomes in 
isolated nuclei with polyamides conjugated with the fluorescent dye Texas Red. I1 ,12 
More recently, these researchers have shown that Texas Red-tandem hairpin conjugates 
can specifically target both insect and vertebrate telomere repeat sequences, and can be 
used for rapid estimations of relative telomere length in vitro.28 Extending these studies 
to intact cells, rapid uptake, nuclear localization, and staining of telomeres was observed 
in Sf9 cells. However, these experiments were performed under fixing conditions with 
methanol.28 
There is no chemical reason for the dramatic effect of fixing agents to be specific 
for polyamide-Bodipy conjugates. It is possible that any molecule that has a high-affinity 
receptor (i.e., DNA) from which it is excluded by cellular processes would exhibit the 
same behavior. However, in a very recent study with fluorescein-labeled oligonucleo-
tides, greater nuclear localization was in fact observed in live cells as compared to fixed 
cells. 29 In surveying the literature, many published reports on cellular uptake and 
localization of designed ligands show data from fixed cells, without evidence of having 
performed a live cell control. These results suggest that such studies should demonstrate 
localization in live cells. 
The finding that polyamide-Bodipy conjugates localize to the nucleus of CEM 
and primary human T -cells is significant. This result is consistent with the previous HIV-
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1 inhibition study, 10 and provides impetus for further screening to find other cell lines 
amenable to nuclear localization. The mechanisms by which polyamide-Bodipy 
conjugates enter live cells and are excluded from the nucleus are unknown at this point. 
These mechanisms could be distinct and also could be variable between different cell 
lines. Understanding the mechanisms of cellular entry and localization is an important 
issue for reengineering second-generation polyamides with specified nuclear uptake 
properties. 
Conclusions 
In the majority of live cells tested, polyamide-Bodipy conjugates were observed 
to localize mainly in the cytoplasm, not the nucleus. These results suggest that nuclear 
localization is likely a hurdle for the development of polyamides as in vivo modulators of 
gene transcription. We are currently in the process of developing modified polyamides 
with enhanced nuclear localization properties which will be reported in due course. 
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Chapter 4B: 
Enhanced Nuclear Localization of Polyamide-Dye Conjugates 1 
Overview 
As described in Chapter 4A, screening polyamide-Bodipy conjugates in over 
twenty cell lines uncovered only two cell lines (primary human CD+ T-cell and cultured 
human T-cell, CEM) in which detectable levels of nuclear localization where observed in 
live cells. This chapter describes efforts to enhance nuclear localization in the majority 
of cell lines. It is noted explicitly that the results described here apply to polyamide-dye 
conjugates, in almost all cases conjugates of Bodipy FL. Independent assays without the 
fluorescent tag will be necessary to confirm that these results apply in the absence of the 
dye. It is also possible that the measures taken will be more effective in the absence of 
the dye. With these caveats, the imaging experiments described here provide a 
consistent, though in some cases confusing, set of data for conjugate uptake and 
localization. All imaging experiments were performed as described in Chapter 4A for 
live cells, using the standard conditions of 5 IlM conjugate and -20 hour incubation, 
unless otherwise noted. The results will be used to determine which classes of 
compounds are best suited for functional assays in particular cell lines. Multiple 
solutions for several cell lines have emerged, and on-going experiments should define 
further solutions. 
Characterization of standard polyamide-fluorescent dyes is presented first, 
followed by conjugates of different polyamide motifs. In particular these studies suggest 
the importance of molecular weight for nuclear localization in some, but not all, cell lines 
examined. Next conjugates of the alkylating agent chlorambucil2 are described, followed 
by small molecule conjugates for receptor-mediated uptake.3•5 The best results in terms 
of generality of nuclear localization across a wide variety of cell lines have come from 
carrier peptides,6 such as the well known TAT7 and the newer derivative R9. 8 However, 
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the peptides which were successful were also highly positively charged. The effects on 
DNA binding of polyamide-cationic peptide conjugates are discussed. The last portion of 
this chapter details attempts to find a balance between enhanced nuclear localization and 
the specificity that is the hallmark of DNA binding polyamides. 
Results and Discussion 
Polyamide-Dye Conjugates. In addition to polyamide-Bodipy conjugates 1-3, 
compounds 4-10 were also synthesized by standard methods (Figure 4.6). Conjugates 4 
and 5 are analogs of polyamides which prevent binding of the transcription factor ESX to 
the HER2 promoter.9 Compound 4 was the first Bodipy conjugate used to address cell 
permeability of polyamides that were active HER2 transcription inhibitors in vitro, but 
not in breast cancer cells (see Chapter 3). Interestingly, the localization of conjugates 4 
and 5, which only differ by the central pairing (Py/Py or ~/~), varied when the imaging 
experiments were performed under fixing conditions. Conjugate 4 strongly stained the 
nucleus of SKBR-3 while conjugate 5 appeared to localize at or near the nuclear 
membrane.1o The discovery of the effect of organic solvents on polyamide-dye 
conjugates was made in control experiments probing the differences between 4 and 5. 
These differences are likely not physiologically relevant as in live SKBR-3 cells neither 
conjugate localizes to the nucleus or the nuclear membrane, instead they show a punctate 
pattern in the cytoplasm (also observed for 1 in SKBR-3 cells, Figure 4.2A). Conjugates 
4 and 5 have been studied in a variety of other cell lines as well, although their utility 
under the live-cell experimental conditions described in Chapter 4A is limited by a 
tendency to precipitate on the glass bottom culture dishes due to poor solubility. 
Conjugate 6, with a central ~lPy pairing was originally synthesized to probe the different 
fixed-cell localization between 4 and 5, and has been investigated sparingly in live (or 
fixed) SKBR-3 cells. Conjugate 7 has also thus far only been investigated in SKBR-3 
cells, although its solubility properties are similar to 1-3 and it could be of general utility. 
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Figure 4.6. A) Representative synthesis of a polyamide-Bodipy conjugate (4) from a standard polyamide-
PAM resin prepared by solid-phase synthesis. B) Polyamide-dye conjugates shown in ball-and-stick 
format, with 1m as a filled cicle, Py as an open circle, ~-alanine (~) as a grey diamond, y-aminobutyric acid 
a curved lined, and dimethylaminopropylamine (Dp) as a plus sign_ The chemical structure of 10, which is 
identical to 4 with tetramethylrhodamine in place of Bodipy is also shown. 
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Like 3, the polyamide portion of 7 is derived from an in vivo inhibitor of HIV-l 
replication. II Compounds 8 and 9 with only two and three Py rings, respectively, are 
netropsin and distamycin-like Bodipy conjugates. Both were cytoplasmic in SKBR-3 
cells, although interestingly, significantly more of the two-ring conjugate 8 was inside the 
cells than the three-ring conjugate 9. These smaller conjugates are currently being 
investigated in a variety of cell lines as part of a program to ascertain the role of 
molecular weight in the nuclear localization of polyamide-Bodipy conjugates. 
Compound 10 was the first non-Bodipy polyamide-dye conjugate tested for 
uptake and localization by the Dervan and Beerman laboratories. The tetramethyl-
rhodamine (TAMRA) conjugate has the same parent polyamide (ESX-binding inhibitor 
on the HER2 promoter) as 4. Unfortunately, it is even less soluble than 4, and 
examination of this dye in live cells on the glass bottom culture dishes is hampered by 
precipitation. Subsequently several other hairpin conjugates with dyes such as TAMRA, 
Cy3, and Cy5 have been investigated. 12 Thus far, the results of confocal microscopy 
screening of various cell lines with the non-Bodipy conjugates such as 10 parallel the 
results for Bodipy conjugates. This suggests that Bodipy in of itself is not directing the 
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Figure 4.7. Fluorescence of Bodipy-polyamide conjugate 4 under various conditions. TKMC is a buffer 
containing 10 mM TrisoHCl, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2, commonly used for DNase I 
footprinting experiments. DNA refers to an eqimolar quantity of the match duplex S'-GGGAAGTAT-
AAGGG-3 ' , derived from the binding site of 4 on the HER2 promoter (Figure 4.8). 0.5% acetic acid is 
representative of the pH of acidic cellular vesicles such as lysosomes. 
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Figure 4.8. Quantitative DNase I footprint titration experiments on a 5,-32P-Jabe1ed 188-bp DNA fragment 
of the HER2 promoterY All reactions contain 15 kcpm DNA fragment, 10 rnM TriseHCJ (pH 7.0), 10 rnM 
KCI, 10 mM MgCl2, and 5 rnM CaCl2. A) Lane I , A reaction; lane 2, DNase I standard; lanes 3-12, 10 pM, 
20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, and 10 nM polyamide-Bodipy conjugate 4, 
respectively; lane l3 , intact DNA. B) Lane I, A reaction; lane 2, DNase I standard; lanes 3-12, 10 pM, 20 
pM, 50 pM, 100 pM, 200 pM, 500 pM, I nM, 2 nM, 5 nM, and 10 nM polyamide-Bodipy conjugate 5, 
respectively; lane l3, intact DNA. 
localization of the polyamides, although in all these cases a significant amount of 
molecular weight has been added to the polyamide. Efforts are underway to determine if 
a fluorescent moiety can be incorporated into the polyamide backbone, without 
significantly altering the DNA binding properties. 
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It was noted in Chapter 4A that the fluorescence of the Bodipy-conjugates was 
unaffected by the presence of cognate DNA. This appears to the exception, rather than 
the rule, for polyamide-dye conjugates. With fluorophores such as T AMRA, Cy3, Cy5, 
and Oregon Green, polyamide-dye conjugates have shown the exciting property of 
enhanced fluorescence when bound to match DNA sequences. 13 T AMRA conjugate 10 
shows a I5-fold fluorescence enhancement in the presence of match DNA. In contrast 
Bodipy conjugate 4 shows less than 1.5-fold enhancement with the same match duplex, 
considerably less than the 4-fold difference between 100% MeOH and buffer (Figure 
4.7). The mechanism of fluorescence enhancement for the non-Bodipy fluorescent 
conjugates is currently under investigation. The fluorescence enhancement exhibited by 
10 has been useful for investigations in the Beerman laboratory aimed at increasing 
nuclear localization of polyamides with external reagents and processes, such as 
liposomes and co-transfection with DNA. 
DNA Binding of Polyamide-Dye Conjugates. The affinity and specificity of 
representative Bodipy conjugates 1,4-7 and TAMRA conjugate 10 have been investigated 
by quantitative DNase I footprinting titration experiments (Table 4.2).14 Representative 
gels for conjugates 4 and 5 are shown in Figure 4.8. In general the conjugates were quite 
specific for their match sites, although some coating of the DNA (non-specific binding to 
all sequences) was noted for 6 and 10 at high concentrations. The affinities of the eight-
and ten-ring conjugates were 75- to100-fold lower than the parent polyamides, while 
affinity of the 2-~-2 conjugate 5 is 9-fold less than the parent (doubly charged) compound 
(K. = 8.7 x 109 M· I). The affinity of 5 (K. = I x 109 M·I) is rather high for a po\yarnide-
dye conjugate,12 suggesting that the placement of a ~-alanine or specifically a ~/~ pair 
adjacent to a modified Py ring may be beneficial for the affinity of similarly modified 
conjugates. Compound 6, which has a ~-a\anine in the N-terminal strand, but a Py 
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Table 4.2. Equilibrium association constants of polyamide-dye conjugates. 
Polyamide Binding Site K, DNA Fragment 
4 5'-gAAGTATAag-3' 1.4 x 108 M·' HER2 Promoter 
5 5 '-gAAGTATAag-3 , 1.0 x 109 M.' HER2 Promoter 
6 5 '-gAAGTATAag-3 , 6.2x 107 M-' HER2 Promoter 
10 5 ' -gAAGTATAag-3 , 3.6x 107 M-' HER2 Promoter 
1 5 ' -tTAGTATTtg-3 , 5.0 x 107 M-' pJTS 
7 5 '-tTAGTACTtg-3 , 3.3 x 108 M.' pJTS 
Table 4.2. Equilibrium association constants (M·') for polyamide-Bodipy conjugates 4-6 and TAMRA 
conjugate 10 with a ISS-bp DNA fragment of the HER2 promoter; and polyamides 1 and 7 with restriction 
fragment pJTS .' 5 Values reported are the mean values obtained from at least three DNase I footprint 
titration experiments. Assays were performed at 22° C at pH 7.0 in the presence of 10 mM TriseHCl, 10 
mM KCl, 10 mM MgCI2 , and 5 mM CaCl,. 
adjacent to the modified position, showed considerably lower affinity (K" = 6.2 x 107 
M·'). The high specificity of many of these compounds and the equilibrium association 
constants above 107 M-I suggest that the Bodipy conjugates are good models of standard 
hairpin polyamides. 
Confocal Microscopy. A summary of cell lines not described in Chapter 4A that 
have been examined with at least one of polyamide-dyes 1-5 is given in Table 4.3. In the 
last two entries on the table, a pre-B-cell (103Bcl2) and a plasmacytoma cell (S194), 
nuclear localization was observed with standard hairpin-dyes, in very recent experiments. 
The Dervan laboratory will be actively pursuing functional assays in these cell lines. In 
the other cell lines, the Bodipy conjugates were concentrated either broadly throughout 
the cytoplasm, as in the insect cell line Hi-5 (Figure 4.9A), or in a more localized, 
punctate pattern, as in the human prostate cancer cell line LnCap (Figure 4.9B). 
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Table 4.3. Screening of standard hairpin-Bodipy conjugates 1-5. 
Nuclear Nuclear 
Cell line Localization Cell line Localization 
MCF-7 Mel 
breast cancer erythroid cancer 
T47D PC-3 
breast cancer prostate cancer 
MOA1B3468 LnCap 
breast cancer prostate cancer 
Hi-5 786-0 
insect renal carcinoma 
S2 A-498 
Drosophila renal carcinoma 
He-La 769-P 
cervical cancer renal carcinoma 
Jurkat H1B-44 
T·cell renal carcinoma 
K-562 103BcI2 + 
bcrlabl pre-B-cell 
A6 S194 + 
Xenopus kidney plasmacytoma 
fibroblast 
Table 4.3. Additional cell lines where at least one of 1-5 has been screened (usually 1-3) according the 
protocol described in Chapter 4A. Cell lines are human-derived except where noted. Cells were imaged 
directly following 20-hour incubation with 5 ~M conjugate under normal growth conditions for each cell 
line. 
Bodipy conjngates of different polyamide motifs. Since hairpin conjugates did 
localize to the nucleus of the majority of live cells tested, it was of interest to investigate 
other polyamide motifs. Bodipy conjugates of a cycle16 (11), a tandem hairpin dimer17 
(12), and two one-to-one binding polyamides1s (13-14) were examined in a variety of cell 
lines (Figures 4.10-4.12, Table 4.4). Whereas hairpin conjugates such as 1-5 are readily 
accessible, synthesis of cyclic polyamides is known to be challenging. In this case newly 
developed protocols for polyamide synthesis on oxime resin (Chapter 5A) were utilized 
to obtain the C-terminal acid intermediate 15 (Figure 4.10), after extensive attempts to 
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Figure 4.9 
A) 
B) 
Figure 4.9. A) Conjugate 3 in live Hi-5 cells. The fluorescent image is on the left. bright field image on 
the right. Bar: 20 11m. B) Conjugate 1 in live LnCap cells. The fluorescent image is on the left. bright 
field image on the right. Bar: 20 11m. 
cyclize eight-ring polyamides directly from the oxime resin proved to be unsuccessful. 
While the DBU-assisted cleavage from the resin to generate 15 was a lower-yielding 
reaction that the corresponding cleavage without the trityl-protected cysteine residue, the 
diphenylphosphorylazide (DPPA)-mediated cyclization16 actually occurred in higher 
yield (a quite respectable 30% recovery following preparative HPLC purification) with 
this bulky substituent close to the nucleophilic amine than without it (8% recovery). The 
Bodipy maleimide unit 17 was reacted with the free thiol following cleavage of the trityl 
and Boc protecting groups from cysteine-appended cyclic polyamide 16, to complete the 
Bodipy-cyclic polyamide conjugate 11. It was envisioned that the cycle might behave 
quite differently from the hairpin-dyes, because of its constrained structure. However, 
thus far the cycle conjugate had similar uptake and localization properties to the hairpin-
dyes, in that it was cell-permeable to the four cell lines tested, but only localized to the 
nucleus in live CEM cells. 
Figure 4.10 
o I HN~ 0 I ~~ ~~ 0 ~ 0 I TrtS N ~ \~ N a o ~>'lh ~~~ orNHBoc 
I 0 '(If h . ~ ~~NHFmoc 
'(l( fQ\-1 
I ON 0 
I 'N 
o I 
O,N 
i, ii 
113 
HN-/~ 
o 
17 
o I 
HN'\Q 0 I ~ ' /, N H ~~O ~ 0 Nr,-N N~~I.' ~I TrtS 
o ~) ... /~O-rrH H \L!(~ I Nj, )0 ~I 
,...- If ~ ~ N N / ~NHBoc 
o N h H H 0 
I 0 '~~N ~ 0 ~NH 
I 0 
v-vii 16 
o I HN~~I.' 0 I 
o ~\L!(~ N 0 I NOH \~ N 0 
HN-/ ~S~" ~~H ~Jl-Q Jl J 
o . ' ~ 0 r I N~ N/ \I 'Ii 0 
o NH, N r I H H N--'1..... ; 
I ON N'QyH ~ lor I N 
11 ~ h NH 
o '(Y 
I 0 
Figure 4.10. Synthesis of the Bodipy-cyclic polyamide conjugate 11: (i) H,o, DMF, DBU, 37°C, 72 hrs; 
(ii) preparative HPLC purification; (iii) DPPA, K,C03, DMF, 4.5 hrs ; (iv) preparative HPLC purification; 
(v) 33 % TFAlCH,Cl" Et3SiH, 15 min.; (vi) 100 mM Na,HP04 , H,O (pH = 7), DMF, 17, TCEP, 30 min. 
(vii) preparative HPLC purification. 
The tandem and one-to-one binding polyamides are on opposite sides of the 
polyamide molecular weight spectrum. Given the high molecular weight, it was 
surprising that the Bodipy-tandem conjugate 12 was not only cell-permeable but also 
localized to the nucleus of live CEM cells. However, like the cycle, it was not observed 
in the nucleus of other live cells, and appeared to be somewhat less permeable to the 
cytoplasm than the standard hairpin-dyes in some cases. The one-to-one binder 
conjugates 13 and 14 have only recently been investigated, however, they have already 
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Figure 4.11. Chemical structures of tandem hairpin dimer and one-to-one binding Bodipy conjugates. 
Table 4.4. Bodipy conjugates of different polyamide motifs. 
11 12 13 14 
CEM nuclear nuclear nuclear cytoplasm 
NB4 cytoplasm cytoplasm nuclear cytoplasm 
SKBR-3 cytoplasm cytoplasm cytoplasm 
MCF-7 cytoplasm 
293 cytoplasm cytoplasm cytoplasm 
Sf9 cytoplasm nuclear nuclear 
Kc cytoplasm nuclear nuclear 
HiS cytoplasm 
Mel cytoplasm cytoplasm 
LnCap cytoplasm 
PC-3 cytoplasm 
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Table 4.4. Localization of polyamide-Bodipy conjugates 11-14 in live cells as determined by confocal 
microscopy. The designation "nucleus" indicates observation of fluorescence in the interior of the nucleus. 
The designation "cytoplasm" indicates cellular, nonnuclear fluorescence. The designation "-" indicates 
that the experiment has not yet been performed. Cells were imaged directly following 20-hour incubation 
with 5 11M 11-14 under normal growth conditions for each cell line. 
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Figure 4.12 
A) 
B) 
C) 
Figure 4.12. A) Conjugate 13 in live NB4 cells. The fluorescent image is on the left, bright field image on 
the right. Bar: 20 /J.m. B) Conjugate 14 in live NB4 cells. The fluorescent image is on the left, bright field 
image on the right. Bar: 20/J.m. C) Conjugate 13 in live Sf9 cells. The fluorescent image is on the left, 
bright field image on the right. Bar: 20 /J.m. 
provided very exciting results. While not a completely general solution, nuclear 
localization of 13 was observed in four cell lines, including CEM, the human leukemia 
cell line NB4 (Figure 4. 12A), and the insect cell line Sf9, where the conjugate appeared 
to localize exclusively to the nucleus (Figure 4.12C). Conjugate 14 also localized 
strongly to the nucleus in Sf9 cells, and both one-to-one binder conjugates were observed 
in the nucleus of Drosophila Kc cells. While a whole organism is tremendously different 
from one of its cells, this result is at least consistent with the exciting work of Laemmli 
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and co-workers, who showed that similar one-to-one binding polyamides caused 
phenotypic changes in live Drosophila as a result of interaction with specific satellite 
DNA repeat sequences. 19,20 Compared to the standard hairpin-dyes, the results of 13 and 
14 suggest that molecular weight is likely a factor for nuclear localization in insect cells 
such as Kc and Sf9. In human cells the importance of molecular weight is less clear, 
although there appears to be some dependence, as the slightly larger 14 did not localize to 
the nucleus of NB4 cells (Figure 4.13B). However, 14 was also only observed in the 
cytoplasm of CEM cells, where conjugates as large as the tandem dimer 12 were 
observed in the nucleus. Molecular weight is usually mentioned as an issue in cell 
permeability, its role once a compound is inside of cells is less clear. Nevertheless, these 
recent results represent an important lead, as it certainly possible that in other human cell 
lines conjugates smaller than 13 would display enhanced nuclear localization. As 
previously mentioned, a study examining a series of progressively lower molecular 
weight polyamide-Bodipy conjugates has been initiated. These results also raise the 
issue that the molecular weight of Bodipy may contribute to the localization properties of 
the conjugates, as it is worth noting that the molecular weight of conjugate 15 is very 
similar to the molecular weight of a standard unmodified eight-ring polyamide. This 
highlights the importance of efforts to develop intrinsically fluorescent polyamides and 
other methods to gage whether unmodified polyamides can reach their DNA targets in 
live cells. 
Chlorambucil-polyamide-Bodipy conjugates. The DNA-alkylating agent 
chlorambucil (CHL) has been attached to hairpin polyamides to produce sequence-
specific alkylating agents . The laboratories of both Terry Beerman and Joel Gottesfeld 
have observed effects such as toxicity and DNA-alkylation in a variety of cell lines.21 
Thus , it was interesting to test polyamide-Bodipy-CHL conjugates for nuclear 
localization by confocal microscopy. Three conjugates were examined in a variety of 
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Figure 4.13 
Figure 4.13. Structures ofCHL-polyamide-Bodipy conjugates 18-19 and non-alkyating analog 20. 
cell lines (Figures 4.13 and 4.14, Table 4.5). In the majority of the cell lines tested, the 
alkylator conjugates 18 and 19 did not localize to the nucleus or appear to cause 
appreciable cell death. The alkylator conjugates did localize to the nucleus of three 
human cell lines: NB4 (Figure 4.15A and 4.15B), CEM, and significantly the primary 
CD4+ T-cells (Figure 4.15C). However, even with nuclear localization, conjugates 18 
and 19 did not cause cell death, as measured by co staining with sytox orange. (Cell 
growth inhibition!cell cycle arrest were not explicitly screened for. Qualitatively, a 
diminution in the amount of cells at the 20-hour imaging point was not observed.) 
Addition of the dye will likely decrease the DNA-binding affinity of the conjugate, which 
will lower alkylation potential, although this alone may account for differences in 
toxicity. Particularly in the cells where the conjugate was not observed in the nucleus, 
Bodipy may alter its localization. Alternatively, the conjugates may faithfully reflect the 
behavior of CHL-polyamides, but, without attenuation by attachment of a dye, a small 
amount reaching the nucleus (below the detection limit in the confocal microscopy 
experiments) may be enough to cause extensive toxic effects. It is also possible that 
ll8 
Figure 4.14 
A) 
B) 
C) 
Figure 4.14. A) Eight-ring hairpin-CHL-Bodipy conjugate 19 in live NB4 cells. The fluorescent image is 
on the left, bright field image on the right. Bar: 20 J.1-m. B) 2-~-2-CHL-Bodipy conjugate 18 in live NB4 
cells. The fluorescent image is on the left, bright field image on the right. Bar: 20 J.1-m. C) 2-~-2-CHL­
Bodipy conjugate 18 and dead cell stain Sytox Orange in live primary human CD4+ T -cells. The 
fluorescen t emission of Sytox Orange (Rhodamine filter) is shown on the left. The fluorescent emission of 
conjugate I (FITC filter) is shown in the center. The bright field image on the right. Bar: 20 J.1-m. 
alkylation of proteins is responsible for toxicity, and that this is also attenuated by 
attachment of the dye. Alkylation of DNA or perhaps proteins is likely a factor in NB4 
cells, since 20 a non-alkylating analog of 19 did not localize to the nucleus, although 
specific physical properties of the extra -CH2CL groups of 19 not related to alkylation 
have not been ruled out. Nuclear localization of the non-alkylating CHL hydrolysis 
product (x = CH2CHPH) is also a possibility. The polyamide portion of the molecule 
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Table 4.5. Polyamide-chlorambucil-Bodipy conjugates. 
18 19 20 
CEM nuclear nuclear 
Primary T -cells nuclear nuclear 
NB4 nuclear nuclear cytoplasm 
SKBR-3 cytoplasm cytoplasm 
293 cytoplasm cytoplasm 
Sf9 cytoplasm 
Kc cytoplasm cytoplasm 
786-0 cytoplasm cytoplasm 
Mel cytoplasm cytoplasm 
LnCap cytoplasm cytoplasm 
PC-3 cytoplasm cytoplasm 
Table 4.5. Localization of polyamide-CHL-Bodipy conjugates 18-19 and non-alkyating analog 20 in live 
cells as determined by confocal microscopy. The designation "nucleus" indicates observation of 
fluorescence in the interior of the nucleus. The designation "cytoplasm" indicates cellular, nonnuclear 
fluorescence. The designation "-" indicates that the experiment has not yet been performed. Cells were 
imaged directly following 20-hour incubation with 5 ~M 18-20 under normal growth conditions for each 
cell line. 
plays a role as well, as greater locatization is observed for the eight-ring conjugate 19 
than the 2-~-2 conjugate 18. It is interesting to note that in CEM and primary human T-
cells, where both 18 and the standard hairpin conjugates are also observed in the nucleus, 
the alkylator 18 showed significantly greater nuclear localization than 3 (which has the 
same 2-~-2 parent polyamide). 
Small molecule conjugates for receptor-mediated uptake. Many small 
molecules such as nutrients and signal transduction messengers are taken up into cells by 
specific receptors. In many cases, it has been shown that large cargo, including DNA and 
PNA oligonucleotides,3.22 and even 31 kD proteins,4 can be transported into cells via 
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Figure 4.15 
A) 
Figure 4.15. A) Polyamide-DHT conjugate 23 in live LnCap cells. The fluorescent image is on the left, 
bright field image on the right. Bar: 20 ~m. B) DHT conjugate 23 in livePC-3 cells. The fluorescent 
image is on the left, bright field image on the right. Bar: 20 ~m. C) Chemical structures of the small 
molecule-poylamide-Bodipy conjugates. 
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Table 4.6. Polyamide-Bodipy-small molecule conjugates. 
21 22 
CEM nuclear 
NB4 cytoplasm cytoplasm cytoplasm 
SKBR·3 cytoplasm cytoplasm cytoplasm 
293 cytoplasm cytoplasm cytoplasm 
Kc cytoplasm cytoplasm cytoplasm 
Mel cytoplasm cytoplasm 
LnCap cytoplasm cytoplasm cytoplasm 
PC·3 cytoplasm cytoplasm cytoplasm 
Table 4.6. Localization of polyamide-Bodipy-small molecule conjugates 21·23 in live cells as determined 
by confocal microscopy. The designation "nucleus" indicates observation of fluorescence in the interior of 
the nucleus. The designation "cytoplasm" indicates cellular, nonnuclear fluorescence. The designation "-" 
indicates that the experiment has not yet been performed. Cells were imaged directly following 20-hour 
incubation with 5 [LM 21·23 under normal growth conditions for each cell line. For folic acid conjugate 21, 
cells were also incubated in folate-free media. 
attachment to small molecules in cells containing the cognate receptor. This approach 
has also been used for small molecule-small molecule conjugates to deliver toxic agents 
only to specific cells.23 The folate receptor is often used as a target, since its receptor-
mediated endocytosis24 is well understood and the receptor is overexpressed in a range of 
cancers.25 Bodipy-polyamide conjugates with folic acid (21), cholic acid (22), and 
dihydrotestosterone (DHT) (23) were investigated in a variety of cell lines (Figure 4.15, 
Table 4.6). The folate experiments were performed with both folate-containing and 
folate-free media;4 however, 21 did not successfully reach the nucleus of any cells under 
either condition. Similarly, DHT conjugate 23 and cholic acid conjugate 22 were 
ineffective at reaching the nucleus, except for 22 in CEM cells. In the case of prostate 
cancer cells, which DHT has previously been used to target,3 there was a marked increase 
of conjugate in the cytoplasm, for 23 as compared to the standard hairpin-dyes (compare 
Figure 4.15A, LnCap, to Figure 4.9B). Note the extremely large vesicle-like structures at 
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the edges of the PC-3 cells (Figure 4.1SB). It appears that DHT is helping the polyamide 
into the cell, but the conjugate remains trapped in cytoplasm. This is in fact somewhat 
counter-intuitive, since DHT itself functions in the nucleus. 
Figure 4.16 
A) 
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peptide: 
24 NLS: (L)PKKKRKV 
25 TAT: (L)YGRKKRRQRRR 
26 R9: (D)RRRRRRRRR 
27 MTS: (L)AA VLLPLLAAP 
peptide: 
28 NLS: (L)PKKKRKV 
29 TAT: (L)YGRKKRRQRRR 
30 R9: (D)RRRRRRRRR 
31 MTS : (L)AAVLLPLLAAP 
Figure 4.16. Chemical structures of (A) polyamide-carrier peptide-Bodipy conjugates, and (B) carrier 
peptide-Bodipy control compounds. 
Carrier peptide conjugates. Carrier peptides have been used to transport small 
molecules, oligonucleotides, and large proteins both into cells and into nuclei ,6 which 
prompted their investigation in this system. Two of the most widely used carrier pep tides 
are TAT,7,26.28 a basic domain derived from the HIV-l Tat protein/9 and the SV 40 NLS 
peptide,3{}-33 derived from a basic region from the SV40 T antigen protein. 34 While the 
NLS (nuclear localization signal) has a well-characterized receptor for nuclear import, 
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Figure 4.17 
A) 
B) 
C) 
Figure 4.17. A) R9 conjugate 26 in live Sf9 cells. The fluorescent image is on the left, bright field image 
on the right. Bar: 20 J.!m. B) NLS conjugate 24 in live Kc cells. The fluorescent image is on the left, 
bright field image on the right. Bar: 20 J.!m. C) NLS-Bodipy control 28 in live Kc cells. The fluorescent 
image is on the left, bright field image on the right. Bar: 20 J.!m. 
karyopherin a,34.35 the mechanism of TAT transduction is still unknown despite 
considerable study. TAT transduction appears not to involve classical receptor-, 
transporter-, endosome- , or adorptive-endocytosis-mediated processes.6,36 Since it is 
likely that, at least in some cells, polyamide conjugates are trapped in endosomes, the 
ability of TAT to bypass endosomes should result in enhanced nuclear localization, 
especially since TAT itself acts a nuclear localization signa1.37 In addition to NLS (24) 
and TAT (25), conjugates of R9 (nine arginines)8 (26) and MTS38 (27) were also 
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Table 4.7. Carrier peptide-polyamide-Bodipy conjugates. 
24 25 26 27 
NLS TAT R9 MTS 
CEM cytoplasm nuclear nuclear cytoplasm 
NB4 cytoplasm nuclear nuclear cytoplasm 
SKBR-3 cytoplasm cytoplasm nuclear* cytoplasm 
MCF-7 cytoplasm cytoplasm cytoplasm cytoplasm 
293 cytoplasm nuclear nuclear* nuclear* 
Sf9 cytoplasm cytoplasm nuclear cytoplasm 
Kc nuclear nuclear nuclear cytoplasm 
HiS cytoplasm cytoplasm cytoplasm cytoplasm 
S2 nuclear cytoplasm cytoplasm cytoplasm 
786-0 cytoplasm cytoplasm cytoplasm cytoplasm 
Table 4.7. Localization of carrier peptide-polyamide-Bodipy conjugates 24-27 in live cells as determined 
by confocal microscopy. The designation "nucleus" indicates observation of fluorescence in the interior of 
the nucleus . The designation "cytoplasm" indicates cellular, non-nuclear fluorescence. The designation 
"*" indicates that the compound may be toxic to those cells under these conditions. Cells were imaged 
directly following 20-hour incubation with 5 ~M 24-27 under normal growth conditions for each cell line. 
investigated, as well as peptide-Bodipy controls lacking a polyamide (28-31) (Figures 
4.16 and 4.17, Table 4.7). MTS is a membrane translocation sequence derived from the 
kaposi FGF signal sequence;38 it should allow the conjugate to pass through the outer 
membrane again bypassing endocytosis. R9 was shown by Wender and co-workers, who 
also investigated a peptoid version, to outperform TAT at uptake into Iurkat cells,8 but 
does not necessarily confer nuclear localization. Of note is that of the peptides 
investigated in this series, only R9 was the D-form, which will limit its potential 
proteolytic degradation relative to the L-peptides. (Polyamides themselves appear to be 
resistant to proteases, at least in vitro.)39 
As seen in Table 4.7, the peptide conjugates ranged from nuclear localization in 
one cell line out of ten examined for the MTS conjugate 27, to six of out ten for the R9 
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conjugate 26. Compound 26 is the best option examined thus far for targeting multiple 
cell lines (see Figure 4.17A with Sf9 cells), including the human breast cancer cells 
SKBR-3 and human kidney fibroblasts 293, although it should be noted that, at the 
concentrations of the assay, 5 /lM, 26 caused some cell-death in these compounds. The 
MTS conjugate 27 was also somewhat toxic to 293 cells, the one cell line that it localized 
to the nucleus in. The TAT (25) and NLS (24) are intermediate, with 25 reaching the 
nucleus of CEM, NB4, 293, and the Drosophila cell Kc. NLS conjugate 24 bound both 
Drosophila cells (Kc and S2), but only those two cell lines. It is very difficult to 
speculate about what the actual role of the peptide is in these experiments, as it may be 
different in different cell lines, and the polyamide conjugates (24-27) either equaled or in 
most cases out-performed the carrier peptide controls (28-31) in terms of nuclear 
localization. One of the biggest surprises in the entire study has been the behavior of the 
carrier peptide-Bodipy conjugates (28-31), which in most cases did not even localize 
inside the cell (compare 4.17B and 4.17C, compounds 24 and 28 in Kc cells). This was 
not expected from the literature, particularly for TAT, but on its own, the TAT-Bodipy 
conjugate went into the nucleus of CEM and was otherwise noncellular. This highlights 
the difficulty of getting Bodipy into the nucleus. The carrier peptides, while being the 
best option tested so far, do not impart the extreme generality attributed to them in the 
literature with regard to cargo and cell type. However, nuclear localization in six out ten 
cell lines for the R9 conjugate 26, four out of ten for TAT conjugate 25, and selectivity 
for Drosophila cells for the NLS conjugate 24, represented major advances. The next 
step in preparation for functional in vivo assays, DNase I footprinting on polyarnide-
carrier peptide conjugates (no dye), was eagerly anticipated. 
DNA binding properties of polyamide-carrier peptide conjugates. The 
success of the cationic carrier peptides prompted an investigation of the DNA binding 
properties of cationic peptide-polyamide conjugates (no Bodipy). Unfortunately, coating 
Figure 4.18 
32 peptide = TAT (L)yGRKKRRQRRR 
33 peptide = R9 (D)RRRRRRRRR 
34 peptide = TAT (L)YGRKKRRQRRR 
3S peptide = R9 (D)RRRRRRRRR 
36 peptide = NLS (L)PKKKRKV 
37 peptide = MTS (L)AAVLLPLLAAP 
Figure 4.18. Structures of compounds examined by DNase I footprinting. 
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of the DNA (nonspecific binding at all sequences) was consistently observed by 
quantitative DNase I footprinting titrations.14 Initially I-imidazole eight-ring hairpin 
compounds 32 (TAT) and 33 (R9) (Figure 4.18) based on the I-imidazole eight ring 
hairpin conjugates 2S and 26, respectively, were investigated on the restriction fragment 
derived from pJT8 15 (Figure 4.19). Next, compounds 34-37 were prepared, with the aim 
of placing the peptides on a more intrinsically specific polyamide (38). A long linker 
Figure 4.19 
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Figure 4.8. Quantitative DNase I footprint titration experiments on a 3'·32P·labeled 229·bp DNA fragment 
of the plasmid pJT81 S All reactions contain 15 kcpm DNA fragment, 10 mM TriseHCl (pH 7.0), 10 mM 
KCl , 10 mM MgCI2, and 5 mM CaCI2• A) Lane 1, A reaction; lane 2, intact DNA; lane 3, DNase I 
standard; lanes 4·12,100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM, 20 nM, and 50 nM polyamide-
TAT peptide conjugate 32, respectively. B) Lane I, A reaction; lane 2, intact DNA; lane 3 DNase I 
standard; lanes 4-12, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM, 20 nM, and 50 nM polyamide-
R9 peptide conjugate 34, respectively. 
between the polyamide and peptide was also employed in the design of these compounds. 
DNase I footprinting assays were carried out using the restriction fragment from plasmid 
pDEH940 (Table 4.8, Figure 4.20). The coating phenomenon was still observed with the 
cationic carrier peptides, which surprisingly had no greater affinity for the match site than 
the singly charged parent hairpin 38 (Ka = 1 x 109 M'l). Coating was not observed for 
conjugate 37 which contains the uncharged, hydrophobic MTS peptide, but this 
compound bound with loo-fold lower affinity than the parent. In order to confirm that 
the observed coating was a real property of DNA binding and not the result of an 
interaction between the cationic peptides and the DNase I enzyme, MPE footprinting 
experimentsl4 were performed which yielded similar results to those shown for DNase I 
footprinting. The affinity and specificity of the cationic peptides themselves were also 
Table 4.8. Equilibrium association constants 
and specificity over coating for polyamide-
carrier peptide conjugates. 
Match Site Specificity 
Polyamide 
-Ka (Mel) over coating 
38~ 1 x 109 
~ MTS 1 x 107 
~ 1 X 109 -5-fold I:AT 
~ 1 x 109 - IO-fold R9 
36 ~ 5 x 108 - 20-fold 
~ 39 1 x 10 10 -75-fold + 
Table 4.8. Values reported are the mean values obtained 
from at least three DNase I footprint titration experiments, but 
are not quantitative, due to the interference of coating. Assays 
were performed at 22°C at pH 7.0 in the presence of 10 mM 
Tris-HCI, 10 rnM KCI, 10 rnM MgCI" and 5 rnM CaCI,. 
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5'3' 
II 
TA 
GC 
AT 
l- CG ~CG 
AT 
TA 
I I 
3'5' 
32p 
Fignre 4,20, Quantitative DNase I footprint titration experiments on a 3'-32P-labeled restriction fragment 
of the plasmid pDEH9.40 All reactions contain 15 kcpm DNA fragment, 10 rnM Tris-HCI (pH 7.0), 10 
rnM KCI, 10 rnM MgCI2 , and 5 mM CaCl,. Lane I , A reaction; lane 2, G reaction; lane 3, DNase I 
standard; lanes 4-13, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 nM, 10 nM, 20 nM, 50 nM and 100 nM 
polyamide-NLS peptide conjugate 3, respectively; lane 14, intact DNA. 
briefly investigated. None were found to exhibit any sequence specificity, and the 
affinities ranged from _105 M· I for NLS to _107 M· I for R9.41 ,42 Consistent with a lower 
intrinsic affinity for DNA, attachment of NLS to the polyamide afforded the most 
specific compound (36, -20-fold over coating) of the cationic series. In order to see if 
the specificity could be further optimized, by moving the attachment point of the NLS 
from the tail the N-methyl position of a Py ring. Indeed both the specificity (-75-fold 
over coating) and affinity CKa = 1 x 1QIO M·1) of the resulting conjugate (39) went up. This 
compound or other N-methyl-linked NLS conjugates are reasonable candidates for in vivo 
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assays in Drosophila cells. The specificity is yet not optimal, but may be good enough to 
see specific effects in cell culture. The analogous compounds with TAT and R9 have not 
yet been investigated, partially because it is unlikely that the specificity over coating for 
those compounds would exceed 75-fold. 
Carrier peptide disulfide conjugate. The loss of DNA binding specificity 
observed for the most effective carrier peptides is a setback. One strategy for 
overcoming the problem is a pro-drug approach, where in the optimal case, a cationic 
carrier peptide is used to bring the polyamide to the nucleus, and is then rapidly cleaved 
so that the polyamide can go about binding DNA specifically. A common way to attach 
carrier peptides to their cargo is through a disulfide bond.6 The carrier peptide brings the 
cargo into the cell, and in that reductive environment the disulfide bond is cleaved. This 
differs from the optimal case for polyamides because it is expected that the disulfide bond 
will be cleaved in the cytoplasm, and then the fate of the polyamide at that point is 
uncertain. Bodipy conjugate 40, which contains a disulfide-linked R9, was synthesized 
to test the utility of this approach (Figure 4.21). If the R9 in conjugate 26 functioned to 
alter the mechanism of uptake such that the conjugate is "free" in the cytoplasm, the 
polyamide portion of conjugate 40 should be able to reach the nucleus and the 
thermodynamic sink of the DNA even with the release of R9 in the cytoplasm. However, 
if R9 plays an active role in nuclear localization from the cytoplasm, either by interacting 
Figure 4.21 
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40 I 0 0 0 R9 = (O)RRRRRRRRR 
Figure 4.21. Chemical structure of the Bodipy-polyamide-disulfide-linked-R9 conjugate 40. 
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with a specific nuclear receptor or by changing the properties of the conjugate so that it 
can escape from vesicles, then the polyamide portion of conjugate 40, with the Bodipy 
reporter attached, might be expected to stay in the cytoplasm. Thus, in addition to 
providing very general solution for trafficking polyamides to the nucleus if successful, 
conjugate 40 was also expected to be a probe for the mechanism of R9-enhanced nuclear 
localization. Unfortunately, the disulfide conjungate 40 defied both expectations and was 
observed only very weakly even in the cytoplasm of all the cell lines tested (primarily 
noncellular). Despite the failure of this particular compound, a pro-drug type of approach 
may still be successful, although other common options such as ester linkages to be 
cleaved by esterases, share the original concern of the disulfide, in that the ester linkage 
would be cleaved in the cytoplasm. 
Cationic polyamide-Bodipy conjugates. A common feature of the successful 
carrier peptides was their cationic charge, and simplistically, the more charges the better. 
This is indeed what Wender et al. observed quantitatively for uptake into Jurkat cells, 
varying from five to nine guanidines .8 For peptides the D-arginine oligomer was 
preferable to the L-arginine oligomer, and in a peptoid series, the longer alkyl chain 
length between the peptoid backbone and the guanidine unit, the better. Their results 
only concerned cellular uptake in a single cell line and not nuclear localization. 
However, since in our case positively charged peptides were beneficial for nuclear 
localization, but were a problem for specificity, replacement of the entire carrier peptide 
by charged groups on the polyamide backbone was investigated. This work is in analogy 
to the Wender peptoids,8 and builds on previous work in the Dervan laboratory 
investigating "positive patch" polyamides.43.44 Quantitative DNase I footprinting 
experiments have revealed that six-ring hairpins with either a primary amine or a 
guanidine and a linker of three or six carbon atoms connected to the N-methyl carbon of 
three of the pyrrole units show good specificity.4s Corresponding compounds with ten 
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Figure 4.22 
Figure 4.22. Chemical structures of Bodipy-cationic polyamide conjugates. 
carbon linkers were also investigated, but showed poorer specificity. Bodipy conjugates 
(41-46) of each member of the series were prepared and examined by confocal 
microscopy (Figure 4.22 and 4.23, Table 4 .9) . Given that the six-rings have only three 
charges, the observation that some members of the series localize to the nucleus of three 
cell lines (NB4, CEM, and Kc) was highly promising. While the entire series localized to 
the nucleus of CEM cells, the conjugates that localized to the nucleus of NB4 cells did 
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Figure 4.23 
A) 
B) 
Figure 4.23. A) Cationic polyamide conjugate 41 in live CEM cells. The fluorescent image is on the left, 
bright field image on the right. Bar: 20 flm. B) Cationic polyamide conjugate 41 in live Kc cells. The 
fluorescent image is on the left, bright field image on the right. Bar: 20 flm. 
Table 4.9. Cationic polyamide-Bodipy conjugates. 
41 42 43 44 45 46 
CEM nuclear nuclear nuclear nuclear nuclear nuclear 
NB4 cytoplasm # cytoplasm nuclear nuclear cytoplasm 
SKBR-3 cytoplasm cytoplasm cytoplasm cytoplasm cytoplasm 
Mel cytoplasm cytoplasm cytoplasm cytoplasm 
293 cytoplasm cytoplasm cytoplasm cytoplasm cytoplasm cytoplasm 
Sf9 cytoplasm cytoplasm nuclear cytoplasm cytoplasm # 
Kc nuclear nuclear nuclear cytoplasm cytoplasm cytoplasm 
LnCap cytoplasm cytoplasm cytoplasm cytoplasm 
PC3 cytoplasm cytoplasm cytoplasm cytoplasm 
Table 4.9. Localization of cationic polyamide-Bodipy conjugates 41-46 in live cells as determined by 
confocal microscopy. The designation "nucleus" indicates observation of fluorescence in the interior of the 
nucleus. The designation "cytoplasm" indicates cellular, nonnuclear fluorescence. The designation "#" 
indicates inconsitent results, and the designation "-" indicates the experiment has not been performed yet. 
Cells were imaged directly following 20-hour incubation with 5 flM 41-46 under normal growth conditions 
for each cell line. 
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not localize to the nucleus of Kc cells, and vice versa with the possible exception of 42 
(for which the results are currently inconistent). The good specificity of the compounds 
with three- and six-carbon linkers suggest that these cationic hairpin polyamides would 
be useful in NB4, Kc, or CEM cells for in vivo experiments. Currently, efforts are 
underway to examine cationic eight-ring hairpin-Bodipy conjugates with three, four, and 
five charges with the goal of localization to the nucleus of human cell lines such as 293 
and SKBR-3 , which were amenable to nuclear localization of the TAT and R9 
conjugates. 
Figure 4.24 
A) 
B) 
47 48 
47 L-PTD-4: (L)YARAAARQARA 
48 D-PTD-4: (D)Y ARAAARQARA 
Figure 4.15. A) PTD-4 conjugates 47 and 48 in live Kc and Sf9 cells. Each fluorescent image is on the 
left, bright field image on the right. Bar: 20 ~m. B) Chemical structures of the L- and D-PTD-4 
polyamide-Bodipy conjugates 47 and 48, respectively. 
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Additional carrier peptide conjugates. Concurrent with the efforts to build 
more positive charges into the polyamide backbone, carrier peptides with fewer positive 
charges were also investigated. Dowdy and co-workers have recently reported an 
alanine-rich derivative of TAT called PTD-4 (protein transduction domain four) which 
only has three of the original eight charges.46 It was shown to be effective at transducing 
into cell s both in culture (Jurkat) and in mice. Polyamide-Bodipy conjugates with both 
the L (47) and D (48) pep tides were prepared and investigated by confocal microscopy. 
Figure 4.24 shows that there is a functional difference between the Land D forms in Kc 
cells, only the latter (48) is observed in the nucleus at the 20-hour imaging point. In Sf9 
cells, both were observed in the nucleus. Unfortunately, these were the only cell lines 
where either 47 or 48 were found in the nucleus (out of over ten cell lines tested). This is 
particularly unfortunate because very recent DNase I footprinting experiments have 
shown that a PTD-4 conjugate has good specificity over coating. DNase I footprinting 
experiments have also recently been performed for truncated versions of R9. Uptake of 
R5 and R7 peptides has been demonstrated in lurkat cells,S and R7 has been used to 
transport a cell-impermeable peptide into cells and intact heart.47 While the R7 conjugate 
had displayed coating similar to R9 conjugates 33 and 35, the R5 conjugate showed 
better specificity, on the order of NLS. The very promising R5 conjugate is currently 
under investigation by confocal microscopy. 
Conclusions 
At the outset of these studies, nuclear localization of standard polyamide-dye 
conjugates had been observed in two related cell lines . Two others were uncovered 
recently, and all four are related to the human immune system. This clearly represents an 
important lead that will be followed up in the future . Currently, the efforts described in 
this chapter have yielded six additional cell lines ranging from Drosophila to human 
breast cancer, amenable to nuclear localization of certain polyamide derivatives. Among 
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the modifications tested, small molecule conjugates for receptor-mediated uptake were 
the least successful, and cationic carrier peptides, particularly TAT and R9, were the most 
successful. The majority of the recent efforts have been focused on exploring the 
complex relationship between positive charges (either appended as carrier peptides or 
attached directly to the polyamide backbone), nuclear localization, and DNA binding 
specificity. However, simply moving to a smaller conjugate with the one-to-one binders 
yielded the same number of positives as TAT. This is also clearly a direction that will be 
followed up in the future, and a molecular weight study has been initiated. Yet, it is 
important to note that it is mainly the same cell lines that are accepting very different 
conjugates. Multiple solutions have now been found for CEM, NB4, Sf9, and Kc. 
Fundamentally different approaches may be necessary to gain access to the nucleus of the 
more recalcitrant cells. Confocal microscopy will inform functional assays and drive 
this ongoing discovery process. 
Experimental 
Polyamide Conjugates. Compounds 2,19-37,39-40, and 47-48 were synthesized 
by Bobby Arora. Compounds 41-46 were synthesized by Ben Edelson and Amanda 
Cashin. Compounds 13-14 were synthesized by Michael Marques and Adam Urbach. 
Compound 18 was synthesized by Nick Wurtz and compound 12 was synthesized by 
Philipp Weyermann. Compound 4 was originally synthesized by Roland Burli and 
subsequently by the author. 1: [M+H] 1538.9, 1538.7 calculated for [M+H]. 3: [M+H] 
1683.1, 1383.8 calculated for [M+H]. 4: [M+H] 1783.8, 1783.7 calculated for [M+H] . 
5: [M+H] 1681.0, 1680.8 calculated for [M+H]. 6: [M+H] 1731.1, 1731.8 calculated for 
[M+H]. 7: [M+H] 1539.0, 1539.7 calculated for [M+H]. 8 : [M+H] 777.5, 777.4 
calculated for [M+H]. 9: [M+H] 899.6,899.5 calculated for [M+H]. 10: [M+H] 1921.0, 
1920.9 calculated for [M+H]. 11: [M+Na] 1703.1,1702.6 calculated for [M+Na]. 
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Quantitative DNase I Footprinting. As previously reported,14 for DNA 
fragments derived from the HER2 promoter,9 plasmid pJT8,IS and plamid pDEH9.40 
Confocal Microscopy under live cell conditions. As previously reported in 
Chapter4A 
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CHAPTERS 
Synthesis and Investigation of DNA Binding Polyamides 
with New C-Terminal Tails 
The text of this chapter was taken in part from a manuscript coauthored with Doan 
Nguyen, Nick Wurtz, and Professor Peter Dervan (Caltech). 
(Belitsky, 1.M.; Nguyen, D.H.; Wurtz, N.R. Dervan, P.B. "Solid Phase Synthesis of 
DNA Binding Polyarnides on Oxime Resin" Boorg. Med. Chern., in press) 
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Abstract 
Control of the energetics and specificity of DNA binding polyamides is necessary 
for inhibition of protein-DNA complex formation and gene regulation studies. Typically, 
solid phase methods using Boe monomers for synthesis have depended on Boc-~-Ala­
PAM resin which affords a ~-alanine-Dp tail at the C-terminus, after cleavage with N,N-
dimethylaminopropylamine (Dp). In Chapter 5A, the energetic consequences of this tail 
for DNA minor-groove binding are addressed through the synthesis of polyamides with 
incrementally shortened C-terminal tails. These polyamides were synthesized using an 
alternative solid-phase method employing the Kaiser oxime resin. Polyamides without 
Dp and having methyl amide tails rather than ~-alanine show similar affinity relative to 
the standard ~-Dp tail. The truncated tails diminish the A,T base pair energetic 
preference of the ~-Dp tail which will allow a greater variety of DNA sequences to be 
targeted by hairpin polyamides. 
Chapter 5B describes an alternate solid-phase route to one of the truncated tails, 
the primary amide. The aminooxy linker employed in this route was derived from a 
novel compound generated for a project aimed at a G-selective ~-alanine analog. 
During the development of the aminooxy route to C-terminal pyrrole primary ami des, an 
unexpected reaction with cyclic secondary amides was uncovered, which provides 
polyamides with tertiary amide tails in moderate yield. The C-terminal cyclic tertiary-
amide polyamides are effective DNA binding agents worthy of further development, and 
have potential as inhibiters of TBP and ESX binding to the HER2 promoter. 
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Chapter SA: 
Solid-Phase Synthesis of DNA Binding Polyamides on Oxime Resin 
Introduction 
Hairpin polyamides containing N-methylpyrrole (Py), N-methylimidazole (1m), 
and N-methyl-3-hydroxypyrrole (Hp) residues bind specific predetermined sequences in 
the minor groove of DNA with affinities and specificities comparable to naturally 
occurring DNA-binding proteins.! DNA recognition depends on the side-by-side amino 
acid pairings in the minor groove that stack the aromatic rings against each other and the 
walls of the groove allowing backbone amide hydrogens and the substituents at the 3-
position of the Py, 1m, and Hp residues to make specific contacts with the edges of the 
DNA base pairs. An ImlPy and Py/lm specifies for GoC and CoG, respectively. A PylPy 
pair binds A-T and T-A and a HplPy pair discriminates T-A over A-T base pairs. These 
modular ring pairs may be considered the "core" of the polyamide recognition motif. For 
hairpins an alkyl amino acid, either y-aminobutyric acid (GABA, y), or the chiral, amine-
function ali zed derivative (R)-2,4,-diaminobutyric acid (DABA, (R)H2Ny), serves as the 
covalent linker region (referred to as the "turn") between the N-terminal and C-terminal 
strands and is specific for AoT and ToA base pairs. The "tail" or C-terminal portion of a 
typical hairpin polyamide is related to the method of synthesis and comprises ~-alanine 
(~) and N,N-dimethylaminopropylamine (Dp), which specify for A,T base pairs at the N-
1 and N-2 positions (Figure 5.1).! 
The ~-Dp tail originated with the C-7N synthesis of polyamides by solid-phase 
methods using Boc monomers on Boc-p-alanine-PAM-resin.2,3 An alkyl primary amine 
such as Dp affords efficient cleavage from the solid support by aminolysis of the 
p-alanine ester linkage to the resin. The sequence requirements of the ~-Dp tail for A,T 
versus G,C at the N-1 and N-2 positions4 presumably results from a steric clash with the 
exocyclic NH2 of a G,C base pair on the floor of the minor groove of DNA (Figure 5.1). 
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Figure 5.1 
/ 
N-2 N-l 
Figure 5.1. Binding model for polyamide 1 with DNA. (Top) Circles with dots represent lone pairs of N3 
of purines and 02 of pyrimidines. Circles containing an H represent the N2 hydrogens of guanine. 
Putative hydrogen bonds are illustrated by dotted lines. The series of truncated tails to be examined are 
denoted. (Bottom) A ball-and-stick representation of polyamide 1 with DNA. Filled circles denote 
imidazole while open circles represent pyrrole. The diamond represents J3-alanine. (R)-diaminobutyric 
acid «R)H2N y) and dimethylaminopropylamine (Dp) are depicted as a curved line and a plus sign, 
respectively. W signifies A or T, N represents any nucleotide . The N-2, N-l , core, turn positions for the 
polyamide/DNA complex are defined in the text. 
Replacement of the ~-Dp tail with a shorter propanol amide, generated by the reductive 
cleavage of the ~-a1anine-P AM ester from the solid support,s removes the preference for 
an A,T base pair at the N-2 position while maintaining the binding affinity for these sites, 
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despite the loss of an energetically favorable positive charge.4 This suggests that the Dp 
tail interaction with the minor groove may be sterically unfavorable. A deeper 
understanding of the effect of incremental changes to the tail on the energetics of DNA 
binding would provide insight on the molecular determinant for A,T versus G,C 
specificity at the N-l position. 
In order to incrementally reprogram the polyamide C-terminus in the minor 
groove of DNA, new solid-phase methodology would be required since the propanol 
amide tail is the shortest C-terminus that can be generated from cleavage of Boc-~-Ala­
PAM resin. Since the reductive cleavage to generate the propanol amide tail results in 
poor overall recovery, we generally do not use it. Therefore, for high-affinity 
recognition, hairpin polyamides are synthesized with ~-Dp tails which require DNA 
binding sites to be composed of the sequence 5'-WW(N)xW-3' (W = A,T; N = A,T,G,C; 
and x = the number of ring pairs in the core of the polyamide). While a large number of 
biologically relevant sequences have been targeted by the current generation of hairpin 
polyamides,6 the necessity for A,T base pairs flanking the polyamide core is a limitation. 
Promoters are known to have high G,C content associated with CpG islands/ and many 
transcription factors bind G,C rich sequences.s In order to effectively inhibit these 
transcription factors, polyamides that can readily target all base pairs at the tail positions 
with high affinity are desirable. 
We describe here the solid-phase synthesis of polyamides with a pyrrole unit 
directly linked to the Kaiser oxime resin.9,IO,11 Six-ring polyamide hairpins with the 
common core sequence ImImpy-(Rt2Ny-IrnPyPy-X (3-6) were synthesized where X 
represents four different C-terminal tails, ethyl amide, methyl amide, primary amide, and 
carboxylic acid (Figure 5.2). The DNA-binding affinity and specificity at the N-I 
position was compared to the parent polyamides having either a ~-Dp (1) or propanol 
amide tail (2) . 
145 
Figure 5.2 
1 ImlmPy-(R)H2Ny-ImPyPy-!l-Dp 2 ImImPy-(R)H2Ny-ImPyPy_PrOH 
3 ImlmPy-(R)H2Ny-ImPyPy-CO- R=NHEt 
4 ImlmPy-(R)H2Ny-ImPyPy-CO- R=NHMe 
5 ImlmPy-(R)H2Ny-ImPyPy-CO- R=NH2 
6 lmImPy-(R)H2 NY-ImPYPy-CO- R=OH 
Figure 5.2. Structures of poJyamides ImlmPY-(R)H2NY-ImPyPy-i3-Dp (1), Imlmpy-(R)H2NY-ImPypy-PrOH 
(2), ImImPy-(R)H2Ny-ImPyPy-CONHEt (3), ImImPy-(R)H2Ny-ImpyPy-CONHMe (4), ImImPy-
(R)H2NImPyPy-CONH2 (5) and IrnImPy-(R)H2Ny-ImPyPy-C02H (6). 
Results 
Polyamide Synthesis. Polyamides ImImPy-(R)H2Ny-ImPyPy-J3-Dp (1) and 
ImImPy-(R)H2Ny-ImPyPy-PrOH (2) were synthesized by solid-phase methods on the usual 
Boc-J3-alanine-P AM-resin. Four new polyamides 3-6 were synthesized by solid-phase 
methods on the Kaiser oxime resin with standard Boc-pyrrole and Boc-imidazole 
monomers (Figure 5.3) . Developed by Kaiser and DeGrado,9,JO the oxime resin is a 
versatile polystyrene solid support that is amenable to Boc chemistry and allows for the 
synthesis of a variety of carboxylic acid derivatives by nucleophilic cleavage from the 
resin. Peptides can be cleaved from oxime resin to yield primary amide,1O alkyl amide, 12 
and carboxylic acid l3 ,14 C-termini. The oxime linker is reported to be somewhat acid 
Figure 5.3 
9 ~~ HO-N7~ 80cHN Vn°B. I 0 
7 
/'- rF~:H 
BocHN" .........- "'n' 
o 
9 
r~~ 
I 0 ~~OH 
I 0 
10 
3 R= NHEt 
4 R=NHMe 
5 R= NH2 
6 R=OH 
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Figure 5.3. Synthesis of polyamide 3·6 from oxime resin using Boc-protected monomers: (i) 7, DIEA, 
NMP; (ii) 20% 1FAlDCM; (iii) 7, DIEA, NMP; (v) 20% 1FAlDCM; (v) 8, HBTU, DIEA, NMP; (vi) 50% 
1FAlDCM; (vii) 9, HBTU, DIEA, NMP, 37° C; (viii) 20% TFAlDCM; (ix) 7 , DIEA, NMP; (x) 20% 
1FAlDCM; (xi) 10, HBTU, DIEA,NMP; (xii) a) R = NHEt, 2.0 M CH3CH,NH,rrHF, DCM, 37° C; b) R = 
NHMe, 2.0 M CH3NH,rrHF, DCM, 37" C; c) R = NH" NH3rrHF, DCM, DBU, 37° C; or d) R = OH, H,O, 
DMF, DBU, 37° C. 
labile, and solutions of less than 25% TFA are recommended for the deprotection of Boc 
groups. Consequently, a 20% TF AJCH2Cl2 solution was used for 30 minutes to remove 
the Boc groups from pyrrole and aliphatic amines . However, it was found that Boc-
imidazole residues could not be fully deprotected under these conditions. Longer 
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deprotection times resulted in increasing degradation of the resin bound polyamide. Boc 
groups could be efficiently removed from imidazoles in 30 minutes with a 50% 
TFAJC~CI2 solution. Remarkably, no premature cleavage of the oxime linker was 
observed at this higher concentration of acid. Attachment of the first pyrrole unit results 
in a bulky aromatic oxime ester that apparently stabilizes the linker relative to the 
aliphatic oxime ester present when conventional amino acids are used. 
Polyamides 3-6 were generated from the common intermediate, lmIrnPy-
(R) FmOCHNy_ImPyPy_Oxime resin 11 (Figure 5.3). Commercially available oxime resin 
was allowed to react directly with Boc-Py-OBt (7) in N-methylpyrrolidone (NMP) and 
diisopropylethylamine (DIEA) overnight at room temperature. The subsequent 
deprotections and couplings were carried out in a stepwise manner using the previously 
outlined deprotection conditions. All other monomers used, namely 8 , 9 and 10, were 
activated with HBTU and coupled in NMP/DIEA for 1.5-8 hours at either room 
temperature or 37° C. All cleavages of resin 11 required a co-solvent (CH2CI2 or DMF) 
to swell the resin and/or solubilize the polyamide. Based on literature methods,lo 
cleavage of resin 11 with a saturated solution of ammonia in THF/CH2CI2 yielded 
polyamide 5 . However, even after more than 60 hours at 37° Conly 60% cleavage was 
observed. Addition of a large excess of DBU, which had been used as a transacylation 
catalyst to generate peptide acids and esters from oxime resin previously, 13 resulted in 
quantitative cleavage of the resin to generate polyamide 5. The C-terminal carboxylic 
acid polyamide 6 was generated in a similar manner with 1:1 H20:DMF, 30 eq. DBU for 
60 hours at 37° C. This method was superior to acidic, basic, or reductive cleavage 
conditions. It is interesting to note that the standard transacylation catalyst, DMAP, was 
ineffective as a replacement for DBU in these cleavage reactions . Both polyamides 3 and 
4 were generated from resin 11 with a 1.0 M solution in THF/CH2CI2 of ethylamine or 
methylamine, respectively overnight at 37° C. The oxime resin is a versatile way to 
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generate modified polyamides under mild conditions in good yield while remaining 
amenable to Boc chemistry. 
Quantitative DNase I Footprinting. It has been shown previously that 
elimination of Dp in the f3-Dp tail in polyamide 1 diminishes the requirement for A,T 
preference at the N-2 position. 4 While empirical observations have suggested that the 
propanol amide tail, like the f3-Dp tail (2) is A,T specific at the N-l position, this had not 
been investigated in detail. Quantitative DNase I footprinting titrations 15 were performed 
to determine the equilibrium association constants (Ka) of polyamides 2-6 for four sites 
on a restriction fragment corresponding to the sequences 5'-AXGGCTA-3'(where X = 
A,T,G,C) at the N-l position (Figure 4A-D, Table 1). The change from f3-Dp (1) to 
propanol amide (2) results in similar affinity and specificity. This retention of affinity 
upon removal of the posititvely charged Dp moiety has previously been observed. 16•I7 
Presumably, the steric clash of propanol amide versus f3-Dp with the exocyclic NH2 of G 
at N -1 is similar. 
Polyamides 3-5 afford similar DNA binding affinity versus the parent f3-Dp while 
diminishing the sequence preference for A,T versus G,C at N-l. Polyamide 3 (ethyl 
amide) maintains a strong preference for A,T versus G,C, while polyamide 4 (methyl 
amide) less so. Polyamide 5 (primary amide) shows a loss in affinity relative to 1-4, and 
little sequence discrimination between the four Watson-Crick base pairs. Polyamide 6 
(carboxylic acid) reveals poor affinity and little sequence discrimination at the N-1 
position (Table 5.1). The decreased affinity of polyamides 5 and 6 suggests that the 
increased Van der Waal contacts with the walls of the minor groove, made by polyamides 
1-4, may be important. 
Figure 5.4 
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R= NHCH3 ~ g 
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Figure 5.4. All reactions contain IS kcpm restriction fragment, 10 mM TriseHCl (pH 7.0) , 10 mM KCl, 10 
mM MgCl" and S mM CaCl,. Data was obtained for the four binding sites indicated at the left of the gel, 
S'-GGGCT-3', S'-AGGCT-3', S'-CGGCT-3', and S'-TGGCT-3', and is shown in the isotherm plot below. 
enonn points were obtained using storage phosphor autoradiography and processed by standard methods. 
Each data point shows the average value obtained from three footprinting experiments. The solid curves 
are best-fit Langmuir binding titration isotherms obtained from nonlinear least squares algorithm where n = 
I as previously described15 A) Quantitative DNase I footprint titration experiment with ImImPy_(R)H,Ny_ 
ImPyPyPrOH (2) on the 3'-32P-labeled 286-bp restriction fragment pSES-TLI4: lane I and 23, intact DNA; 
lane 2 and 22, A reaction; lane 3 and 21, G reaction; lane 4 and 20 DNase I standard; lanes S-19 DNase I 
digestion products in the presence of I 11M, SOO nM, 200 nM, 100 nM, 20 nM, 10 nM, S nM, 2 nM, I nM, 
SOO pM, 200 pM, 100 pM, SO pM, 20 pM, 10 pM polyamide, respectively. B) Quantitative DNase I 
footprint titration experiment with ImImPy-(R)H,Ny-ImPyPyCONHCH3 (4) on the 3,-3'P-labeled 286-bp 
restriction fragment pSES-TL1 4: lane 1 and 24, intact DNA; lane 2 and 23, A reaction; lane 3 and 22, G 
reaction; lane 4 and 21 DNase I standard; lanes S-20 DNase I digestion products in the presence of I J.LM , 
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500 nM, 200 nM, 100 nM, 50 nM, 20 nM, 10 nM, 5 nM, 2 nM, I nM, 500 pM, 200 pM, 100 pM, 50 pM, 
20 pM, 10 pM polyamide, respectively. C) Quantitative DNase I footprint titration experiment with 
ImImPy-(R)H,Ny-ImPyPyCONH, (5) on the 3,-32P-labeled 286-bp restriction fragment pSES-TLI 4 : lane I 
and 24, intact DNA; lane 2 and 23, A reaction; lane 3 and 22, G reaction; lane 4 and 21 DNase I standard; 
lanes 5-20 DNase I digestion products in the presence of I iJ.M, 500 nM, 200 nM, 100 nM, 50 nM, 20 nM, 
10 nM, 5 nM, 2 nM, I nM, 500 pM, 200 pM, 100 pM, 50 pM, 20 pM, 10 pM polyamide, respectively. D) 
Quantitative DNase I footprint titration experiment with ImlmPy-(R)H,Ny-ImPyPyCO,H (6) on the 3,_32p_ 
labeled 286-bp restriction fragment pSES-TLI4: lane I and 24, intact DNA; lane 2 and 23, A reaction; lane 
3 and 22, G reaction; lane 4 and 21 DNase I standard; lanes 5-20 DNase I digestion products in the 
presence of I iJ.M, 500 nM, 200 nM, 100 nM, 50 nM, 20 nM, 10 nM, 5 nM, 2 nM, I nM, 500 pM, 200 pM, 
100 pM, 50 pM, 20 pM, 10 pM polyamide, respectively. 
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Table 5.1. Equilibrium association contants (M-I ). 
R- -~-Dp(l) 
-
- NHCH3 (4) -NH2 (5) -OH (6) 
x·y 
A·T 1.7 X 109(+0.5) 5.9 x 108(±0.4) 1.1 x 109(±O.I) 1..1 X 109(= 0.1) 1.9 X ]()8(±0.2) 2.1 X 107(±0.1) 
T·A 1.6 X 109(±0.2) 4.7 X 108(=0.4 ) 9.2 x 108(±0.3) 1.4 x 109(±0.3) 2.1 x 108(±0.2) 1.2 x 10 7(±0.2) 
G·e 5.8 X 107(±1.4) 2.1 X 107(±0.3) 8.2 X I07(±1.3) 2.4 X 108(=0. 1) 6.8 X 107(±0.5) 1. 1 X ]()7(±0.2) 
e·G 3.2 x 107(±O.3) 6.2 x 106(~0. 7) 3.0 X 107(±O.5) l.J X 108(±0.2) 3.5 X 107(±0.2) 4.9 X 106(±0.2) 
Table 5.1. Polyamide 1-6 at the N-l position. Equilibrium association constants (M-I ) for polyamide 1-6 
with restriction fragment pSES-TL1.4 Values reported are the mean values from at least three DNase I 
footprinting titration experiments with the standard deviation for each data set in parentheses. Equilibrium 
association constants for polyamide 1 at the N-l position were obtained from Swalley e/ ai' Assays were 
performed at 22° C at pH 7.0 in the presence of 10 mM Tris.HCl, 10 mM KCl, 10 mM MgCl2, and 5 mM 
CaCl2• 
Discussion 
In sequences with an A-T or T-A at the N-l position, structural evidencel8-22 
suggests that the C-terminal pyrrole secondary amide makes a hydrogen bond with the 
N3 of adenine and/or the 02 of thymine (Figure 1). However, hydrogen bonds could also 
be made to the N3 of guanine and/or the 02 of cytosine. Assuming these hydrogen 
bonds are similar energetically, the discrimination of A,T versus G,C is likely due to 
steric reasons. Thus, the methylene groups of the propanol amide and ~-Dp tails clash 
with the exocyclic amine of guanine and by default incur a lower energetic penalty at 
A,T. The influence of the exocyclic amine of guanine on specificity can be inferred from 
the observation that the sequence XY = C·G was the lowest affinity site for all of the 
polyamides examined in this study. At this site the guanine base is on the bottom strand 
of the DNA proximal to the C-terminus of the hairpin where the steric clash between the 
tail and the exocyclic NH2 of guanine should be most severe. 
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Polyamides 3 and 4 with the ethyl and methyl amide tails provide a way to 
investigate whether specificity could be assigned to a particular methylene group of the 
propanol amide tail. The specific hydrogen bond made by the amide of the C-terminal 
pyrrole would point the first methylene group away from the floor of the minor groove, 
such that the energetic penalty and hence specificity might be attributable to the second 
methylene group. However, the methyl amide did exhibit about 8-fold preference for 
binding A,T or G,c. The ethyl amide tail disfavors both G-C and C-G sites by about 3-
fold more than the methyl amide tail. Clearly, both alkyl groups contribute to A,T 
specificity, and even greater steric bulk beyond the second carbon is likely necessary to 
account for the greater than 50-fold specificity of the ~-Dp and propanol amide tails. The 
high affinity of polyamides 3 and 4 suggests an energetic balance between increased Van 
der Waals contacts with the walls of the minor groove relative to the primary amide tail 
(5) and decreased steric clashing relative to the ~-Dp tail (1). 
Polyamides with C-terminal carboxylic acid tails have been synthesized as 
intermediates to cyclic polyamides23•24 but their DNA binding properties have not been 
investigated The carboxylic acid tail polyamide (6) binds all four sites with low affinity 
and poor sequence discrimination. To act as a hydrogen bond donor in analogy to the 
amides, the carboxylic acid would have to be protonated in the minor groove. The acid is 
likely deprotonated in the minor groove and the lO-fold lower affinity compared to the 
primary amide tail may be due to loss of this hydrogen bond. Additionally, in water 
polyamide 6 is expected to be a zwitterion with a net charge of zero which one would 
expect to have a lower affinity for DNA than the positively charged polyamides 1-5. 
In summary, hairpin polyamides with incrementally truncated C-terrninal tails can 
be synthesized using Boc chemistry , in high yield, on an oxime resin by solid-phase 
methods . The polyamides are lower molecular weight than the corresponding ~-Dp 
polyamide and bind all four base pairs at the N-I position with high affinity which will 
enable targeting of new biologically relevant sequences by hairpin polyamides. If at the 
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N-l position, one desires specificity for A,T > G,C while maintaining high affinity, then 
the ethyl amide (3) is the end group of choice. If at the N-l position, one prefers less 
sequence preference with high affiinity, then the methyl amide is the best choice. It 
remains to be seen whether we can design an energetically favorable end group 
compatible with solid-phase methods with the criteria of efficient cleavage from solid-
phase resin which favors G,C > A,T. 
Experimental 
Materials. Polyamides 1 and 2, and the restriction fragment pSES-TLI have 
been previously described. 4 DNase I footprinting titrations on the 32P-Iabeled restriction 
fragment pSES-TLl were performed as previously described.4 2.0 M methylamine in 
THF, 2.0 Methylamine in THF, DBU and anhydrous ammonia gas were purchased from 
Aldrich. Oxime resin was purchased from Nova Biochem. All other synthetic and 
footprinting reagents were as previously described.2.15.16 IH NMR were recorded on a 
Varian Mercury 300 instrument. UV spectra were measured on a Beckman Coulter DU 
7400 diode array spectrophotometer. Autoradiography was performed with a Molecular 
Dynamics Typhoon Phosphorimager. Matrix-assisted, laser desorption/ionization time of 
flight (MALDI-TOF) mass spectrometry was carried out at the Peptide and Protein 
Microanalytical Facility at the California Institute of Technology. HPLC analysis was 
performed on a Beckman Gold system using a RAINEN C18, Microsorb MV, 5 /-Lm, 300 x 
4.6 mm reversed-phase column in 0 .1 % (w/v) TFA with CH3CN as eluent and a flow rate 
of 1.0 mL/min, gradient elution 1.25% CH3CN/min. Preparatory HPLC was carried out 
on a Beckman HPLC using a Waters DeltaPak 25 x 100 mm, 100 /-Lm C IB column, 0.1 % 
(w/v) TFA, 0.56% CH3CN/min. l8MQ water was obtained from a Millipore MilliQ 
water purification system, and all buffers were 0.2 /-Lm filtered. Reagent-grade chemicals 
were used unless otherwise stated. 
154 
ImlmPY-(R)H2Ny-ImPypyCONHEt (3). ImlmPy-(R)FmOCHNy-ImPyPyCO_Oxime 
resin (11) was generated by manual solid phase synthesis from oxime resin (1 g, 0.48 
mmol/g) using previously described Boc-protected monomers.z Boc-Py-OBt (7) (358 
mg, 1 mmol) was dissolved in 2 ml of NMP and added to 1 g of oxime resin followed by 
1 ml of DIEA. The coupling was allowed to proceed overnight at room temperature. The 
resin was then acetylated with 3 ml of acetic anhydride (AcP), 4 ml of NMP and 1 ml of 
DIEA for 30 minutes at room temperature. The Boc group was removed upon treatment 
with 20% TFAIDCM for 30 minutes. The second pyrrole residue was coupled in the 
same fashion as the first but complete coupling could be achieved in 2 hours at room 
temperature followed by the acetylation and deprotection steps outlined above. Boc-Im-
OH (8) (241 mg, 1 mmol) was dissolved in 2 ml of NMP to which 360 mg (1 mmol) of 
HBTU and 1 ml of DIEA was added for activation of this monomer. Coupling was 
allowed to proceed for 1.5 hours at room temperature followed by acetylation. The Boc-
1m residue was deprotected using a 50% TF NDCM solution for 30 minutes at room 
temperature. The next residue, a-Fmoc-y-Boc-(R)-diaminobutyric acid (DABA) (9) (660 
mg, 1.5 mmol) was activated with HBTU (540 mg, 1.5 mmol) in 2 ml of NMP and 1 ml 
of DIEA. Coupling of this residue onto the resin took 2 hours at 37° C. After acetylation 
and treatment with 20% TFAlDCM for 30 minutes, the next Boc-Py-OBt was attached in 
exactly the same manner as the second residue. The terminal two imidazoles were added 
as an Imlm-OH dimer.z 249 mg (1 mmol) of the ImIm-OH dimer (10) was activated 
with HBTU (360 mg, 1 mmol) in 2 ml of NMP and 1 ml of DIEA and allowed to couple 
overnight at room temperature. It should be noted that the progress of the stepwise 
couplings were all monitored by analytical HPLC. The resin was washed thoroughly 
with DMF, DCM, MeOH and EtzO then dried in vacuo. A 75 mg sample of dried resin 
was suspended in 2 ml of CHzCl2 to which was added 2 ml of 2.0 Methylamine in THF. 
This cleavage mixture was placed in a 37° C oven and allowed to stand overnight in a 
sealed scintillation vial. The resin was filtered, the eluant concentrated in vacuo, then 
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purified by reverse phase HPLC. ImImPy-(R)H2Ny-ImPyPyCONHCH3 (1.9 mg, 2.2 J.1mol, 
10.6% recovery) was recovered upon lyophilization of the appropriate fractions as a 
white powder; UV (HzO) Arnax310 (52140); lH NMR (DMSO-d6) 011.02 (s, IH), 10.36 
(s, lH), 10.10 (s, IH), 9.89 (s, lH), 9.71 (s, lH), 8.20 (m, lH), 7.98 (m, lH), 7.56 (s, lH), 
7.52 (s, lH), 7.45 (d, lH, J = 0.9 Hz), 7.25 (d, lH, J = 1.5 Hz), 7 .23 (d, IH, J = 1.5 Hz), 
7.15 (d, IH, J = 1.8 Hz), 7.11 (d, lH, J = 1.8 Hz), 7.06 (d, lH, J = 0.9 Hz), 7.03 (d, lH, J 
= 1.8 Hz), 6.83 (d, lH, J = 1.8 Hz), 3.99 (s, 3H), 3.98 (s, 3H), 3.96 (s, 3H), 3.83 (s, 3H), 
3.80 (s, 3H), 3.78 (s, 3H), 3.17 (dd, 2H, J = 6.6 Hz), 2.42 (m, 2H), 2.26 (m, lH), 1.99 (m, 
2H), 1.62 (m, lH), 1.05 (t, 3H J = 6.6 Hz), MALDI-TOF-MS 866.5 (866.39 calc for 
[M+H] C39H4SNl70/). 
Imlmpy-(R)H2Ny-ImpyPyCONHMe (4). A 35 mg sample of dried resin 11 was 
suspended in 2 ml of CH2Cl2 to which was added 2 ml of 2.0 M methylamine in THF. 
This cleavage mixture was placed in a 37° C oven and allowed to stand overnight in a 
sealed scintillation vial. The resin was filtered, the eluant concentrated in vacuo, then 
purified by reverse phase HPLC. ImImPy-(R)H2Ny-ImPyPyCONHCH3 (850 J.1g, 996 nmol, 
8.9% recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder; UV (H20) Amax 310 (52140); lH NMR (DMSO-d6) 0 11.01 (s, lH), 10.35 (s, IH), 
10.09 (s, IH), 9.90 (s, lH), 9.70 (s, lH), 8.19 (m, IH), 7.92(m, IH), 7.56 (s, IH), 7.51 (s, 
IH), 7.45 (d, IH, J = 0.9 Hz), 7.25 (d, IH, J = 1.8 Hz), 7.23 (d, lH, J = 1.8 Hz), 7.16 (d, 
lH, J = 1.5 Hz), 7.10 (d, lH, J = 1.5 Hz), 7.05 (d, lH, J = 0.9 Hz) , 7.03 (d, lH, J = 1.8 
Hz), 6.79 (d, IH, J = 1.8 Hz) , 3.99 (s, 3H), 3.98 (s, 3H), 3.96 (s, 3H), 3.82 (s, 3H), 3.79 
(s, 3H), 3.77 (s, 3H), 2.66 (m, lH), 2.41 (m, 2H), 2.25 (m, IH), 1.98 (m, 2H), 1.62 (m, 
2H), MALDI-TOF-MS 852.5 (852.38calc for [M+H] C3sH46N170/). 
Imlmpy-(R)H2Ny-ImpyPyCONH2 (5). A 30 mg sample of dried resin 11 was 
placed into a pressure tolerant screw cap test tube, suspended in 4 rnl of dry THF and 
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cooled for 20 minutes in a _10°C icelbrine bath. Anhydrous NH3 gas was bubble into the 
suspension at a steady rate for 30 minutes to generate a saturated ammonia solution. 1.5 
ml of a 10%v/v solution of DBU in CH2Cl2, cooled to -20° C was quickly added to the 
cleavage mixture and the tube immediately sealed. The cleavage was allowed to proceed 
in a shaker at 37° C for 72 hours. The mixture is filtered and concentrated in vacuo, then 
purified by reverse phase HPLC. ImImPy-(R)H2Ny-ImPyPyCONH2 (330 ~g, 390 nmol, 
4.1 % recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder; UV (H20) Amax 310 (52140); IH NMR (DMSO-d6) 810.65 (s, lH), 10.32 (s, 
1H), 10.20 (s, lH), 9.90 (s, lH), 9.75 (s, lH), 8.09 (bs, lH), 7.55 (s, 3H), 7.47 (s, 1H), 
7.44 (s, lH), 7.25 (d, lH, J = 2.1 Hz), 7.21 (d, lH, J = 2.1 Hz), 7.19 (bs 2H), 7.11 (d, lH, 
J = 1.8 Hz), 7.05 (d, lH, J = 1.2 Hz), 6.98 (d, lH, J = 1.2 Hz), 6.83 (d, lH, J = 1.5 Hz), 
6.65 (d, lH, J = 1.2 Hz), 6.53 (d, 1H, J = 2.4 Hz), 3.99 (s, 3H), 3.98 (s, 3H), 3.96 (s, 3H), 
3.82 (s, 3H), 3.79 (s, 1H), 3.77 (s, 3H), 2.97 (m, 1H), 1.96 (m, 2H), 1.43 (m, 2H), 
MALDI-TOF-MS 838.4 (838.35 calc for [M+H] C37H44N170/) 
ImlmPy-(R)H2Ny-ImpypyC02H (6). A 35 mg sample of dried resin 11 was 
cleaved by treatment with 1 ml of HP, 1 ml DMF, and 75 ~l DBU (0.48 mmol) at 37° C 
for 60 hours. After filtration the cleavage solution was concentrated in vacuo and 
purified by reverse phase HPLC. ImImPy-(R)H2Ny-ImPyPyC02H (294 ~g, 350 nmol, 
3.1 % recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder; UV (H20) Amax310 (52140); IH NMR (DMSO-d6) 8 12.67 (bs, 1H), 11.53 (s, 
lH), 10.88 (s, lH), 10.62 (s, 1H), 10.43 (s, lH), 10.22 (s, lH), 8.83 (m, lH), 8.07 (s, lH), 
8.03 (s, 1H), 7.96 (d, lH, J = 0.9 Hz), 7.93 (d, lH, J = 1.8 Hz), 7.76 (d, lH, J = 0.9 Hz), 
7.75 (d, lH, J = 1.8 Hz), 7.64 (d, lH, J = 1.2 Hz), 7.57 (d, 1H, J = 1.2 Hz), 7.54 (d, lH, J 
= 1.8 Hz), 7.34 (d, lH, J = 1.8 Hz), 4.50 (s, 3H), 4 .50 (s, 3H), 4.47 (s, 3H), 4.34 (s, 3H), 
4.31 (s, 3H), 4.31 (s, 3H), 2.50 (m, 2H), 2.11 (m, 2H), 2.06 (m, 3H), MALDI-TOF-MS 
839.4 (839.34 calc for [M+H] C37H43NI60S+)· 
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Quantitative DNase I Footprinting. As previously reported. 15 
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Chapter 5B: 
From an Aminooxy ~-Alanine Analog to Novel Polyamide Tails I 
Introduction 
The development of polyamide synthesis on the versatile oxime resin allows for a 
large variety of C-termini, including the "truncated tails" described in Chapter SA. The 
primary amide (5) was the first of this class of compounds synthesized, prior to the 
development of polyamide synthesis on oxime resin. The initial route began from the 
unusual starting point of an aminooxy acid. Aminooxy acids are analogs of ~-amino 
acids where the ~-carbon is replaced by oxygen. Peptides of arninooxy acids, which have 
hydroxamic ester linkages instead of normal amide bonds, have attracted attention as 
peptidomimetics.2-6 In the context of DNA binding polyamides, an aminooxy acid was 
investigated as a potential G-selective ~-alanine analog (Figure 5.5).7 That project was 
ultimately unsuccessful due to unusual DNA binding properties of the resulting 
polyamide.s However, it was successful synthetically, in that conditions were found for 
the incorporation of an arninooxy acid unit into a full-length polyamide. 
Figure 5.5 
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Figure 5.5. A) Model of an aminooxy acid as a potential G-selective ~-alanine analog.' B) The polyamide 
(12) synthesized to test the model. The aminooxy acid unit is shown in red. 
Given the compatability of the hydroxamic ester with standard solid phase 
synthesis conditions,9 it was reasoned that the chemistry of the N-O bond could be 
exploited to produce polyarnides with C-terminal pyrrole primary amides. The aminooxy 
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acid unit was incorporated as a linker between the resin and the growing polyamide 
chain. After completion of resin synthesis, the well-known reduction of hydroxamic 
esters to amides 10, I I was accomplished on solid phase,12.13 cleaving the C-terminal primary 
amide polyamide from the resin. The advantage of this route is that the target compound 
is obtained using standard solid phase conditions for polyamide synthesis (Boc-protected 
monomers and PAM resin).9 Subsequently a complimentary route to primary amide 
polyamides was devised, using recently developed Fmoc-protected monomers l4 and Rink 
resin. IS Finally, polyamide synthesis was developed on the extremely versatile oxime 
resin (Chapter SA), providing access to a variety of truncated tails, including the primary 
amide. However, solid phase synthesis with the aminooxy linker also yielded a variety of 
different C-termini, due to an unexpected reaction with cyclic secondary amines. The 
resulting polyamides with C-terminal cyclic tertiary amides have favorable DNA binding 
properties based on preliminary Dnase I footprinting titrations . 
Results 
Aminooxy linker route to C-terminal primary amide polyamides. Although a 
Boc-protected aminooxy acid analog of p-alanine is readily accessible in one step from 
commercially available carboxymethoxylamine hemihydrochloride,1 6 use of this 
monomer under standard solid phase conditions9 was highly problematic. Difficulties 
with primary aminooxy groups on solid phase have been previously noted. 17,18 After 
considerable experimentation, a simple solution presented itself in the one step, solution 
phase synthesis of the Boc-pyrrole-aminooxy acid (13) derived from the standard HOBt 
activated pyrrole monomer9 (7) and carboxymethoxylamine hemihydrochloride (Figure 
5.6). This unit was found to be compatible with standard solid phase conditions, and is 
readily incorporated into a polyamide chain by activation as the N-hydroxysuccinimide 
ester, followed by reaction with the amine of the pyrrole residue (as in 12) or p-alanine. 
Figure 5.6 
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Figure 5.6. Synthesis of Boc-pyrrole-aminooxy acid 13. 
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The synthesis of 5 (Figure 5.7) began with the deprotection of commercially 
available Boc-~-A1a-PAM resin, followed by coupling of N-hydroxysuccinimide (NHS) 
activated 13, in DMF for six hours at room temperature with DIEA as a base. Removal 
of the Boc group from the resulting Boc-PyCONHOCH2CO-~-Ala-PAM resin (14) was 
accomplished using standard deprotection conditions (80% TFA, 20% DCM, 004 M 
thiophenol). Five standard coupling and deprotection cycles9. 19 followed to yield 
ImImPy-(RlmOCHNy-ImPyPyCONHOCH2CO-~-Ala-PAM resin. Some degradation was 
observed in a coupling which requires heating at 37" C, suggesting that the hydroxamic 
ester unit is best handled at room temperature, which may limit the generality of this 
method. Attempts to remove the Fmoc group with piperidine led to unexpected cleavage 
from the solid support (see below), therefore the Fmoc group was not removed prior to 
cleavage from resin. After surveying various reducing agents including zinc dust11 and 
triphenylphosphine, best results for the reduction of the hydroxamic ester in the full 
length polyamide resin were obtained with palladium acetate and ammonium formate. 2o 
The Fmoc group was also removed under these reductive conditions21 to yield the 
truncated tail polyamide, ImImPy-(R)H2Ny-ImPyPyCONH2 (5). Results of quantitative 
DNase I footprinting titrations with 5 are reported in Chapter 5A (Figure 5AC) . 
Aminooxy linker route to C-terminal cyclic tertiary amide polyamides. An 
eight ring polyamide resin, ImPyPyPy-(R)FmOCHNy-PyPyPyPyCONHOCH2CO-~-Ala-PAM 
resin (15) (Figure 5.8), was constructed in eight standard coupling and deprotection 
Figure 5.7 
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Figure 5.7. Aminooxy linker route to polyamide 5 starting from Boc-j3-Ala-PAM resin: (i) 80% 
TFAlDCM, 0.4 M PhSH; (ii) 13, DCC, NHS, OlEA, DMF; (iii) 80% TFAlDCM, 0.4 M PhSH; (iv) 7, 
OIEA, DMF; (v) 80% TFAlOCM, 0.4 M PhSH; (vi) 8, HBTU, OIEA, OMF, 37° C; (vii) 80% TFAlOCM, 
0.4 M PhSH; (viii) 9, HBTU, OlEA, DMF; (ix) 80% TFAlDCM, 0.4 M PhSH; (x) 7, DIEA, DMF; (xi) 
80% TFAlDCM, 0.4 M PhSH; (xii) 10, HBTU, DIEA, DMF (xiii) Pd(OAc)" HC02NH4, H,o, DMF, 37°C. 
cycles from resin 14. Resin 15 was initially treated with 80% piperidinelDMF for 30 
minutes at room temperature to remove the Fmoc group. Loss of material from the resin 
was visible by eye and reverse phase HPLC analysis. The putative deprotection reaction 
was repeated on a new sample of resin 15, and a product was isolated from the resulting 
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Figure 5.8. Aminooxy linker route to C-terminal cyclic teriary amide polyamides 16-18. (i) x = CH2, 2: 1 
piperidine:DMF, 1 hour, room temperature. x = 0 , 2: 1 morpholine:DMF, 1 hour, room temperature. x = 
NH, 1 M piperazine in DMF, 1 hour, room temperature. 
solution. The product was identified by HPLC, UV-vis, and MALDI-TOF mass 
spectrometry as being a relatively nonpolar polyamide with a mass consistent with the 
direct incorporation of piperidine as in structure 16 (Figure 5.S). Confirmation of the 
proposed structure was achieved synthetically by repeating the reaction with morpholine 
in place of piperidine. Indeed a more polar polyamide (17) with a molecular weight of 
two mass units higher was isolated. The unexpected cleavage reaction was also 
successful for piperazine, generating 18, the most polar of the three new polyamides, with 
the predicted molecular weight. Optimized conditions for the synthesis of C-terminal 
cyclic tertiary amide polyamides 16-18 via the unexpected cleavage of resin 15 are 
shown in Figure 5.S. In all cases, the Fmoc group is also removed under these 
conditions. For polyamide-PAM resins lacking the aminooxy linker, deprotection of the 
Fmoc group is the only observed reaction. The reaction with resin 15, which results in 
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Figure 5.9. Products obtained from the reaction of aminooxy linker resin 15 with Dp (19 major, 20, minor) 
or reductive cleavage conditions (21). 
transamidation from a hydroxamic ester to a tertiary amide, occurs under remarkably 
mild conditions, one hour at room temperature with a large excess of the cyclic secondary 
amine. The reactions were quite clean, with 16-18 as the major pyrrole/imidazole-
containing products, but the cleavage yield in all cases was below 50%, even with 
extended reaction time. In contrast to cyclic secondary amines in DMF, neat Dp reacted 
selectively with the PAM ester of resin 15 to yield the aminooxy acid containing 
polyamide 19 at both 37°C (18 hours) and 95 °C (5-10 minutes), although the Dp 
transamidation product (20) was observed as a minor product (<10% of 19) in the former 
case (Figure 5.9). Treatment of resin 15 with palladium acetate and ammonium formate 
led to expected primary amide polyamide 21. 
Quantitative DNase I Footprinting. Preliminary investigation of the C-terminal 
cyclic tertiary amide tail polyamides was carried out on a DNA fragment derived from 
the HER2 gene promoter.22 Quantitative DNase I footprinting titrations23 were performed 
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Figure 5.4. All reactions contain 15 kcpm DNA fragment, 10 mM Tris.HCl (pH 7.0), 10 mM KCl , 10 
mM MgCl" and 5 mM CaCl,. Quantitative DNase I footprint titration experiment with C-terminal cyclic 
tertiary amide tail polyamides 16-18 on a 5,-3'P-labeled 188-bp DNA fragment of the HER2 promoter22: 
lanes 1 and 27, intact DNA; lanes 2 and 26, A reaction; lanes 3 and 25 DNase I standard; lanes 4-10 DNase 
I digestion products in the presence of 50 pM, 100 pM, 1 nM, 5 nM, 10 nM, 50 nM polyamide 17, 
respectively; lanes 11-17 DNase I digestion products in the presence of 50 pM, 100 pM, 1 nM, 5 nM, 10 
nM, 50 nM polyamide 16, respectively; lanes 18-24 DNase I digestion products in the presence of 50 pM, 
100 pM, 1 nM, 5 nM, 10 nM, 50 nM polyamide 18, respectively. 
to determine the equilibrium association constants (Ka) of polyamides 16-18 (Figure 
5.1O,Table 5.2) . The polyamides bound the expected match site 5'-AAGTATA-3' (the 
TATA box of the HER2 promoter) with good specificity and affinity. The equilibrium 
association constants (7.5 x 108 M- l - 5.0 X 109 M-l ) are in the range typically observed for 
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Table 5.2. Equilibrium association constants. 
Polyamide Binding Site K, DNA Fragment 
16 5'-gAAGTATAag-3' 7.5 x 108 M·I HER2 Promoter 
17 5'-gAAGTATAag-3' 2.3 x 109 M" HER2 Promoter 
18 5'-gAAGTATAag-3' 5.0x 109 M" HER2 Promoter 
17 5'-tTAGTATTtg-3' 2.4 x 109 M·I pJT8 
22- 5'-tTAGTATTtg-3' 3.5 x 109 M·I pJT8 
17 5'-tTAGTAl:Ttg-3' 3.1 x 108 M" pJT8 
22- 5'-tTAGTAl:Ttg-3' 5.0x 108 M· I pJT8 
Table 5.2. Equilibrium association constants (M") for polyamides 16-18 with a 188-bp DNA fragment of 
the HER2 promoter," and polyamides 17 and 22 with restriction fragment pJT8.24 Mismatched base pairs 
are underlined. -Equilibrium association constants for polyamide 22 were obtained from Trauger et at. 24 
Assays were performed at 22° C at pH 7.0 in the presence of 10 mM TrisoHCI, 10 mM KCI, 10 mM 
MgCI2, and 5 mM CaCI2. 
the standard ~-Dp tail polyamide (ImPyPyPy-y-PyPyPyPy-~-Dp, 22). The piperazine-
amide polyamide 18 had the highest affinity, and the piperidine-amide polyamide 16 the 
least. Morpholine-amide polyamide 17, which had the middle value on the HER2 
fragment, was compared directly with standard polyamide 22 on the restriction fragment 
pJT8,24 which contains the match site 5'-TAGTATT-3' and the mismatch site 5'-
TAGTACT-3' (Table 5.2) . The affinity and specificity observed for polyamide 17 was 
strikingly similar to the published values for 22.24 
Discussion 
In the course of developing an aminooxy linker route to C-terminal primary amide 
polyamides (5 and 21) an unexpected reaction was uncovered, which resulted in cleavage 
of the polyamide from the resin and replacement of the aminooxy linker with a cyclic 
secondary amine. The direct transamidation of a hydroxamic ester to a tertiary amide is 
unprecedented in the literature. Intermolecular transamidations usually take place only at 
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highly elevated temperatures, and very few transamidations of hydroxamic esters at any 
temperature are known. 25.29 However, the primary aminooxy group may be a better 
leaving group than it is generally considered. 3D For example, Canne et al. found that a 2-
chlorobezyloxy (2-CI-Z) protecting group on an aminooxy acetyl group was 
unexpectedly sensitive to nucleophilic attack, as the 2-CI-Z group was deprotected by 
mercaptoethanol.31 The closest reaction in the literature to the resin cleavage observed 
here is the ring-opening of diacetyl-D-cycloserine, in which a highly activated acetylated 
hydroxamic lactam reacts very rapidly with n-butylamine in water at room temperature to 
give the ring-opened butylamide.29 However, note that a large excess of the primary 
amine Dp at 37°C or 95 °C was far less effective in the present case than a large excess 
of cyclic secondary amine in DMF at room temperature. Preliminary studies with model 
substrates such as 13 have not shown evidence of replacement of an aminooxy group by a 
cyclic secondary amide, suggesting that the mechanism of the unexpected resin cleavage 
is likely more complex than direct transamidation. This unusual and potentially novel 
reaction warrants further study, especially in the context of the growing use of aminooxy 
acids as peptidomimetics. 
Whatever the mechanism of the unexpected cleavage, the reaction was fortuitous 
in that C-terminal cyclic tertiary ami des would have been low on the list of new hairpin 
polyamide tails to synthesize. Firstly, there is no longer a proton on the amide for 
hydrogen bonding with the minor groove acceptor functionalities. Secondly, several 
studies have demonstrated that steric bulk at the C-terminal side of a hairpin polyamide is 
deleterious for binding and specificity.32'35 However, in retrospect, all of these studies 
place substituents on the N-terminus, which presumably clash with the ~-Dp tail. The 
loss of a hydrogen bond may be compensated by favorable Van der Waals interactions 
within the minor groove. The difference between morpho line and piperidine may be a 
negative steric interaction of the extra set of piperidine hydrogens, or the result of 
conformational preferences of the ring as a whole. As expected, piperazine is preferred 
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by the negatively charged minor groove. The toleration of cyclic non-aromatic six-
membered rings at the C-terminus raises allows one to envision hairpin dimers and 
conjugates with significantly different kinds of linkages than were previously envisioned. 
It is expected that the C-terminal cyclic tertiary amide polyamides will be extremely 
selective for A,T against G,C at the N-1 position (see Figure 5.1). On the other hand, 
they may be compact enough not to interact with the N-2 position. This would be a very 
desirable set of properties, and warrants further investigation. It will also be interesting 
to see if C-terminal acyclic tertiary amides, such as dimethyl- or diethylamide would bind 
with similar affinity. Also of note is that given their binding site on the HER2 promoter, 
compounds 16-18 are expected to inhibit both TBP- (Chapter 3) and ESX-binding.22 
These potential inhibitors of HER2 transcription may display different uptake and nuclear 
localization properties than standard P-Dp hairpins, while maintaining favorable DNA 
binding properties. While the aminooxy route to the new C-terminal tails is interesting 
in-and-of-itself from a chemical point of view, from a practical point of view the 
development of polyamide synthesis on oxime resin should allow for the facile 
production of these and other unexplored derivatives. 
Experimental 
Carboxymethoxylamine hemihydrochloride, morpholine, and piperazine were 
purchased from Aldrich. All other materials were as previously described.9.19.2o High 
resolution electrospray ionization mass spectrometry was carried out at the University of 
California, Los Angeles Mass Spectrometry Facility. All other procedures and 
equipment were as described in Chapter 5A. 
Boc-Pyrrole-Aminooxy acid (13). 1,2,3-Benzotriazol-1-yl 4-[(tert-butoxy-
carbonyl)amino]-1-methylpyrrole-2-carboxylate9 (5) (3.56 g, 10 mmol) and carboxy-
methoxylamine hemihydrochloride (1.09 g, 10 mmol) were dissolved in DMF (50 mL). 
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DIEA (7 mL, 40 mmol) was added and the mixture was stirred at room temperature for 
10 hours. The solution was concentrated in vacuo and the resulting oil was partitioned 
between 250 mL saturated NaHC03 and 250 mL ether. The aqueous layer was acidified 
to pH 3 with concentrated HCl, and extracted with EtOAc (2 x 600 mL). The combined 
ethyl acetate extracts were concentrated in vacuo to 200 mL and washed with 0.1 N HCl 
(2 x 400 mL). The organic layer was dried over N~S04' and concentrated in vacuo to 
yield 4 as a yellow oil (2.64 g, 8.43 mmol, 84% yield): JH NMR (DMSO-d6) 0 11.40 (s, 
IH), 9.06 (s, lH), 6.93 (s, 1H), 6.57 (s, lH), 4.40 (s, 2H), 3.71 (s, 3H), 1.41 (s, 9H); 
ElMS rnJe 313.1278 (313.1274 calc. for CJ3HJ9N306). 
ImlmPy-(R)H2N'Y-ImPyPyCONH2 (5). Boc-/3-Ala-PAM resin (1 g, 0.25 mmol/g) 
was deprotected with 80% TFAlDCM and 0.4 M PhSH. Boc-pyrrole-hydroxamic ester 4 
(313 mg, 1 mmol) was activated by treatment with DCC (206 mg, 1 mmol) and N-
hydroxysuccinimide (116 mg, 1 mmol) in 2 mL DMF for one hour. The solution was 
filtered and added to the resin, 1 mL of DIEA was added and the mixture was shaken at 
room temperature for six hours to yield Boc-Py-CONHOCH2CO-/3-Ala-PAM resin (14), 
which was elaborated to ImIrnPy-(R{mOcHNy-IrnPyPyCONHOCH2CO-/3-Ala-PAM resin in 
a stepwise fashion by manual solid phase synthesis.9.I 9 A sample of the polyamide resin 
(155 mg) was treated with 160 mg Pd(OAc)2in 2 mL DMF. The mixture was shaken at 
37° C for 2 hours, 600 mg of HC02NH4 in 900 !J,L H20 was added, and shaking at 37° C 
continued for seven hours. The reaction mixture was filtered and diluted to 8 mL with 
0.1 % (w/v) TFA, and the crude polyamide was purified by reverse-phase HPLC as 
previously described. 9 ImIrnPy-(R)H2Ny-ImPyPyCONH2 (302 !J,g, 360 nmol , 1.2% 
recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder. Spectroscopic analysis confirmed this product was identical to 5 produced by 
the oxime resin route (Chapter 5A). 
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ImPypypy-(R)H2Ny-PyPyPyPyCO-piperidine (16). Resin 14 was elaborated to 
ImPyPyPy-(R)FmOCHNy-PyPyPyPyCONHOCH2CO-~-Ala-PAM resin (15) in a stepwise 
fashion by manual solid phase synthesis.9.19 A sample of polyamide resin 15 (100 mg) 
was treated with 1 mL piperidine in 2 mL DMF. The mixture was shaken at room 
temperature for one hour. The reaction mixture was filtered and concentrated in vacuo, 
then purified by reverse-phase HPLC as previously described.9 ImPyPyPy_(R)H2Ny_ 
PyPyPyPyCO-piperidine (92 fJ.g, 80 nmol, 0.42% recovery) was recovered upon 
lyophilization of the appropriate fractions as a white powder: UV (HzO) Amax 312 (69520); 
MALDI-TOF-MS 1148.60 (1148.52 calc for [M+H] CS6H6SNI90 9)' 
Impypypy-(R)H2Ny-PyPyPypyCO-morpholine (17). A sample of polyamide 
resin 15 (100 mg) was treated with 1 mL morpholine in 2 mL DMF. The mixture was 
shaken at room temperature for one hour. The reaction mixture was filtered and 
concentrated in vacuo, then purified by reverse-phase HPLC as previously described.9 
ImPyPyPy-(R)H2Ny-PyPyPyPyCO-morpholine (121 fJ.g, 105 nmol, 0.55% recovery) was 
recovered upon lyophilization of the appropriate fractions as a white powder: UV (H20) 
Amax 316 (69520); MALDI-TOF-MS 1150.60 (1150.50 calc for [M+H] CSSH63NIPIO)' 
Impypypy-(R)H2Ny-PyPyPyPyCO-piperazine (18). A sample of polyamide 
resin 15 (100 mg) was treated with 3 mL 1 M piperazine in DMF. The mixture was 
shaken at room temperature for one hour. The reaction mixture was filtered and 
concentrated in vacuo, then purified by reverse-phase HPLC as previously described.9 
ImPyPyPy-(R)H2Ny-PyPyPyPyCO-piperazine (138 fJ.g, 120 nmol , 0.63% recovery) was 
recovered upon lyophilization of the appropriate fractions as a white powder: UV (H20) 
Amax314 (69520); MALDI-TOF-MS 1149.50 (1149.52 calc for [M+H] CSSH64N2009)' 
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Quantitative DNase I Footprinting. As previously reported ,23 for DNA 
fragments derived from the HER2 promoter22 and plasmid plT8.24 
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